1. Prenatal Stressors as Risk Factors for ADHD
Author: Ulrich Brennecke
Review (June 2024): Waldemar Zdero, M.A. in Psychology
Even before birth, the unborn child can be harmed by toxic influences or diseases.
Many toxins and diseases that increase a child’s risk of ADHD do so by affecting the dopaminergic system. Toxins can also increase the risk of ADHD even before conception through epigenetic mechanisms.
Mental and physical stress (toxins, illnesses) generally have a similar effect on the stress systems (HPA axis, autonomic nervous system, and others).
The percentage values listed for a potential increase in ADHD risk indicate the magnitude of the impact of the respective risk factor. For entries without a percentage value, we have no known figures.
The use of nicotine, alcohol, or harder drugs during pregnancy increases the risk of ADHD in children. Nicotine increases the risk even if the parents smoked only before conception.
Another source of risk is toxins to which the mother is exposed during pregnancy. These include pesticides such as organophosphates and pyrethroids, as well as chemicals such as lead, cadmium, thallium, bisphenols, polychlorinated biphenyls, and polycyclic aromatic hydrocarbons.
Air pollution, particularly fine particulate matter and nitrogen oxides, can also increase the risk of ADHD.
A high salt intake by the mother during pregnancy can increase the unborn child’s sensitivity to stress.
Various maternal health factors, such as illness, obesity, stress, infections, and hormonal disorders, are also associated with an increased risk of ADHD in the child. Thyroid hormone levels, in particular, should be closely monitored. Higher levels of omega-3 fatty acids in newborns may reduce the risk and severity of ADHD and autism spectrum disorders. Vitamin D3 deficiency during pregnancy and after birth is associated with dopaminergic abnormalities in the brain.
High cortisol exposure in the fetus or newborn—whether due to cortisol administration or the mother’s stress during pregnancy—can also increase the risk of ADHD.
It is well known that many medications can pose a risk to the unborn child during pregnancy. With regard to ADHD, paracetamol (acetaminophen), SSRIs (antidepressants), β-2-adrenergic receptor agonists, pregabalin, antibiotics, and valproate are of particular relevance during pregnancy.
Finally, factors related to the pregnancy—such as whether the child is the firstborn or whether the interval between this pregnancy and the previous one was particularly short or long—influence the child’s risk of ADHD.
Higher prenatal stress appeared to promote slower brain development during adolescence only in individuals with a higher genetic susceptibility to ADHD (with a higher polygenic risk score for ADHD), whereas prenatal stress promoted faster brain development in individuals with a lower genetic susceptibility to ADHD.1 Animal studies may provide further insights.
There appear to be gender differences with regard to some of these risk factors.
A cohort study found that 78% of all children were exposed to at least one prenatal risk factor. The number of prenatal risk factors correlated in a dose-dependent manner2
- with an increased risk of clinically significant psychopathology according to the CBCL
- The increased risk of ADHD diminished with age
- The increased risk of depressive symptoms rose over time
- with accelerated age-related cortical thinning in 36 of 68 cortical regions
- with higher total CBCL scores and accelerated cortical thinning in 5 cortical regions among siblings
It remains unclear to what extent the factors mentioned are causal (responsible for) ADHD. Many of these factors could also be consequences of genetic causes passed from the mother to the child, which affect the mother just as much as they do the child. For example: Is a mother’s smoking during pregnancy the cause of ADHD in her child, or is it a consequence of the mother’s genes, which she simultaneously passes on to the child? Methods that can help clarify this include prenatal cross-fostering studies (egg and embryo donation from unrelated donors), studies on prenatal cross-fostering (surrogacy involving an unrelated surrogate mother), children of identical twins, multiple pregnancies by the same mother under different environmental conditions (e.g., with and without smoking), or comparisons between mothers and fathers.3 In this context, animal studies should be considered, as they allow for comparisons that are ethically prohibited in humans.
The percentage values indicate the potential increase in ADHD risk associated with each cause.
By way of comparison: Genetic Variants and ADHD
For comparison, here is the prevalence of a small selection of ADHD risk gene variants.4 Unfortunately, it is not always clear whether the percentage indicates the change in the frequency of the gene polymorphism in ADHD or the change in the risk of ADHD in the presence of the gene polymorphism.
Dopaminergic genes:
- Dopamine beta-hydroxylase
- DRD4
- DRD5
- DRD3
- rs6280: no significant correlation (meta-analysis, k = 6)6
- DRD2
- DAT1/SLC6A3
- 2R: +25% (meta-analysis, k = 5)6
- rs27072: +20% (meta-analysis, k = 7)6
- 10R (= 480 bp): ADHD risk +17% (meta-analysis, k = 18, N = 1,373, p = 0.004)13, + 13% (meta-analysis)5, + 12% (meta-analysis, k = 34)6, + 4%7, no correlation11
- rs6347: no significant correlation (meta-analysis, k = 6)6
- No correlation for DAT1/SLC6A31210
Noradrenergic Genes:
- NAT/SLC6A2
- ADRA2A
Serotonergic Genes:
- 5HTTLPR/SLC6A
- HTR1B
- HTR2A
- Tryptophan hydroxylase 1
- rs1800532: no significant correlation (meta-analysis, k = 4)6
- Tryptophan hydroxylase 2
Other genes:
- MAOA:
- /+ 94% among Han Chinese15
- CHRNA4
- SNAP-25
- BDNF
- rs6265: no significant correlation (meta-analysis, k = 8)6
- COMT
- rs4680: no significant correlation (meta-analysis, k = 16)6
To identify statistically significant genetic variants, the standard significance threshold of 0.05 must be significantly raised, since—given the more than 10 million genetic variants—this threshold would result in the identification of 250,000 to 500,000 SNPs that are significant by chance. Therefore, a p-value of 5 × 10⁻⁸ was set (= 5e-8 = 0.00000005).4
Although the following list is extensive, there are likely many other factors associated with an increased risk of ADHD.
Each of these factors represents only a part of a complex mosaic of risk factors and does not automatically lead to ADHD.
We have begun to identify the possible mechanisms through which environmental factors can cause ADHD.
1.1. Preconception Exposure to Toxins as a Risk Factor for ADHD—Epigenetic Inheritance
1.1.1. Nicotine use by a parent before conception (+259%)
Children whose fathers smoked before their mothers became pregnant were 2.59 times more likely to have ADHD than children whose fathers had never smoked.
Children whose parents were exposed to smoking or secondhand smoke before pregnancy had a 1.96-fold increased risk of ADHD.
Children whose parents were exposed to tobacco smoke both before and during pregnancy had a 2.01-fold increased risk of ADHD.16
Signal transduction pathway: Epigenetics
Parental Nicotine Use Before Conception: Epigenetic Inheritance of Nicotine-Induced Damage Causes ADHD Symptoms in Offspring Across Multiple Generations
Mice whose fathers or mothers were chronically exposed to nicotine prior to conception exhibited hyperactivity, impaired nicotine-induced motor sensitization, and reduced dopamine and norepinephrine levels in the striatum and PFC.1718 19 They also exhibited depressive20 and anxious21 behavior.
Nicotine use by the father or mother before conception causes epigenetic changes in their offspring
- the dopamine D2 receptor.22
- the dopamine transporter (DAT) in the striatum and mPFC23
- altered expression and dysfunction of nicotinic acetylcholine receptors (nAChRs)23
- Hypersensitivity to nicotine-induced nAChR-mediated dopamine release23
The first- and second-generation children exhibited impairments typical of ADHD:
1st Generation:
- significantly increased spontaneous motor activity (hyperactivity) (males and females)2223
- The reduced DAT expression led to increased dopamine levels in the striatum, which, through activation of D2 receptors, caused the dephosphorylation of AKT, leading to increased activation of GSK3α/β and ultimately caused hyperactivity in the mice’s offspring.24
- risk-taking behavior23
- Significant deficits in reversal learning (males and females)22
- Significant attention deficits (boys)22
- significantly reduced levels of monoamines in the brain (males)22
- reduced dopamine receptor mRNA expression (males)22
- increased preference for nicotine23
- Altered activity rhythm23 Note: This could be related to the altered circadian rhythm seen in ADHD
2nd generation:
- Significant deficits in reverse learning (Männchen)22
- Hyperactivity23
- risk-taking behavior23
- increased preference for nicotine23
- Change in activity pattern23
It can be assumed that the mechanisms are similar to those in humans.
1.1.2. Parental drug use prior to conception (+44%)
Maternal drug use (heroin, amphetamine, ketamine, or other substances) prior to conception was associated with an increased risk for the offspring (registry study, N = 1,969,006)26
- by 43% to 45% for ADHD
- by 5% for ASA
- by 18% to 21% for intellectual disabilities
Dopaminergic drugs taken before conception increase ADHD symptoms in offspring up to the second generation. This suggests an epigenetic mechanism.
- Long-term methamphetamine use causes epigenetic changes in mice27
- MPH administered in injectable form over a 3-week period starting at 6 weeks of age in male ICR mice (not ADHD model animals) causes ADHD symptoms in their offspring
1.1.3. Penicillin use up to 2 years before conception
A mother’s use of penicillin increased the child’s risk of ADHD even if the penicillin was taken 2 years before pregnancy. Repeated use of penicillin further increased the risk of ADHD.30
Possible mechanism of action: gut microbiome
Antibiotics affect the gut microbiome. The gut microbiome is passed from the mother to the newborn during vaginal birth and breastfeeding (especially during the first three months). See there.
1.1.4. Silver nanoparticles across 4 generations
Offspring of rats that were administered silver nanoparticles orally were bred to exhibit 1.8 times the level of hyperactivity within four generations through the selection of hyperactive individuals.31 The offspring appeared to maintain hyperactivity across generations via DNA methylation status in the mesencephalon.
It is unclear to us whether the increased hyperactivity in the fourth generation is a consequence of breeding or a consequence of the silver nanoparticles.
1.1.5. Few green spaces in the surrounding area before conception (+6%)
Exposure to green spaces prior to conception was associated, for each interquartile increase (IQR = 0.12) in the green space index within the ZIP code area, with a reduced risk of:32
- ADHD: down 6%
- ASS: down 7%
- Learning difficulties: down 11%
- intellectual disability: minus 16%
- Behavioral disorders: down 11%
1.2. Toxins and Adverse Effects During Pregnancy (up to +778%)
Toxic effects on the unborn have been demonstrated for:
1.2.1. Alcohol During Pregnancy (up to +778%)
About 5% of children in the U.S. are believed to have FASD, meaning they have been harmed by their mother’s alcohol consumption during pregnancy.33
The vast majority of studies conclude that maternal alcohol consumption during pregnancy significantly increases the likelihood of ADHD in children.3435 up to 8.78 times,36 Attention problems are also more common.37 In rats, male offspring are particularly affected.38
A combination of alcohol and stress in the mother during pregnancy increased the likelihood that male rats would develop more feminine sexual behavior.39
Among children with FAS (fetal alcohol syndrome), 47.2% also had ADHD.40
In a Taiwanese cohort study of 5-year-old children, the risk of ADHD was 71% higher, although this increase was not statistically significant.41
There is evidence that a mother’s alcohol consumption during pregnancy or while breastfeeding has significant effects on the child’s dopamine system.4243 44 45 The regulation of the neurotransmitters serotonin46, glutamate, norepinephrine, acetylcholine, and histamine is also affected.47 48
Some studies found no association between:
- Alcohol consumption during pregnancy and ADHD.495051
- Binge drinking during early pregnancy and the risk of ADHD in children aged 5 to 19.52
A study found a correlation between ethoxyacetic acid (one of six alcohol metabolites examined) in the mother’s urine and behavioral problems in children.53
A meta-analysis found that maternal alcohol consumption of less than 70 g/week during pregnancy did not increase the risk of ADHD.54 Boys were at lower risk from alcohol exposure during pregnancy than girls.
Neill et al. focus on the differential diagnosis of ADHD and FASD (Fetal Alcohol Spectrum Disorder).55
Mechanisms of action, including:
1.2.2. Nicotine During Pregnancy (up to +478%)
1.2.2.1. Maternal nicotine use during pregnancy (+49% to +478%)
Prenatal smoking is associated with an increased risk of ADHD in children5859 60 on the
- A 5.36-fold increase (436% higher) in the risk of61, as well as an increased risk of bipolar disorder by 533%, major depression by 92%, and anxiety disorder by 3%. Not significantly increased: ASA and schizophrenia.
- 4.78 times (a 378% increase)36
- 3.34 times higher among the 10% of mothers who smoke the most62
- 2.7 times (an increase of 170%)63
- 2.5 times (increased by 150%)64
- 2.33 times higher (+133%) for smoking during pregnancy and for one year afterward; no statistically significant increase in the risk of ASS (cohort study covering 25 years, N = 16,365).65
- 2.21 times higher in cases of heavy nicotine exposure (cotinine level > 50 ng/ml)62
- 2.11 times (cohort study, N = 5,548)66
- 4.18 times higher for girls
- 1.64 times higher for boys
- 1.75 times higher among heavy female smokers67
- 1.60 times higher (a 60% increase) on average among female smokers67
- 1.58 times (a 58% increase; meta-analysis, N = 17,304)68
- 1.54 times higher among light female smokers67
- 1.5 times higher, even with secondhand smoke, but only for boys69
- 1.5 times (here: risk of hyperactivity/impulsivity symptoms in the child)69
- 1.49 times70
- 1.42 times higher in preschoolers, dose-dependent71
- 1.34-fold (OR) in a meta-analysis of k = 10 studies with N = 7,014; for CD and ODD, an OR of 2.19 was found in each case72
- 1.09-fold (OR) when the mother’s socioeconomic status, maternal age, maternal psychopathology, paternal age, paternal psychopathology, and the child’s birth weight for gestational age were taken into account
- No statistically significant association in a relatively small study (N = 142, n = 26)73
Other studies also found significantly elevated risk levels.74757618777879
Children with ADHD were more likely to have mothers who had smoked during pregnancy:
Two studies (with overlapping authors)383 , a study with a small sample size84, a larger study51, and a meta-analysis reached a different conclusion85; one study found rather weak evidence.86
Studies that distinguished between maternal smoking during pregnancy and genetic influences found no evidence of a causal effect of prenatal smoking on the risk of ADHD.87
However, there are several arguments against this:
- Mice exposed to nicotine prenatally serve as an animal model for ADHD8889 90 91 In addition, prenatal nicotine exposure in the mouse model leads to reduced birth weight in offspring92, which constitutes a risk factor for ADHD in its own right.
- Studies have examined the link between prenatal smoking and certain genetic polymorphisms:
- In the absence of genetic risk factors, maternal smoking during pregnancy increases the child’s risk of ADHD by 20 to 30 percent.
- Risk genes alone (if the mother does not smoke during pregnancy) increase the risk by 20 to 40 percent.
- However, when risk genes and maternal smoking during pregnancy occur together, the child’s risk of ADHD increases significantly:
- The risk of ADHD in children of mothers who smoke was slightly reduced when the mothers quit smoking:96
- Overall risk compared to the offspring of nonsmoking women:
- ADHD: OR = 2.07 = 207%, learning disability: OR = 1.93 = 193%
- when quitting smoking during the first trimester
- ADHD: OR = 1.72 = 172%, learning disability: OR = 1.52 = 152%
- when quitting smoking during the second or third trimester
- ADHD: OR = 2.13 = 213%, learning disability: OR = 1.82 = 182%
- not quitting smoking
- ADHD: OR = 2.17 = 217%, learning disability: OR = 2.10 = 210%
- Overall risk compared to the offspring of nonsmoking women:
- In rodents, nicotine consumed even before conception causes ADHD in offspring, and this ADHD is passed down epigenetically across several generations (see above)
The rate of smoking among pregnant women has been declining for a long time. Between 1959 and 1966, 59% of all pregnant women are said to have smoked.87 In Germany, the rate of mothers who smoked during pregnancy fell from 19.9% between 1996 and 2006 to 10.9% between 2007 and 2016.9798 In the U.S., the prevalence of smoking during pregnancy fell from 15.2% in 2000 to 13.8% in 200599 and to 7.2% in 2021 100 or to 5.4% based on self-report (which is subject to social desirability bias).101
The prevalence of smoking after childbirth fell from 18.1% in 2000 to 16.4% in 200599 and to 7.2% in 2021 after childbirth; 12.1% reported having smoked before pregnancy, based on self-reports.101
Smoking during pregnancy is also associated with a lower level of education (2008: 4.3% among those with a high school education, 36% among those without a high school education) and a low socioeconomic status (2008: 7.4% among those with an annual income of 40 TUSD or more, 18.7% if annual income is at or below 150% of the poverty line)102, both of which are, in turn, risk factors for ADHD.
Nevertheless, more than 70 million women in the EU smoked during pregnancy in 2020.103
There are no studies examining the extent to which the decline in smoking during pregnancy has influenced the prevalence of ADHD. While there are studies comparing the development of emotional problems over a 20-year period104, we have not yet found any such study that explicitly addresses ADHD. Since awareness of ADHD has increased significantly today, it will be difficult to compare prevalence rates retrospectively. Furthermore, while smoking during pregnancy is strongly correlated with ADHD, it is not the sole cause of the disorder, so conclusions suggesting that the declining rate of smoking during pregnancy has had no impact on ADHD rates4 are, in our view, so difficult to substantiate that they can barely be used as an argument against a causal link between smoking during pregnancy and ADHD.
While the correlation between smoking and depression was still weak in 1952 and 1970, by 1992 the risk of depression among smokers was three times higher than among nonsmokers.105 Participants who became depressed were more likely to start smoking, were more likely to continue smoking, and were less likely to quit.
Mechanisms of action:
Most experiments on prenatal nicotine exposure show a reduction in dopamine levels in the PFC and striatum.90 Under certain circumstances, elevated dopamine levels have also been observed.106 Neurophysiologically, ADHD is closely associated with reduced dopamine levels in the dlPFC (impaired working memory) and the striatum (impaired motivation and motor hyperactivity).
This should be distinguished from smoking by people with ADHD—which increases dopamine levels (at least in the striatum), as it reduces DAT, which is overly active in ADHD and lowers extracellular dopamine levels in the striatum. Acute smoking thus increases dopamine levels in the striatum.
Prenatal Nicotine
- reduces birth weight92, which is a risk factor for ADHD in its own right.
- increases the risk of apnea and hypoxia107
- delays brain development108.
- increases the risk of birth complications109110 , which is a risk factor for ADHD in itself.
Maternal smoking during pregnancy alters glutamate NMDA receptors in the laterodorsal tegmentum of offspring.111 Another study also found changes in glutamatergic signaling in the hippocampus due to increased glutamate receptor expression,103, which was associated with learning difficulties, attention problems, and increased impulsivity.
ProBDNF proteolysis is disrupted by an imbalance between proBDNF and BDNF and by the downregulation of furin, the enzyme responsible for processing proBDNF. Glucocorticoid receptor activity is altered by a reduced relative nuclear localization of GR. Basal plasma corticosterone levels are decreased. The HPA axis is disrupted. This affects not only the offspring themselves but also their children, meaning it is passed down through generations.112
A study of mice whose mothers were exposed to nicotine during pregnancy found evidence that nicotine exposure during pregnancy causes various consequences that persisted into the grandchild generation, suggesting epigenetic inheritance:113
- Deficits in the expression of corticostriatal DNA methyltransferase 3A (DNMT3A)
- Downregulation of methyl-CpG-binding protein 2 (MeCP2) in the frontal cortex and hippocampus
- Downregulation of histone deacetylase 2 (HDAC2) in the frontal cortex and hippocampus
- Abnormalities in HDAC2 (Ser394) phosphorylation in the frontal cortex, striatum, and hippocampus
- No change in the expression of Ten-Eleven translocase methylcytosine dioxygenase 2 (TET2)
- No abnormalities in MeCP2 (Ser421) phosphorylation in the frontal cortex, striatum, and hippocampus
Maternal smoking increases fetal testosterone levels.114 Elevated prenatal testosterone levels are a risk factor for ADHD. For more information, see Gender Differences in ADHD.
Compared to other environmental factors, maternal smoking was associated only with ADHD, but not with autism alone. A history of psychiatric disorders in the parents showed similar associations with all subgroups. Living in an urban area was most strongly associated with autism and ADHD and least strongly associated with ADHD alone.115
It is possible that the effects of a mother’s nicotine use during pregnancy could be offset by breastfeeding.116
1.2.2.1. Secondhand Smoke During Pregnancy
Even secondhand smoke—that is, a mother’s passive exposure to tobacco smoke during pregnancy—increases the risk that her unborn child will develop ADHD symptoms later in life.69
Similar findings were reported regarding the link between secondhand smoke and developmental coordination disorder (DCD).118
Secondhand smoke exposure during pregnancy, combined with maternal stress during the child’s fifth year of life, increased the risk of attention problems at age 7.119
A study found no evidence of a correlation.84
1.2.3. Polycyclic aromatic hydrocarbons (PAH) (+99 to +406%)
Prenatal exposure to polycyclic aromatic hydrocarbons appears to exacerbate the damage caused by early childhood stress and contribute to later attention and memory problems.120
High prenatal PAH exposure was correlated with
- Attention symptoms121 according to DSM-IV (OR = 5.06, +406%)122. dose-dependent123
- Total ADHD score according to DSM-IV (OR = 3.37, +237%)122124
- Anxiety and Depression121125
A meta-analysis found that four studies by one author suggested a 1.57-fold increase in the risk of ADHD associated with PAHs (OR 2.57), while the combined results of all studies suggested a twofold increase in risk (OR 1.99), although this was not statistically significant.126
PAHs enter the body through microplastics and nanoplastics, among other sources.127
1.2.4. Lead Exposure During Pregnancy (up to +243%)
Lead exposure during pregnancy128129 130 affects the mesocorticolimbic circuit and increases the risk of ADHD in children.131
Female rats were exposed to acute stress and lead during pregnancy. The effects on their offspring differed depending on whether the exposure was to lead alone or to lead combined with stress. Male rat pups showed elevated corticosterone levels and reduced dopamine levels in the PFC only when exposed to lead alone, while female rat pups showed these changes only when exposed to a combination of lead and stress. Even short-term lead exposure of the mothers caused this effect.132 In female rat pups, maternal lead exposure and stress during pregnancy contributed to learning difficulties as cumulative factors. Neurophysiologically, these effects were mediated by the glucocorticoid system acting on the mesocorticolimbic system.133
A doubling of lead levels in umbilical cord blood increased hyperactivity by a factor of 3.43 (+243%) at ages 7 to 8 only among boys, while girls showed no significant association.134
Other studies have also found evidence that lead exposure, like stress during pregnancy, impairs the mesocorticolimbic dopamine/glutamate system in female offspring (to a lesser extent in males) and that these effects potentiate each other.135 Under similar conditions, male rat pups showed a tendency toward serotonergic disorders of the mesocorticolimbic system and altered delay discounting.136
Even lead levels in drinking water that are below the limits are said to be problematic.129
In general, lead water pipes pose little danger in areas with hard water, since the calcium deposits form a reliable protective layer inside the pipes. However, in such cases, a water softener must not be installed for the drinking water. Nevertheless, it is generally recommended to replace lead-containing water pipes during renovations.
In ADHD, metabolism may be altered with regard to cobalt, copper, lead, zinc, and vanadium. Reduced cycle stability (determinism), duration (mean diagonal length), and complexity (entropy) of the exposure profiles were observed.137
Lead is a divalent cation that mimics Ca2+ and activates PKC signaling.138
Arnsten139 describes lead as a toxin that causes symptoms that can be mistaken for ADHD.
Mechanisms of action:
Lead appears to have a number of harmful neurophysiological effects, which, among other things, also affect the dopaminergic system:
- Impairment of the mesocorticolimbic dopaminergic system140
- Impairment of dopamine receptors140
- Impairments in attention regulation in the PFC141
- Apoptosis142
- Excitotoxicity142
- Reduced cellular energy metabolism142
- Impaired heme biosynthesis and anemia142
- Oxidative stress142
- Lipid peroxidation142
- Altered activity of the second messenger system142
- Altered neurotransmitter release142
- Altered neurotransmitter receptor density142
- Impaired neuropsychological functioning142
- Impaired development and function of oligodendrocytes142
- Abnormal myelination142
- Abnormal expression of neurotrophic factors142
- Abnormal dendritic branching patterns142
- Disorder of the blood-brain barrier142
- Disorder in transport of thyroid hormones to the brain142
- Altered regulation of gene transcription142
- Reduction in gray matter volume in the PFC, particularly in the ACC143
Lead also appears to be capable of triggering the following behaviors:
- Impulsivity141
- sociopathic behavior144145
- irresponsible behavior144145
- criminal behavior144145
- Lower IQ142
- Impaired academic performance142
In the United States, lead poisoning is strongly correlated with crime rates and out-of-wedlock pregnancies.144145
Children with elevated blood lead levels are said to be particularly vulnerable to other toxins during early childhood.146 In particular, warnings have been issued about lead in wall paint. During pregnancy, lead can be transferred from the mother to the child through the placenta.
1.2.5. Pesticides During Pregnancy (up to +171%)
1.2.5.1. Exposure to Organochlorine Compounds During Pregnancy (up to +171%)
Exposure to hexachlorobenzene during pregnancy increased the risk of ADHD among Spanish children between 1997 and 1999. Children with HCB concentrations of more than 1.5 ng/ml at birth showed an increased risk of social skills problems (RR = 4.04; +304%) and ADHD (RR = 2.71; +171%). Cognitive and psychomotor performance remained unaffected.147
A large study of 7 European birth cohorts found no correlation between HCB or DDE (a breakdown product of DDT) during pregnancy or the first 2 years of life and ADHD.148 Another study found that a doubling of p,p’-DDE in umbilical cord blood was associated with a 4.71-fold increase in scores on the Strengths and Difficulties Questionnaire at ages 7 to 8 among girls only, while boys showed no significant association.134
Children of mothers with high serum HCB levels in the first trimester (≥90th percentile) (but not those whose mothers were exposed to HCB during pregnancy) showed the following at age 4:149
– impaired perceptual performance
- impaired general cognitive abilities
- impaired executive functions
- impaired working memory
Organochlorine compounds (dichlorodiphenyltrichloroethane (DDT), dieldrin, heptachlor, endosulfan) have been shown to affect neural development following prenatal exposure (in rodents), for example:150
- DAT increased
- Increased dopamine reuptake
- Loss of dopaminergic cells
- Changes in key dopaminergic proteins at the presynapse in response to organochlorine pesticides in the striatum or substantia nigra
- Norepinephrine increases
- Increased serotonin
- Reduced GABA receptors
- Reduced NMDA receptors
- Altered mGluR5 receptors
- altered GABAergic, glutamatergic, and dopaminergic responses to endosulfan in the PFC
- Altered dopaminergic responses to heptachlor exposure identified
with disabilities affecting, among other things:
- Attention processes
- cognitive ability
- Memory
- Social Development
- cognitive and psychomotor development
- Fine motor skills
- Reflexes
- visual processing
Organochlorine compounds were, however, primarily associated with ASS.
Organochlorine compounds are believed to have been largely replaced by organophosphates commercially by the end of the 2010s, but they are very persistent and therefore still present in the environment.4
1.2.5.2. Exposure to Organophosphates During Pregnancy
The organophosphates chlorpyrifos and diazinon had significant effects on brain development in newborns, including the dopaminergic system.151 Prenatal exposure to the widely used pesticide chlorpyrifos impaired IQ and working memory in 7-year-old children152153 as well as executive functions.154
Organophosphates inhibit acetylcholinesterase (the enzyme that breaks down acetylcholine).150 In addition to the well-known downregulation of cholinergic receptors, the organophosphate diisopropyl fluorophosphate (DFP) has been reported to increase dopamine and GABA receptors. A single dose of 1 mg/kg DFP resulted in elevated dopamine levels, while a single toxic dose of 2 mg/kg DFP led to increased dopamine breakdown. After 6 hours, the levels had returned to normal. Chronic administration of 1 mg/kg DFP resulted in reduced dopamine levels after 1 and 2 weeks, which returned to normal with continued administration. A single dose of DFP increased dopamine turnover in the striatum of rats, while chronic administration decreased it. The authors hypothesized that the changes in dopamine and GABA levels might be consequences of the downregulation of cholinergic receptors.155
Chlorpyrifos disrupts the serotonin system. Exposure during pregnancy can cause tremors in children and impair their cognitive and neurobehavioral development.39
A study based on prenatal urinary dialkyl phosphate metabolites (diethyl phosphate and dimethyl phosphate), as well as an analysis of the maternal PON1 gene variants Q192R and L55M, found no association between the mother’s exposure to organophosphates during pregnancy and the child’s subsequent ADHD.156
A Norwegian cohort study found an increased risk of ADHD in children when the following were detected in the mother’s blood during pregnancy:157
- Di-n-butyl phosphate (DnBP)
- Bis(1,3-dichloro-2-propyl) phosphate (BDCIPP)
- Bis(2-butoxyethyl) phosphate (BBOEP)
- Only in boys. In girls, the risk decreases as the level of exposure increases.
Higher levels of vitamin D in the mother appear to reduce the negative effect of the organophosphate chlorpyrifos on the risk of ADHD in their children.158159
Chlorpyrifos inhibits FAAH, an enzyme that breaks down endocannabinoids. As a result, chlorpyrifos causes changes in exploratory and social behavior in young rats during puberty.160
Another Norwegian registry study found no evidence of an increased risk of ADHD in children when the mother was exposed to organophosphates during the 17th week of pregnancy.161
1.2.5.3. Exposure to pyrethroids before or during pregnancy (up to +76%)
Pyrethroids are widely used as insecticides and pesticides.
Each doubling of the pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA) in the mother’s urine during the 28th pregnancy week increased the child’s risk of ADHD by 3% and the risk that any ADHD diagnosis would fall among the 10% of the most severe ADHD cases by 13%.162
The pyrethroid deltamethrin appears to impair the dopaminergic system in mice following early exposure:163
- DAT reduced
- Reduced D1 receptor
- Apoptosis
The pyrethroid deltamethrin impairs long-term potentiation (LTP) at CA3-CA1 synapses in the hippocampus, a functional correlate of learning and memory.164
Furthermore, (in cases of prenatal, but not postnatal, exposure)165 permanent behavioral changes were observed with regard to:163
- Physical activity
- acoustic startle reflex
- Learning
- Memory
3-PBA and chlorpyrifos mutually enhance each other’s effects with regard to ADHD.162
Each detection of trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (trans-DCCA), a metabolite of permethrin, cypermethrin, and cyfluthrin (trans isomers of pyrethroids), in urine increased the risk of ADHD in offspring by 76%.162
Prenatal and postnatal exposure to low doses of the pyrethroid pesticide deltamethrin (within officially approved limits) led to molecular disorders in the brains of adult mice in signaling pathways that regulate the circadian rhythm and neuronal growth (MAP kinase), as well as to behavioral changes relevant to neurodevelopmental disorders.166
The pyrethroid fenvalerate is known for its developmental toxicity.
Offspring of female mice that received fenvalerate orally during pregnancy exhibited epigenetic changes in the regulation of dopamine synthesis:167
- reduced dopamine levels in the striatum
- reduced levels of tyrosine hydroxylase in the midbrain of both fetal and weaned puppies
- reduced levels of 5-hydroxymethylcytosine (5hmC) in CpG-rich regions and specific sites within the TH gene in the fetal midbrain
- reduced activity of the Ten-Eleven translocation enzymes (TET) in the fetal midbrain
- A dose of ascorbic acid, a cofactor for TET enzymes
- attenuated the fenvalerate-induced decrease in 5hmC levels in CpG-rich regions of the TH gene in the fetal midbrain
- reversed the Fenvalerat-induced downregulation of TH expression in the midbrain and of striatal DA levels in weaned offspring
- eliminated the ADHD-like behavior in the weaned offspring
- A dose of ascorbic acid, a cofactor for TET enzymes
A study conducted in rural China found PYR metabolites in the urine of more than 97% of children aged 1–3 years. The prevalence of ADHD symptoms was a very high 15.14% (20.55% for boys, 10.27% for girls) and was, strangely enough, described as “moderate” in the study.168
- Elevated 4F3PBA concentrations at age 2 were associated with a 6% increased risk of ADHD in preschool-aged children
- Elevated ΣPYRs at age 1 were associated with a 2% increased risk of ADHD in preschool-aged children
- Elevated 3PBA levels in 1-year-old boys were associated with a 7% increased risk of ADHD in preschool age
- Elevated 4F3PBA levels in 2-year-old boys were associated with a 5% increased risk of ADHD in preschool age
- Elevated DBCA levels in girls aged 1 were associated with a 30% increased risk of ADHD in preschool-aged children
- Elevated 4F3PBA levels in 2-year-old girls were associated with a 10% increased risk of ADHD in preschool age
- Elevated ΣPYRs scores in girls aged 1 were associated with a 2% increased risk of ADHD in preschool age
1.2.5.4. Exposure to Glyphosate During Pregnancy
Glyphosate (e.g., Roundup) is a broad-spectrum herbicide belonging to the phosphonic acid group.
In rats, oral exposure of the mother to glyphosate (0.5 and 50 mg/kg body weight/day) during pregnancy and lactation resulted (in particular) in the following effects in the (female) offspring:169
- Symptoms of depression
- Symptoms of anxiety
- social deficits
- reduced expression and hypermethylation of the tryptophan hydroxylase 2 gene in the hippocampus
- Tryptophan hydroxylase is involved in serotonin synthesis in the brain
- altered gut microbiota in female offspring
- reduced prevalence of Akkermansia
- increased abundance of Alistipes and Blautia
(Bacteria involved in tryptophan metabolism and associated with depression- and anxiety-like disorders)
This suggests a link between glyphosate and depression and anxiety disorders. However, this does not yet establish a connection to ADHD.
Glyphosate is also suspected of being a possible cause of ASS.170
1.2.5.5. Neonicotinoids
Neonicotinoids are the most widely used type of insecticide. There is evidence that neonicotinoids may harm the fetus during pregnancy.171 Neonicotinoids lead to reduced size in certain brain regions, such as the striatum and the corpus callosum. The corpus callosum is often smaller in individuals with ADHD,
1.2.6. Phthalates During Pregnancy (up to +142%)
According to most studies, phthalate esters increase the risk of ADHD in the unborn child,172173 174 although the mechanisms underlying these associations remain unclear.175176 The potential impact on thyroid function177 and inflammatory pathways178 is discussed. Higher levels of phthalate metabolites in the urine of pregnant women correlated with increased distractibility in preschool-aged children179 as well as with impaired executive functions180.
Prenatal exposure to dimethoxyethyl phthalate (DMEP) caused abnormal brain morphology and function in mice. DMEP significantly reduced the number of neurons in the parietal cortex by impairing neurogenesis and gliogenesis during cortical development and disrupted dendritic spine architecture and synaptic activity in the parietal cortex. In addition, prenatal DMEP exposure in mice induced hyperactivity and reduced anxiety-related behavior.181
Prenatal phthalate exposure, in combination with a genetic predisposition to phthalate-induced inflammation, increased the risk of ADHD in offspring at age 11.5 years by a factor of 2.42 and the risk of ASD by a factor of 2.15.178
High levels of phthalates in umbilical cord blood were associated with a risk of:182
- ASS: 2.09 times
- ASS in boys: 2.47 times
The risk of ASD was increased by:182
- High LMWP values: 3.43 times the risk
- High DEHP levels: 3.24-fold increased risk
- High total phthalate levels: 4.87 times the risk
The risk of ADHD was increased by:182
- High MBP exposure in late pregnancy: 1.61-fold increased risk
High phthalate exposure impaired the metabolism of linoleic acid and arachidonic acid.182
1.2.7. Caffeine Consumption During Pregnancy (+130%)
A study of N = 9,978 children found a correlation between prenatal caffeine intake—even at the widely recommended “safe” dose—and externalizing problems, particularly conduct disorder, with a very high Effect size comparable to that of prenatal alcohol or cannabis exposure. Internalizing problems remained unchanged. Furthermore, when mothers consumed more than 3 cups of coffee per day, the children’s BMI and consumption of soft drinks were elevated. Prenatal caffeine exposure correlated with structural changes in the brain, including greater thickness of the posterior and inferior frontal cortex and altered depth of the parieto-occipital sulcus.183 Higher caffeine consumption during pregnancy was associated with increased internalizing and externalizing symptoms in the parents.
A review found no correlation between caffeine consumption during pregnancy and ADHD in 4 out of 5 studies.184
Caffeine consumption of 10 cups of coffee a day or more was associated with a 130% increased risk of ADHD in children.185
A study found a slight increase in risk associated with caffeinated soft drinks during pregnancy, but not with coffee or tea.186
Caffeine consumption during pregnancy—at less than 10 cups a day—did not increase the risk of ADHD.18718818919019151192
Children of mothers who drank tea consistently throughout their entire pregnancy had higher scores for cognition, fine motor skills, and gross motor skills than children whose mothers drank tea only during the first trimester of pregnancy. Tea consumption during the second and third trimesters was more strongly associated with these outcomes than tea consumption during the first trimester. Coffee consumption showed no significant association with the children’s cognitive development.193
Caffeine consumption during pregnancy is associated with a higher BMI in children.194195191
1.2.8. Maternal drug use during pregnancy (up to +80%)
Children who were exposed to their mothers’ multiple drug use before birth and who subsequently grew up in foster care were found to have a threefold increased risk of ADHD between the ages of 17 and 22.196
7.7% of mothers used cannabis during pregnancy (meta-analysis, k = 17, N = 534,445).197
Several studies have linked cannabis use during pregnancy to an increased risk of ADHD in children.198199200
A meta-analysis found a relatively small increase in risk of ADHD—13%—associated with maternal cannabis use during pregnancy, and a 4% increase associated with ASA; a 29% increased risk of psychosis, a 34% increased risk of anxiety, and a 28% reduced risk of depression (k = 17, N = 534,445)197
A study of N = 141,570 children of N = 117,130 mothers found a reduced risk among their children for ADHD (16% lower) and disruptive behavior disorder (DBD, 17% lower).201 One study does not address the risk of ADHD in offspring associated with cannabis use during pregnancy, but notes that cannabis use during pregnancy correlates with localized differences in the gray and white matter of the frontal and parietal cortex, the associated white matter tracts, and the connectivity of the striatum at rest.202
Translated with DeepL.com (free version)
Maternal drug use (heroin, amphetamine, ketamine, or other substances) during pregnancy was associated with an increased risk for the offspring (registry study, N = 1,969,006)26
- by 77% to 80% for ADHD
- 35% to 41% for intellectual disability
- by 7% to 12% for ASS
1.2.9. Copper (+51%)
Elevated copper levels in the placenta increased the risk of ADHD by 51%.203
1.2.10. Cadmium during pregnancy (+22% to +36%)
Exposure to cadmium during pregnancy increased the risk of ADHD in 6-year-old girls, but not in boys. A twofold increase in the mother’s cadmium exposure during pregnancy increased the risk of ADHD in girls by 22.3%.204
Elevated cadmium levels in the placenta increased the risk of ADHD by 36%.203
A twofold increase in cadmium levels in umbilical cord blood was associated with a 1.53-fold increase (+53%) in emotional problems at ages 7 to 8 only among boys, while girls showed no significant association.134
Possible mechanism of action: blood-brain barrier.205
1.2.11. Manganese (up to +34%)
There is limited evidence suggesting a link to ADHD, although elevated manganese levels have been found only in the hair—and not in the blood—of people with ADHD.206
A doubling of the manganese content in teeth from both the prenatal and postnatal periods increased the risk of attention problems and ADHD symptoms during school age by 5%. Manganese exposure during childhood had no effect.207
An animal model involving developmental manganese exposure showed that manganese can cause persistent attention and sensorimotor deficits similar to those seen in ADHD-I. Oral methylphenidate was able to completely reverse the deficits caused by early manganese exposure.208
Elevated manganese levels in the placenta increased the risk of ADHD by 34%.203
1.2.12. Air Pollution During Pregnancy (up to +26%)
A study found that air pollution causes changes in the immune systems of children.209
A study of approximately 43,000 families in Shenzhen found positive correlations between ADHD, beginning at age 3, and exposure during pregnancy to210
- Steam cooking
- Tobacco smoke
- Fumes from home renovations
- Mosquito coils (burned-out mosquito pyramids; especially when used in combination with incense smoke)
- Incense smoke (especially when combined with mosquito-repellent smoke)
Another study found no increased risk of ADHD associated with air pollution.211
A meta-analysis found that more studies (not related to pregnancy) supported a link between air pollution and ADHD than refuted it.212
1.2.12.1. Particulate matter (+26%)
To avoid repetition, the introduction to the topic of air pollution and particulate matter can be found at Air Pollution in Childhood
A cohort study of 425,736 births examining prenatal exposure to fine particulate matter using satellite data found that a 10 μg/m³ increase in PM2.5 concentration during the first trimester increased the risk of ADHDrisk by 26% and that this risk continued to rise at PM2.5 concentrations above 16 μg/m³.213
In one study, exposure to fine particulate matter during pregnancy was associated with a reduced volume of the corpus callosum and a tendency toward increased hyperactivity.214 Another study found a link between fine particulate matter and ADHD at low exposure levels, while higher exposure levels caused more severe brain damage.124
In rats, inhaled printer particles led to a fivefold increase in dopamine levels, which was likely due to increased synthesis rather than reduced breakdown.215
In laboratory experiments, diesel exhaust particles caused functional impairments in dopamine neurons. Prenatal exposure via inhalation resulted in the following effects in mice:216
- in the striatum
- reduced dopamine turnover
- reduced levels of dopamine metabolites
- in the amygdala
- elevated dopamine levels
- elevated levels of dopamine metabolites
- in the nucleus accumbens
- elevated dopamine levels
Traffic-related ultrafine particulate matter in the air inhaled after birth caused the following effects in female mice:216
- increased dopamine turnover in the hippocampus
Both prenatal and postnatal exposure to reduced levels of particulate matter and gaseous pollutants in rodents reduced the expression of oxytocin receptors in the hippocampus217 and hypothalamus, resulting in reduced maternal caregiving behavior.218 Oxytocin and vasopressin signaling appears to be disrupted by endocrine-active chemicals219, many of which are present in outdoor air.216
Studies have found an association between PM2.5 and symptoms of hyperactivity and inattention (OR = 1.12)220, hyperactivity221, ADHD symptoms222, and between PM2.5 exposure during the first trimester and a tendency toward attention problems and hyperactivity.223
Other studies found no association between PM2.5 and ADHD224225226
A meta-analysis reports a correlation between PM10 and ASA.227 One study broke down the increased risk of ASA by PM1 (+86%), PM2.5 (+76%), and PM10 (+68%).228
The following are considered potential pathways linking prenatal exposure to fine particulate matter to ADHD:229
- In the placenta
- Increased inflammation
- Oxidative stress
- Disorder in blood flow and placental development
- Effects on nutrient and oxygen supply
- Epigenetic dysfunction
- In the fetal brain
- Increased neuroinflammation
- Elevated cytokines
1.2.12.2. Nitrogen oxides (+26%)
Several studies have found a correlation between exposure to nitrogen oxides during pregnancy and ADHD.120
- NOx was correlated with hyperactivity, with a stronger association between ADHD and NO than between ADHD and NO2. (NO: aOR = 1.26)226
- NO₂ exposure during pregnancy was strongly correlated with ADHD symptoms, such as
Other studies found no significant or clear correlations between NOx and ADHD.224231232
A study found a correlation with ASA in children, but not with ADHD.233
Nitrogen oxide emissions in Germany fell by just under two-thirds between 1990 and 2020.234
1.2.12.3. Ozone
Ozone had the following effects on rats:216
- in the substantia nigra
- reduced number of dopamine neurons
- in the hippocampus
- reduced expression of the serotonin receptors 5-HT1A, 5-HT1B, and 5-HT4
- increased expression of the serotonin receptor 5-HT2C
- in the hypothalamus
- reduced serotonin levels
To date, no correlation with ADHD has been found in humans.221120
1.2.13. Polychlorinated biphenyls / Polychlorinated biphenyl ethers (+23%)
Polychlorinated biphenyls (PCBs) may increase the risk of ADHD.235236 PCBs inhibit dopamine synthesis, as well as the storage of dopamine in vesicles and its release, thereby causing dopamine levels to be too low. Polychlorinated biphenyls caused hyperactivity and impulsivity (in rats even at subtoxic doses).237 Polychlorinated biphenyls can directly affect dopaminergic processes, disrupting the dopamine system and causing Parkinson’s-like symptoms.238 Other studies have also found that PFAS reduce dopamine levels.239240 as well as effects on acetylcholine, serotonin, and glutamate neurotransmitter balance.241
PFOS can cross the placenta and the blood-brain barrier.242
Children of mothers with high serum PCB levels during the first trimester (≥90th percentile) (but not those whose mothers were exposed to PCBs during pregnancy) showed the following at age 4:149
- impaired working memory
- unchanged: perceptual abilities, general cognitive abilities, executive functions
A meta-analysis of k = 30 meta-studies examined the association between prenatal exposure to PFOA and PFOS and ADHD in children aged 4–11 years.243
A statistically significant increase in the risk of ADHD was found among girls, but not among boys.
It is also possible that newer PFAS alternatives increase the risk of ADHD.244
A large-scale study of 7 European birth cohorts found no correlation between PCB-153 exposure during pregnancy or the first 2 years of life and ADHD.148
PFOS also increases the risk of obesity. This risk is compounded by that of a high-fat diet (HFD). A combination of HFD and PFOS worsened general behavior, such as time spent in the center and rearing, while PFOS alone affected the distance traveled. PFOS may therefore promote hyperactivity, while a combination of PFOS and HFD altered social behaviors such as rearing and withdrawal. PFOS exposure affects calcium signaling, MAPK signaling pathways, transmembrane ion transport, and developmental processes. The combination of HFD with PFOS amplifies the effect of PFOS in the brain and affects signaling pathways associated with ER stress, axon guidance and elongation, and neuronal migration. PFOS and HFD increase the effects on inflammatory pathways, the regulation of cell migration and proliferation, and MAPK signaling pathways.242
1.2.14. Perfluoroalkyl compounds (PFAS) during pregnancy (up to +23%)
A long-term study found no correlation between perfluoroalkyl exposure during pregnancy and ADHD. Weak correlations—both positive and negative—were found with working memory functions in childhood.245 A meta-analysis also found no significant correlation between maternal PFAS exposure and the prevalence rate of early childhood ADHD. Nevertheless, the odds ratios were elevated in some cases:246
- Perfluorooctanoic acid (PFOA): 1.00
- Perfluorooctane sulfonate (PFOS): 1.01
- Perfluorohexanesulfonate (PFHxS): 1.08
- Perfluorononanoic acid (PFNA): 1.13
- Perfluorodecanoic acid (PFDA): 1.23
PFOS concentrations in the children’s blood and PFNA concentrations in the mothers’ blood correlated with the prevalence of early childhood ADHD.
Another study found a correlation between perfluorooctanoic acid (PFOA) and ADHD, but not between perfluorooctanesulfonate (PFOS) and ADHD or ASD.247 Another study found an increased risk of ADHD among school-aged children exposed to low to moderate levels of PFAS at age 2.248
1.2.15. Thallium During Pregnancy
High thallium exposure during the second trimester of pregnancy increased the risk of ADHD in 3-year-old boys, but not in girls.249
1.2.16. Bisphenols During Pregnancy
Bisphenol A (BPA) increases the risk of ADHD (meta-analysis, k = 32, N = 15,669).250236251
Bisphenol A is one of the most widely produced synthetic compounds in the world. BPA is found in epoxy resins and polycarbonate plastics, which are commonly used for food storage and baby bottles.252
BPA can cross the placenta253254 255 and is found in human breast milk.256 BPA disrupts the gut-brain axis and the blood-brain barrier.257252258259260
BPA can:
- impair memory (meta-analysis, k = 22)261
- impair cognitive abilities (meta-analysis, n = 22)261
- bind to estrogen receptors252261
- cause various structural and molecular changes in the brain252
- promote oxidative stress252
- alter the expression levels of several important genes and proteins252
- Affect neurotransmitters252
- Alter neurotransmitter levels (meta-analysis, k = 22)261
- Cause excitotoxicity252
- Promote neuroinflammation252
- impair the function of the blood-brain barrier252
- cause nerve damage252
- Promote apoptosis252
- disrupt intracellular Ca2+ homeostasis252
- increase reactive oxygen species (ROS)252
- influence the release of intracellular lactate dehydrogenase252
- reduce the length of the axon252
- cause DNA damage in microglia252
- Trigger astrogliosis252
- cause a significant reduction in myelination252
- acts as a broad-spectrum endocrine disruptor262
- is metabolized via glucuronidation262
- This process involves the attachment of glucose to the target molecule and is catalyzed by uridine-5’-diphospho-glucuronosyltransferases (UGTs)
- The mechanism linking BPA glucuronidation efficiency to disease could be direct or indirect
- Direct mechanism of action: free BPA is the actual cause; impaired BPA detoxification leads to elevated BPA levels in sensitive tissues, where it can act as an endocrine disruptor
- Indirect mechanism of action: BPA is not the causative agent; rather, it serves as a marker for the reduced glucuronidation efficiency of other compounds that are metabolized by a similar combination of UGTs and efflux transporters as BPA
- inhibit the ERK-CREB-BDNF signaling pathway (meta-analysis, k = 22)261
- alter the expression of synaptic proteins (meta-analysis, k = 22)261
- affect the morphology of pyramidal neurons in the hippocampus (meta-analysis, k = 22)261
- Dysregulate thyroid hormones (meta-analysis, n = 22)261
Exposure to BPA increases the risk of neurological disorders, including
- neurovascular disorders (e.g., stroke)252
- neurodegenerative diseases (e.g., Alzheimer’s and Parkinson’s)252262
- Neurodevelopmental disorders
- Depression252
- emotional problems252
- Anxiety252
- cognitive disorders252
- Polycystic ovary syndrome (PCOS)262
Bisphenol A (BPA) is a glucocorticoid receptor agonist and has been linked to changes in the HPA axis response. In female rats, prenatal BPA exposure correlated with elevated basal corticosterone levels as well as reduced glucocorticoid receptor expression in the hypothalamus. In response to stress, these female rats exhibited anxious coping behavior and a blunted corticosterone response, with a lack of downregulation of glucocorticoid receptor expression in the hypothalamus. In contrast, BPA-exposed male rats showed no altered basal HPA axis function but were unable to upregulate CRH-1 receptor expression in the pituitary gland in response to acute stress.39 The dose administered to the rat mothers during pregnancy and lactation—40 micrograms/kg/day—was very low.264
5 milligrams per cubic meter in the air we breathe can cause eye irritation.265 A review confirmed evidence that bisphenol A during pregnancy may increase the risk of ADHD in children, particularly boys.176
BPA and BPS caused a sharp increase in dopamine (3- to 5-fold) and a sharp decrease in serotonin (by 80%) in mouse placentas. GABA levels remained unchanged.266 BPA is an endocrine disruptor and mimics estrogenic activity. As a result, BPA affects various dopaminergic processes to increase mesolimbic dopamine activity, leading to hyperactivity, attention deficits, and increased susceptibility to substance abuse.238
1.2.17. Dioxin Exposure During Pregnancy
Children who were exposed to dioxin during pregnancy have an increased risk of ADHD.267
1.2.18. Prenatal Sulfur Dioxide Exposure
Prenatal exposure to sulfur dioxide (SO2) was associated with DNA methylation and increased ADHD symptoms.268269
According to a review at120, two other studies found no significant association.226221
1.2.19. Polybrominated diphenyl ethers
Polybrominated diphenyl ethers (PBDEs) are brominated organic chemicals. They were used as flame retardants in many plastics and textiles.
Its concentration in breast milk rose exponentially between 1972 and 1998.
German industry voluntarily stopped using it in 1986. Sweden banned its production and use in 1999.
Throughout the EU, since 2003, PentaBDE and OctaBDE may be placed on the market or used only at concentrations of up to 0.1 percent by weight.
Prenatal exposure to PBDEs appears to increase ADHD symptoms in girls.270
1.2.20. Low urinary fluoride levels in the mother
A study found an inverse association between fluoride levels in the mother’s urine and cognitive problems in her children at age 11. The higher the fluoride concentration, the fewer cognitive problems were observed.271 This did not align with the results of other studies, which found an increased risk of ADHD associated with elevated urinary fluoride levels in the children themselves.272273
1.3. Illnesses of the Mother / Parents (up to +370%)
Psychiatric disorders in the family increased the child’s risk of ADHD by a factor of 9.37.117
Children with ADHD were more likely to have mothers who experienced health problems during pregnancy:81
- Maternal illnesses during pregnancy:
Among children with ADHD, 34.4% had a mother who was ill during pregnancy, compared with 14.4% of children without ADHD.- Children with ADHD: 34.7%
The mother’s illnesses during pregnancy occurred in the following trimester:- 1st and 2nd trimesters only: 56.4%
- 3rd trimester only: 12.7%
- Entire pregnancy: 30.9%
- Children not affected: 14.4%
The mother’s illnesses during pregnancy occurred in the following trimester:- 1st and 2nd trimesters only: 0%
- 3rd trimester only: 33.3%
- Entire pregnancy: 66.7%
- Children with ADHD: 34.7%
- Other pregnancy-related issues:
- Children with ADHD: 14.5%
- Children not affected: 3.8%
A 25-year cohort study (N = 16,365) found no statistically significant increase in the risk of ADHD associated with maternal illnesses unrelated to pregnancy; however, it did find a 1.52-fold increase in the risk of ASD (+52%).65 Furthermore, maternal infections during pregnancy were not a risk factor for ADHD, but were a risk factor for ASD in the offspring: 1.33-fold (+33%) (25-year cohort study, N = 16,365)65
1.3.1. Intrahepatic cholestasis (ICP) during pregnancy (+7% to +370%)
Intrahepatic cholestasis of pregnancy (ICP) is the most common pregnancy-related liver disease. It is associated with an increased risk of iatrogenic preterm birth and adverse consequences for the infant.274
An ICD increased the risk of ADHD/ASD:
- before the 28th week of pregnancy
- 2.62 times the risk of ADHD (+162%)
- 1.69 times the risk of ASS (+69%)
Weeks 28 through 36 of pregnancy
-
1.36 times the risk of ADHD (+36% (+37%))
-
1.37 times the risk of ASS
-
after the 36th week of pregnancy
- 1.07 times the risk of ADHD (+7%)
- 1.13 times the risk of ASS (+13%)
Of 30 people with ADHD who have citrine-induced cholestasis, 14 were diagnosed with ADHD (47%).275 Assuming an ADHD prevalence of 10% among children, this translates to a 370% increased risk of ADHD.
1.3.2. Parental asthma during and outside of pregnancy (+26% to +330%)
1.3.2.1. Maternal Asthma During Pregnancy
Asthma in the mother during pregnancy increases the risk of ADHD and ASD in her child.276
- 330%. Among the children of mothers in the COPSAC2000 birth cohort (all of whom have asthma), 20% have ADHD.277
- 49% of children born to N = 106,163 mothers who had asthma during pregnancy showed a risk of:278
- 47% risk of ADHD by age 18 if the mother had asthma during pregnancy279
- 43% (meta-analysis, k = 12, N = 7.38 million)280
- Boys: +36%
- Girls: +45%
- ASS: +36%
- A 41% increased risk of ADHD in children whose mothers have asthma (cohort study, N = 961,202 children)281
Another study also found an increased risk of ADHD among the children of mothers with asthma, particularly among girls.282
Children of N = 106,163 mothers who had asthma during pregnancy had a risk of:278
- ASS + 33%
- motor development disorders + 37%
- Learning disabilities + 51%
1.3.2.2. Father’s Asthma
- 26% for ADHD up to the 18th birthday if the father had asthma during pregnancy279
- 13% increased risk if the father has asthma281
1.3.3. Elevated or decreased thyroxine levels
1.3.3.1. Elevated or decreased thyroxine levels in the mother (up to +310%)
Abnormal thyroid hormone levels during pregnancy can have profound effects on a child’s brain development and cognition283284 and impair
- Neurodevelopmental processes285
- Cell differentiation
- Neurite growth
- Synaptogenesis
- Myelination
- Neurotransmitter systems286
- monoaminergic system
- cholinergic system
- which can lead to attention deficits and hyperactivity
Even temporary subclinical thyroid abnormalities during pregnancy can have serious consequences.287 Treating severe maternal hypothyroidism before the third trimester appears to prevent cognitive impairments288 and preterm births.289
Studies in mice with a mutated human thyroid receptor TRb-1 gene (TRbeta transgenic mice)290 found that these
- Normal levels of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) (euthyroid), except for a brief period during postnatal development
- into adulthood
- Changes in the dopaminergic system (increased dopamine turnover)
- ADHD symptoms
- Hyperactivity
- Inattention
- ADHD symptoms are reduced by MPH
A study of N = 5,602 mother-child pairs found a 54.1% higher risk of ADHD in children aged 3 to 7 whose mothers had a thyroid disorder during pregnancy.291
One study found a 7% increased risk of ADHD in children when the mother had untreated mild thyroxine deficiency during early pregnancy.292 In another study, reduced or untreated normal thyroxine levels in the mother had no effect on ADHD in the children. In contrast, thyroxine treatment in the mother—particularly when thyroxine levels are elevated due to an overdose—appears to increase the risk of ADHD in children.293 Another study also found evidence suggesting that thyroxine may be a possible cause of ADHD,294 while yet another study found no effect of the mother’s thyroxine levels during pregnancy.295
A Norwegian cohort study found a 2.27-fold increased risk of ADHD (+127%) when the mother’s thyroid hormone T3 levels at 17 weeks of gestation were in the top 1/5 compared to the bottom 1/5. For free T4, both elevated and reduced levels were associated with an increased risk: the top 1/5 as well as the bottom 1/5 showed a 1.6-fold increased risk of ADHD in the offspring.296
A study of male mice found significantly reduced dopamine and serotonin turnover in the striatum, nucleus accumbens, hypothalamus, and hippocampus as a consequence of prenatal thyroxine deficiency.297 Dopamine deficiency in the striatum and nucleus accumbens is responsible for hyperactive symptoms in ADHD.
A study found that maternal hyperthyroidism or hypothyroidism diagnosed and treated before the child’s birth had no effect on the child’s risk of ADHD or ASD.
However, maternal hyperthyroidism—which was first diagnosed and treated after the child’s birth—increased the child’s risk of ADHD by 23%, while hypothyroidism diagnosed in this manner increased the risk of ASD by 34%.298
1.3.3.2. Decreased and increased TSH levels in newborns (ranging from +14% in boys to +310% in girls)
Children with congenital hypothyroidism (congenital hypothyroidism, connatal hypothyroidism) had an ADHD incidence of 3.97% (versus 1.87%, +112%) and a rate of ASD of 0.71% (versus 0.13% = +346%).299
A cohort study from Norway found that newborns with TSH levels that were either too low or too high had an increased risk of ADHD later in life, but only among girls. TSH levels in the lowest 20% increased the risk of ADHD in girls by a factor of 3.1, but only by 14% in boys.300
In rodents, primary hypothyroidism reduced the levels of the glucose transporter GLUT1 in the brain, had no effect on GLUT3, and compensatorily increased hexokinase enzyme activity. However, these changes were pronounced only during the immediate neonatal period and disappeared after weaning.301
1.3.4. Maternal weight and eating disorders before or during pregnancy (+14% to +280%)
1.3.4.1. Severe obesity in the mother before or during pregnancy (+14% to +280%)
Severe obesity in the mother during pregnancy increased the risk of the child developing ADHD later in life
- by a factor of 2.8.302
- by 62%303
- by 57% for ADHD and 42% for ASD304
- by 46% for ADHD and CD, by 67% for eating disorders, by 55% for specific developmental disorders, by 44% for mood disorders, and by 33% for anxiety disorders (aHR = 1.33) and by 23% for other behavioral and emotional disorders305
- Being overweight (rather than obese) was associated with a 26% increased risk of intellectual disability, a 15% increased risk of mood disorders, a 12% increased risk of ADHD or conduct disorder, and a 9% increased risk of other behavioral and emotional disorders305
The risk of ADHD among children increased306
- by 23% to 28% due to being overweight
- by 47% to 89% due to obesity
- by 88% to 95% due to severe maternal obesity
In a Finnish registry study (n = 392,098 mothers, 649,956 children), children of mothers who were overweight or underweight during pregnancy had an increased risk of mental disorders:307
- Severe obesity in the mother (BMI of 35.0 or higher)
- ADHD and CD: 1.88 (+88%)
- ASS: 1.74 (+74%)
- Social functioning problems and tics: 1.31 (+31%)
- Affective disorders: 1.67 (+67%)
- Anxiety: 1.51 (+51%)
- Feeding problems as an infant or child: 1.10 (+10%, not statistically significant)
- Sleep disorders: 0.99 (down 1%, not statistically significant)
- Intellectual disability: 2.04 (+104%)
- Specific developmental disorders: 1.83 (+83%)
- Maternal overweight (BMI 30 to 34)
- ADHD and CD: 1.48 (+48%)
- ASS: 1.51 (+51%)
- Social functioning problems and tics: 1.24 (+24%)
- Affective disorders: 1.31 (+31%)
- Anxiety: 1.29 (+29%)
- Feeding problems as an infant or child: 1.06 (+6%, not statistically significant)
- Sleep disturbances: 1 (+0%, not statistically significant)
- Intellectual disability: 1.61 (+61%)
- Specific developmental disorders: 1.48 (+48%)
- The mother is slightly overweight (BMI 24 to 29)
- ADHD and CD: 1.19 (+19%)
- ASS: 1.16 (+16%)
- Social functioning problems and tics: 1.01 (+1%, not statistically significant)
- Affective disorders: 1.16 (+16%)
- Anxiety: 1.11 (+11%)
- Feeding problems as an infant or child: 0.96 (down 4%, not statistically significant)
- Sleep disorders: 1.08 (+8%, not statistically significant)
- Intellectual disability: 1.25 (+25%)
- Specific developmental disorders: 1.20 (+20%)
- Underweight mother (BMI of 18.5 or lower)
- ADHD and CD: 1.05 (+5%, not statistically significant)
- ASS: 1.11 (+11%)
- Social functioning problems and tics: 1.18 (+18%)
- Affective disorders: 1.01 (+2%, not statistically significant)
- Anxiety: 1.10 (+10%)
- Feeding problems as an infant or child: 1.07 (+7%, not statistically significant)
- Sleep disturbances: 0.98 (down 2%, not statistically significant)
- Intellectual disability: 1.33 (+33%)
- Specific developmental disorders: 1.18 (+18%)
A study from Benin reports increased motor activity and impaired cognitive function in children whose mothers were underweight.308
Even a high BMI in the mother before pregnancy increased the risk of ADHD in her future children.309 A BMI of 25 to 30 increased the child’s risk of ADHD by 14%, a BMI of 30 to 35 by 96%, and a BMI of more than 35 by 82%.310
Other fluctuations in the mother’s weight before and at the end of pregnancy do not appear to affect the risk of ADHD.74 In rats, however, there is evidence of an effect on the offspring’s dopamine levels.311
A Norwegian registry study found only limited evidence that a mother’s pre-pregnancy BMI influences her child’s risk of ADHD.312
If obesity was accompanied by high blood pressure, this led to an increased risk of:305
- + 219% for affective disorders
- + 140% for specific developmental disorders
- + 246% for ASS
- + 174% for ADHD or CD
Children of mothers with chronic hypertension and overweight had a higher risk of SDD (aHR = 1.58) and ADHD or CD (aHR = 1.43) compared to the reference group (Figure 1 and Table S2). Nevertheless, the effect sizes of the combined exposure were no greater than those of individual exposure to chronic hypertension or overweight.
1.3.4.2. Eating Disorders During Pregnancy (+53% to +112%)
In a Finnish registry study (n = 392,098 mothers, 649,956 children), children of mothers who had eating disorders during pregnancy had an increased risk of mental disorders:307
- Anorexia in the mother
- ADHD and CD: 1.53 (+53%)
- ASS: 1.56 (+56%)
- Social functioning problems and tics: 2.16 (+116%)
- Affective disorders: 1.46 (+46%)
- Anxiety: 1.63 (+63%)
- Feeding problems as an infant or child: 1.24 (+24%, not statistically significant)
- Sleep disorders: 2.12 (+112%)
- Intellectual disability: 1.08 (+8%, not statistically significant)
- Specific developmental disorders: 1.37 (+37%)
- The mother’s bulimia
- ADHD and CD: 1.94 (+94%)
- ASS: 1.75 (+75%)
- Social functioning problems and tics: 2.48 (+148%)
- Affective disorders: 1.92 (+92%)
- Anxiety: 1.88 (+88%)
- Feeding problems as an infant or child: 1.88 (+88%)
- Sleep disorders: 2.35 (+135%)
- Intellectual disability: 0.89 (down 11%, not statistically significant)
- Specific developmental disorders: 1.09 (+9%, not statistically significant)
- Eating disorder in the mother, not otherwise specified
- ADHD and CD: 2.12 (+112%)
- ASS: 2.04 (+104%)
- Social functioning problems and tics: 2.79 (+179%)
- Affective disorders: 2.30 (+130%)
- Anxiety: 2.19 (+119%)
- Feeding problems as an infant or child: 2.69 (+169%)
- Sleep disorders: 3.34 (+234%)
- Intellectual disability: 1.18 (+16%, not statistically significant)
- Specific developmental disorders: 1.54 (+54%)
- any eating disorder in the mother
- ADHD and CD: 1.73 (+73%)
- ASS: 1.68 (+68%)
- Social functioning problems and tics: 2.18 (+118%)
- Affective disorders: 1.66 (+66%)
- Anxiety: 1.79 (+79%)
- Feeding problems as an infant or child: 1.59 (+59%)
- Sleep disorders: 2.36 (+138%)
- Intellectual disability: 1.16 (+16%, not statistically significant)
- Specific developmental disorders: 1.28 (+28%, not statistically significant)
1.3.5. Preeclampsia (gestosis) during pregnancy (+23% to +277%)
The percentage figure in the headline was calculated by excluding the lowest and highest values.
Preeclampsia impairs the fetus’s oxygen supply and is often accompanied by high blood pressure in the mother. Both conditions, even on their own, are risk factors for ADHD in the child.
Preeclampsia (gestosis) during pregnancy increases the risk of ADHD in children313314
- by 408%.117
- by 277% (RR 2.77)315
- by 30 to 188 percent.316
- by 43% (cohort study)317
- by 29% (meta-analysis, k = 15)318
- by 19%319
Among individuals of normal weight, the risk associated with preeclampsia was increased:
-
48% for intellectual disability305
-
43% for specific developmental disorders305
-
for ASS
-
35% for epilepsy (meta-analysis, k = 15)318
-
34% for other behavioral and emotional disorders305
In cases of overweight, the risk associated with preeclampsia was higher compared to both the reference group and those who had either preeclampsia alone or overweight alone:305
-
123% for affective disorders
-
85% for anxiety disorders
-
82% for specific developmental disorders
-
115% for other behavioral and emotional disorders
In cases of obesity, the risk associated with preeclampsia was increased:305
-
94% for ADHD or CD
-
98% for other behavioral and emotional disorders
High blood pressure during pregnancy increased the risk of ADHD by 24% (HR: 1.24), of ASD by 29% (HR: 1.29), and of intellectual disability by 58% (HR: 1.58). The cause was usually preeclampsia.320314
Preeclampsia combined with a urinary tract infection increased the risk by 53%.319
Preeclampsia in some mothers of preterm infants increased the infants’ risk of impairments in gross and fine motor skills, adaptability, language, and social-emotional responses, as well as the rate of abnormal test results.
While no abnormalities were observed in the aforementioned areas at 3 to 6 months of age, by 12 months of age there was a significant decline in gross and fine motor skills, accompanied by a significantly reduced risk of abnormal speech scores.321
Several reviews confirm an increased risk of ADHD associated with preeclampsia during pregnancy.322323
Preeclampsia is associated with changes in the adenosine system, including adenosine transporters and adenosine receptors. SHR are born into a preeclampsia-like state due to their mothers’ high blood pressure. Caffeine (an adenosine antagonist) administered to 7-day-old SHR prevented the negative consequences of preeclampsia (hyperactivity, impaired social interaction, and impaired contextual fear conditioning), whereas it exacerbated these symptoms in Wistar rats.324
Hypoxia (oxygen deprivation) increases adenosine levels. Adenosine antagonists can prevent or reverse the negative consequences of hypoxia. For more information, see ⇒ Adenosine in the chapter “ : Neurological Aspects”.
High levels of the (weak) adenosine antagonist theobromine were negatively correlated with preeclampsia.325
1.3.6. Maternal psychological stress during pregnancy (+72% to +210%; with 5HTTLPR +800%)
Maternal stress during pregnancy increased the risk of ADHD in children
- by 400% (OR = 5.02).326
- by 210% among boys whose mothers had lost a child or a spouse during pregnancy 327
- by 147% among boys whose mothers had suffered the death of a child or spouse in the 0–6 months prior to pregnancy327
- by 100%328
- a 95% increase in ADHD symptoms at age 16, but no increase in hyperactivity symptoms at age 8 (a 13% decrease)329
- by 75.1% among children whose mothers experienced significant stress during the first trimester of pregnancy, compared with children of mothers who experienced low levels of stress291
- by 72% among boys whose mothers had suffered the unexpected death of a child or a spouse327
- by 72%330
- by 60%; no statistically significant increase in the risk of ASA (25-year cohort study, N = 16,365)65
- by 56.9% among children whose mothers experienced significant stress during the first trimester of pregnancy, compared with children of mothers who experienced moderate stress291
- by 31% due to maternal stress in the third trimester (and by 58% for ASA)331
- Stress during the second and third trimesters did not significantly increase the risk of ADHD in the child291
- Administration of corticosterone during pregnancy caused learning and memory problems in the offspring of rats332
Prolonged and severe stress (which is anxiety-laden and perceived as threatening = leading to higher cortisolergic levels) significantly increases the risk of colic333 (see also 2.2.2.3.2), anxiety disorders, and ADHD.334335336337338
In this context, chronic stress (in this case, financial problems) is more harmful than short-term stress (in this case, the loss of a loved one).339
High levels of anxiety-laden or perceived as threatening stress also significantly increase the risk of borderline personality disorder in children.
Children with ADHD were more likely to have mothers who experienced stress or emotional problems during pregnancy:81
- Children with ADHD: 53.8%
If stress or emotional problems occurred, they occurred during the following trimester:- 1st and 2nd trimesters only: 36.0%
- 3rd trimester only: 6.7%
- Entire pregnancy: 57.3%
- Children not affected: 27.6%
If stress or emotional problems occurred, they took place during the following trimester:- 1st and 2nd trimesters only: 28.6%
- 3rd trimester only: 24.9%
- Entire pregnancy: 28.6%
Hair cortisol levels in mothers and their children indicated that psychological stress experienced by the mothers was transmitted to their children.340
A study found no increased incidence of psychiatric disorders at age 9 among children of women who were exposed to one month of repeated rocket attacks on the civilian population during the 2006 Lebanon War.341 It is possible that one month of repeated stress is not a sufficiently intense stressor.
The cortisol released by the mother during anxiety-inducing or threatening stress is absorbed by the unborn child and leads to permanent damage to the HPA axis, which regulates stress responses via cortisol.342343
Severe anxiety in the mother during pregnancy, specifically between the 12th and 22nd week after the last menstrual period, significantly increases the risk of ADHD, whereas severe anxiety between the 32nd and 40th week does not increase the risk.344 Elevated cortisol levels in the mother during the third trimester of pregnancy increased the child’s risk of ADHD symptoms only in boys at age 3; however, this risk was no longer significant by age 5. ADHD symptoms were not elevated at either age 3 or age 5.345
So it seems to depend heavily on when the stressful experience occurs.
Severe anxiety in the mother during pregnancy increased the risk of ADHD in the unborn child, depending on the child’s COMT gene variant (gene-environment interaction).346
In mothers with ADGRL3 (Latrophilin 3, LPHN3) gene variants (SNPs)
- rs6551665
- rs1947274
- rs6858066 or
- rs2345039
Even low levels of stress during pregnancy were found to significantly increase the child’s risk of ADHD.347
A combination of the 5-HTTLPR L/L genotype and stress during pregnancy resulted in an eightfold increased risk of ADHD/C or ADHD-HI.348
Children with ADHD whose mothers were exposed to moderate and severe stress during pregnancy tend to develop more severe ADHD symptoms.349
Early prenatal stress increases the levels of immune response genes, including the proinflammatory cytokines IL-6 and IL-1β, particularly in male placentas. Male children exhibit stress-induced motor hyperactivity, a hallmark of dopaminergic dysregulation, which was improved by treatment of the mother with nonsteroidal anti-inflammatory drugs. In addition, the expression of dopamine D1 and D2 receptors was altered in male offspring due to early prenatal stress.350 This confirms the effect of early stress on the dopaminergic system.
High cortisol exposure in the fetus or newborn can cause methylation of the GAD1/GAD67 gene, which encodes the key enzyme for glutamate-to-GABA synthesis, glutamate decarboxylase 1, and lead to elevated glutamate levels. This epigenetic mechanism may increase children’s risk of ADHD.351 Exposure to glucocorticoids during hippocampal development in utero influences the onset of the stress response through epigenetic changes involving mRNA and methylation.352 Another study reports that the increased risk to the fetus for developmental disorders such as ADHD, mediated by the mother’s psychological stress, may be mediated through mRNA expression of glucocorticoid pathway genes in the placenta.353
Another study also describes epigenetic changes in the unborn child resulting from the mother’s psychological stress during pregnancy.354
A study found no significant increase in the risk of mental disorders by age 10 due to increased glucocorticoid exposure in the fetus.355
A natural disaster that affected the mother during pregnancy increased the risk of ADHD.356
Elevated cortisol levels caused by maternal stress during pregnancy can cross the placenta357 and alter the fetal epigenome, particularly in genes that regulate the HPA axis and the stress response.358 Maternal depression or anxiety in the third trimester correlated with increased DNA methylation of the NR3C1 promoter in the umbilical cord blood of newborns.359 The NR3C1 gene encodes the glucocorticoid receptor, which is supposed to downregulate the HPA axis (and thereby also cortisol levels) in response to high cortisol levels at the end of a stress response. The specific CpG methylation in NR3C1 triggered by the mother’s stress correlated with reduced gene expression, which was functionally associated with increased cortisol reactivity in these infants at three months of age. An increased cortisol response to stress in the 3-month-old infants correlated with greater methylation of the NR3C1 gene.359
Maternal stress during pregnancy can epigenetically program the infant’s HPA axis to be more sensitive to stress, which may increase the risk of anxiety or depression later in life, and that prenatal stress correlates with methylation changes in the offspring’s genes associated with stress regulation, such as NR3C1, FKBP5, and SLC6A4 (serotonin transporter).360
In primates, the stress hormone cortisol is converted into its inactive form by the enzyme hydroxysteroid 11-β-dehydrogenase 2 (HSD11B2). This conversion in the placenta also protects the fetus.361362 However, chronic maternal stress (as well as malnutrition or hypoxia) reduces HSD11B2 expression in the placenta.362 Fetuses of chronically stressed mothers are therefore exposed to high cortisol levels, which trigger developmental delays and neurodevelopmental disorders such as ADHD.363364 362 In rodents, however, the expression of Hsd11b1—which encodes an enzyme that regulates the activity of stress-related hormones in the neocortex—is reduced.365
Maternal stress during pregnancy or complications during childbirth—such as maternal infections during pregnancy or oxygen deprivation at birth—also increase the risk of other disorders, such as schizophrenia.366
1.3.7. Maternal fever during pregnancy (+31% to +164%)
A cohort study of 114,000 children showed that a fever during the first trimester of pregnancy increases the risk of ADHD by 31%, and multiple fevers by 164%. However, fever increased only inattention, not hyperactivity/impulsivity—this was also true for the second trimester. The results were independent of whether or not the mother took paracetamol (acetaminophen).367
1.3.8. PTSD During Pregnancy (+132%)
According to a Swedish cohort study, post-traumatic stress disorder in the mother during pregnancy is associated with a 2.32-fold increased risk of ADHD in the child.368
1.3.9. Chemical/medication intolerance (+110% to 130%; ASA +201% to 470%)
Children of mothers with chemical or medication intolerance (positive result on the Quick Environmental Exposure and Sensitivity Inventory (QEESI), a validated screening tool for chemical intolerance) had a 2.3-fold increased risk of ADHD and a 3.01-fold increased risk of ASD.369370
1.3.10. Parental depression before, during, or after pregnancy (up to +100%)
Particularly among boys, the severity of the mother’s depression during pregnancy, as well as higher scores on measures of cyclothymic, irritable, and anxious temperament in the mother, appear to be relevant risk factors for the development of ADHD.371
A cohort study found that
- Depression in parents increased the risk for their children, depending on when the depression occurred (figures given as HR):372
- ADHD (prenatal: 1.95 = 95% increase; at any time: 1.98 = 98% increase; postnatal: 2.0 = 100% increase)
- ASD (prenatal 1.76, any time 1.52)
- Tic disorders (prenatal 1.52, at any time 1.40)
- Developmental delay (prenatal 1.40, any time 1.32, postnatal 1.24)
- Language development disorder (prenatal 1.29, at any time 1.17)
- Developmental Coordination Disorder (HR: 1.73; at any time: 1.76; postnatal: 1.78)
- Intellectual disability (at any time: 1.26)
The risk of ADHD was increased (meta-analysis, k = 21, 796,157 mother-child pairs)373
- by 67% due to the mother’s antenatal depression (pre-birth)
- by 53% due to the mother’s postpartum depression (after childbirth)
A large-scale study found no causal link between depression, anxiety disorders, or infections in the mother during pregnancy and the child’s risk of neurodevelopmental disorders (ASD, ADHD, intellectual disability, cerebral palsy, or epilepsy).374
1.3.11. Crohn’s disease / Ulcerative colitis (+95%)
If a mother has Crohn’s disease or ulcerative colitis during pregnancy, the child’s risk of ADHD increases by 95% by the time the child turns 18.279
A father’s diagnosis of Crohn’s disease or ulcerative colitis did not increase the child’s risk of SADHS until the child’s 18th birthday.279
1.3.12. Polycystic Ovary Syndrome (PCOS) During Pregnancy (+31% to +95% in boys)
Children of women with polycystic ovary syndrome (PCOS) appear to have an increased risk of ADHD.375376
A possible link could stem from the fact that one treatment method involves the use of dopamine agonists.377378 Another possible link could be that PCOS is associated with hyperandrogenism. Elevated prenatal testosterone levels are a risk factor for ADHD. For more on this, see Gender Differences in ADHD.
A study found a 95% increased risk of ADHD among 3-year-old boys whose mothers had PCOS, while this risk was not elevated among 3-year-old girls.379 This also suggests a link to sex hormones, although elevated testosterone levels during pregnancy also cause increased ADHD symptoms in female offspring. For more on this, see Gender Differences in ADHD. It is also known that ADHD manifests later in girls than in boys.
A Chinese study found a 31% increased risk of ADHD (only) among boys aged 3 to 6.380 Since ADHD can often not be diagnosed until age 6 or older, we suspect the rate is higher among school-aged children.
Women with PCOS themselves had an increased risk of ADHD, although no association was found between testosterone and ADHD symptoms.381
1.3.13. Decreased C-reactive protein (CRP) (+92%)
Children of mothers whose CRP levels were in the lowest third of the study group had a risk of ASD and ADHD that was nearly double that of children of mothers in the middle third of the CRP distribution.382
1.3.14. Cerclage for Cervical Insufficiency (up to +70%)
A cerclage is a procedure in which a thread is placed around a weak or prematurely dilating cervix (cervical insufficiency). It is usually performed during the second trimester of pregnancy.
Children born to mothers who underwent a cerclage during pregnancy had an increased risk of death:383
- increased by 1,485% for cerclage performed on or after the 25th week of pregnancy
- increased by 107% with cerclage performed between the 16th and 24th weeks of pregnancy
- increased by 49% in cases of cerclage performed before the 24th week of pregnancy
Furthermore, a cerclage performed on or after the 25th week of pregnancy increased the children’s risk of:383
- ADHD: 70%
- ASS: 131%
- cognitive developmental delay: 81%
- Cerebral palsy: 1,832%
1.3.15. Rheumatic Diseases / Musculoskeletal Disorders (+64%)
Rheumatic diseases or musculoskeletal disorders in the mother during pregnancy increased the child’s risk of ADHD by 64% through his or her 18th birthday.384
1.3.16. Unhealthy diet during pregnancy (+13% to +60%)
An unhealthy or “Western” diet during pregnancy increased the likelihood of children developing ADHD by more than 60%.385
A 13% higher risk of ADHD was found among boys who consumed a highly processed, high-fat diet.386
Since stress increases the preference for “convenience foods,” we believe that this correlation could also potentially reflect, indirectly, increased stress levels in the mother during pregnancy, as stress shifts food preferences toward easily digestible foods and convenience foods.
1.3.17. Systemic lupus erythematosus (SLE) (+60%)
Children born to mothers with systemic lupus erythematosus (SLE) were found to have a 60% increased risk of ADHD.387
ADHD, for its part, is associated with a 2.17-fold increased risk of lupus.388
1.3.18. Threatened miscarriage (up to +51%)
If there was a risk of miscarriage during pregnancy, this increased the risk of
1.3.19. Diabetes in one parent; diabetes during pregnancy (+20% to +150%)
A cohort study of more than 5 million people found that children had an increased risk of ADHD if one of their parents had diabetes.391
Maternal diabetes before or during pregnancy increases the child’s risk of ADHD392 —this applies to gestational diabetes mellitus as well as to pre-existing type 1 diabetes mellitus or type 2 diabetes mellitus,393 —and also to ASD.394395
- 150%: Type 1 diabetes in the mother during pregnancy increased the child’s risk of ADHD by 95% through his or her 18th birthday.384
- 140%: A study found a 2.4-fold increased risk of ADHD among children of mothers with diabetes mellitus and a 3.7-fold increased risk of ADHD among male offspring of mothers with diabetes mellitus. No differences were found between gestational diabetes and other types of diabetes.396
- 86 High levels of diabetes mellitus throughout pregnancy increased the risk of ADHD at ages 6 to 9 to 2.8%, compared with 1.5% for low levels throughout pregnancy397
- 40%: Maternal diabetes mellitus prior to pregnancy increased the risk of ADHD in children by 40% (meta-analysis, k = 13, N = 5,000,000)398
- 39%: Type 1 diabetes mellitus in the mother before pregnancy increased the risk of ADHD in children by 39% (meta-analysis, k = 13, N = 5,000,000)398
- 20%: Diabetes mellitus or type 1 diabetes mellitus in the father increased the children’s risk of ADHD by 20% (meta-analysis, k = 13, N = 5,000,000)398
Children of severely obese mothers with type 2 diabetes who were not treated with insulin were twice as likely to have psychiatric disorders as children of normal-weight mothers. Children of severely obese mothers with pregestational diabetes who were treated with insulin were 2.7 times more likely to have psychiatric disorders than the children of normal-weight mothers.399
A study found no increased risk of ADHD severe enough to require inpatient treatment.400
1.3.20. Migraines in parents (+37%)
A cohort study of N = 250,517 participants found an increased risk for children of mothers—but not of fathers—with migraine:401
- ADHD (+37%)
- Bipolar disorder (+35%)
- Depression (+33%)
1.3.21. Immune disorders (+36%)
Immune disorders in the mother (excluding allergies) during pregnancy increased the child’s risk of ADHD by 36% through his or her 18th birthday.384
1.3.22. Anemia in the mother during pregnancy (+31%)
A cohort study of 532,232 children over 23 years showed that maternal anemia during the first 30 weeks of pregnancy increases the risk of ADHD by 31%, whereas anemia in later weeks of pregnancy increased the risk barely (by 1.4%). 402
In a small Lebanese case-control study (n = 119), maternal anemia during pregnancy increased the risk of ADHD by a factor of 3.7 (OR = 3.654).326
1.3.23. Infections in the Mother During Pregnancy
1.3.23.1. Infections in general (+30%)
A meta-analysis found a 30% increase in the risk of ADHD in children due to maternal infections during pregnancy.403 A registry-based cohort study (n = 2,885,662, of which N = 1,864,660 were full siblings) found a slight increase of 14% (ASD + 19%; intellectual disability +21%), which was no longer significant after adjusting for twin status.404
Mycoplasma antibodies at birth were associated with a 30% increased risk of ADHD later in life.405
1.3.23.2. Viral Infections
A viral infection in the mother during pregnancy increases the risk of ADHD in her child406 and can affect the development of the unborn child’s dopaminergic system, for example:407
- Measles
- Chickenpox
- Rubella
- Even a subclinical rubella infection in the mother during pregnancy increases the child’s risk at ages 8 to 9 of:408
- ASS
- ADHD
- Developmental Disorders
- Even a subclinical rubella infection in the mother during pregnancy increases the child’s risk at ages 8 to 9 of:408
- Enterovirus 71
- Herpesvirus 6
- Influenza A
- Cytomegalovirus (+30%)405
A link seems less certain in the case of
- Streptococcal infection
- Middle ear infection (otitis media)
Birth complications such as maternal infections during pregnancy, maternal stress during pregnancy, or oxygen deprivation during birth also increase the risk of other disorders409, such as schizophrenia366, ASD410, or depression.409
1.3.23.3. Urinary tract infections (+29%)
A urinary tract infection in the mother during pregnancy was associated with a 29% increased risk of ADHD.319 Chlamydia/non-gonococcal urethritis, trichomoniasis, urinary tract infections, and candidiasis increased the risk of ADHD, whereas gonorrhea did not.
A urinary tract infection and preeclampsia increased the risk by 53%.319
Another study also found an increased risk of ADHD as a consequence of urinary tract infections in the mother during pregnancy.411
1.3.24. Fetal Inflammatory Syndrome (FIRS) (+27%)
Children born to mothers with fetal inflammatory syndrome (FIRS, an inflammation of the placenta during pregnancy) had an increased risk of:412
- diagnosed with neuropsychiatric disorders (OR = 1.21)
- ASS (OR = 1.35)
- ADHD (OR = 1.27)
- Conduct disorder (OR = 1.50)
- PTSD (OR = 2.46)
1.3.25. High blood pressure during pregnancy (+27%)
High blood pressure during pregnancy significantly increases the risk of ADHD in offspring.323. The cause of the high blood pressure was usually preeclampsia.320
High blood pressure during pregnancy increased the risk of
- ADHD
- ASS
- intellectual disability
- Developmental delay
- +77% (meta-analysis, k = 121, N = 29,649,667)413; no longer significant after adjusting for gestational age and birth weight
- Depression +130%.414
If obesity was present in addition to chronic high blood pressure, this resulted in an increased risk of:305
- + 246% for ASS
- + 219% for affective disorders
- + 140% for specific developmental disorders
- + 174% for ADHD or CD
If pregnancy-induced hypertension was accompanied by being overweight (rather than obesity), this resulted (compared to hypertension or being overweight alone) in an increased risk of:305
- + 143% for anxiety disorders
- + 145% for ADHD or CD
When obesity was present in addition to gestational hypertension, this resulted (compared to those not affected) in an increased risk of:305 (The effect sizes of the combined exposure were no greater than those of the individual exposures to gestational hypertension or obesity):
- + 60% for anxiety disorders
- + 40% for ADHD or CD
- +84% for affective disorders
- +76% for specific developmental disorders
High blood pressure is associated with genetically inherited risks for ADHD. It will therefore be necessary to determine whether high blood pressure during pregnancy causally increases the risk of ADHD or whether elevated blood pressure during pregnancy is a manifestation of the underlying genetic predisposition that contributes to ADHD.
1.3.26. Allergies During Pregnancy (+20% to 23%)
Allergies in the mother during pregnancy increased the child’s risk of ADHD by 20% to 23% by the time the child turned 18.384
1.3.27. Uncontrollable nausea (hyperemesis gravidarum) (+16%)
Persistent nausea and vomiting in the mother during pregnancy were associated with a 16% (based on two cohort studies) to 287% increased risk of ADHD in the offspring.415
1.3.28. Mineral and Vitamin Deficiencies During Pregnancy
For more information, visit ⇒ Vitamins, Minerals, and Dietary Supplements for ADHD As well as ⇒ Nutrition and Diet for ADHD in the chapter at ⇒ Treatment and Therapy.
1.3.28.1. Vitamin D3 Deficiency During Pregnancy
Vitamin D3 deficiency during pregnancy and after childbirth causes permanent developmental abnormalities in the brain, particularly in the dopaminergic system.416417418419
In a meta-analysis, studies with larger sample sizes and stricter definitions of vitamin D deficiency showed positive associations with ADHD420421 and schizophrenia.421 Vitamin D3 deficiency during pregnancy reduces dopamine turnover in the offspring’s brain422, leading to a decrease in COMT.423
Vitamin D3 Deficiency During Pregnancy Increases Risk: 8 Studies
A cohort study of n = 3,937 children showed that the mother’s vitamin D levels, multivitamin supplementation, and better dietary quality were associated with lower rates of ADHDor ASD symptoms in children; that vitamin D and dietary quality were associated with greater volume of certain brain regions in childhood; and that greater volume of these brain regions was associated with fewer ADHD and ASD symptoms.424A study in Finland found a significant correlation between reduced maternal vitamin D3 levels during pregnancy and ADHD in children. The increased risk reached over 50%.425
The prevalence of ADHD-like symptoms in children decreased by 11% for every 10 ng/ml increase in the mother’s 25(OH)D level.426 A relatively low maternal 25(OH)D level at 24 weeks of gestation increased the risk of ADHD and ASD, as well as the severity of ASD. High vitamin D3 supplementation (2,800 iE/day) during pregnancy did not increase the risk of ADHD or ASD.427
The severity of ADHD symptoms in the children correlated with the degree of maternal 25(OH)D deficiency.428429
Lower maternal vitamin D3 levels between the 35th and 37th weeks of pregnancy were significantly correlated with increased signs of ADHD in the children at 6 months and 2 years of age.338
It remains unclear whether a D3 deficiency during other weeks of pregnancy has different effects, since later mental disorders are associated in particular with those brain regions that are undergoing a developmental surge during the respective week of pregnancy. For more on this, see ⇒ The Effects of Stress at Different Stages of Brain Development In the chapter ⇒ Stress-Induced Damage – Effects of Early / Prolonged Stress.
Rodents whose mothers had a vitamin D deficiency exhibited typical ADHD symptoms:430
- Hyperactivity
- Impulsivity
- Reduced social behavior
- Change in the frequency of ultrasonic vocalizations
- More frequent soiling
- Reduced grooming of the puppies
- Reduced levels of the growth factors NGF and GDNF
- Thinner cortical layers and larger lateral ventricles
- Smaller hippocampus and smaller lateral ventricles
Vitamin D3 Deficiency During Pregnancy Does Not Increase the Risk of ADHD: 3 Studies
Lower serum vitamin D3 levels in the mother during the 30th week of pregnancy were significantly associated with depression in the offspring up to age 22, but not with ADHD.431
A large-scale, long-term study in Spain on vitamin D3 deficiency during pregnancy found no correlation between low maternal blood levels of D3 during pregnancy and ADHD in children aged 5 to 18 years.432 Similarly, a Norwegian cohort study found no association between maternal vitamin D levels during pregnancy and the children’s later risk of ADHD, but did find an association between ASA and (consequently) reduced vitamin D levels and ADHD due to (as a consequence) lower omega-3 levels.433
1.3.28.2. Omega-3 Fatty Acid Levels
1.3.28.2.1. In newborns
A meta-analysis found evidence that higher levels of omega-3 fatty acids in newborns may reduce the risk and severity of ADHD and autism spectrum disorders. It is possible that an adequate intake of omega-3 fatty acids during the third trimester of pregnancy could help prevent this.434
1.3.28.2.2. During Pregnancy
Another study found a 13% increased risk of ADHD in children at age 7 associated with an elevated omega-6-to-omega-3 ratio (high omega-6 and low omega-3 levels).435
1.3.29. Sleep Deprivation During Pregnancy
Girls whose mothers slept less than 8 hours during the last trimester of pregnancy were more likely to exhibit hyperactivity, inattention, and higher overall ADHD scores.436
Sleep problems during pregnancy were associated with an increased risk of neurodevelopmental disorders and sleep problems in early childhood.437, in particular
- Reduced and poorer sleep during the second trimester of pregnancy was associated with ADHD
- More severe sleep problems during the first trimester were associated with ADHD
- Sleep problems during the third trimester were associated with sleep problems in the child
1.3.30. Testosterone During Pregnancy
Prenatal exposure to testosterone was significantly correlated with inattention and hyperactivity/impulsivity in offspring.438 Elevated maternal testosterone levels during pregnancy were significantly correlated with increased signs of ADHD in children at 6 months and 2 years of age.338
1.3.31. Inflammation in the Mother During Pregnancy
Perinatal inflammation is associated with higher ADHD symptom scores in children aged 8–9 years and increases the genetic predisposition to ADHD (the polygenic risk score).439440
A possible mechanism of action: IL-6
Inflammation increases, among other things, IL-6 (interleukin 6). IL-6 can cross the placenta and the fetal blood-brain barrier. In mice, administration of IL-6 in the absence of inflammation on days 3 through 6 (corresponding to the third trimester of human pregnancy441) resulted in:442
- increased ultrasonic vocalization in males
- reduced ultrasonic vocalizations in females
- reduced social interaction among males
- Self-grooming nearly doubled in males
- increased tactile sensitivity in females
1.3.32. Bipolar Disorder in a Parent
A parent’s bipolar disorder increased the children’s risk of ADHD.443
1.4. Medications Taken by the Mother During Pregnancy as a Risk Factor for ADHD (up to +250%)
Children with ADHD were more likely to have mothers who took medication during pregnancy:81
Medication Use by the Mother During Pregnancy:
- ADHD: 43.5%
If stress or emotional problems occurred, they took place during the following trimester:- 1st and 2nd trimesters only: 36.2%
- 3rd trimester only: 14.5%
- Entire pregnancy: 49.3%
- Those not affected: 31.4%
If stress or emotional problems occurred, they took place during the following trimester:- 1st and 2nd trimesters only: 31.1%
- 3rd trimester only: 46.9%
- Entire pregnancy: 21.9%
The following list is provided for illustrative purposes only and is by no means exhaustive.
1.4.1. Paracetamol (Acetaminophen) During Pregnancy (+37% to +250%)
50% of all women take acetaminophen during pregnancy.444
A meta-analysis of 20 studies found consistent evidence that prenatal use of acetaminophen by the mother is associated with a significantly increased risk of ADHD and ASD in the offspring. (Meta-analysis, n = 20)445
Taking acetaminophen (known as paracetamol in North America and Iran) during pregnancy increased the risk of ADHD by up to 37%. According to two very comprehensive studies involving a combined total of over 110,000 participants, even short-term use is harmful.446447 Further studies confirm this.448449 450 Gilman et al. offer a critical perspective on this.451 While previous studies were based on mothers’ self-reports of use, a study based on blood levels found a 2.3- to 3.5-fold increased risk of ADHD and a 1.6- to 4.1–fold increased risk of ASD in children when taken during the second or third trimester of pregnancy.452
The risk of ADHD associated with paracetamol (acetaminophen) increases when taken453
- by 19% during the second trimester of pregnancy
- by 28% in the first and second trimesters
- by 20% during the first through third trimesters
A cohort study of 116,000 children showed that a fever during the first trimester of pregnancy increases the risk of ADHD by 31%, and multiple fevers by 164%. However, fever increased only inattention, not hyperactivity/impulsivity—this was also true for the second trimester. The results were independent of whether or not the mother took paracetamol (acetaminophen).367
A meta-analysis confirms an increased risk of ADHD and ASD in children when paracetamol is taken during pregnancy.454
A small study that assessed acetaminophen use based on blood test results rather than self-reported data found a 3.15-fold increased risk of ADHD in children whose mothers took acetaminophen during the second trimester of pregnancy.455
A meta-analysis of 22 studies involving N = 367,775 participants found an increased risk of ADHD associated with paracetamol use during pregnancy, which remained unchanged after adjusting for other factors (such as parental diagnoses).456
A study calls into question the critical findings to date by focusing on ADHD diagnoses in parents that had not been taken into account previously.457 Damkier also expresses skepticism.458459 Another study found no evidence of an increased risk of ADHD or ASD associated with acetaminophen use during pregnancy.460 A review also found no association.461
A cohort study of N = 217,602 children found a 22% increased risk of ADHD, on the one hand, and evidence that the result may have been inflated due to an overestimation caused by unreported over-the-counter use of acetaminophen, on the other.462
A long-term study analyzed paracetamol, methionine, serine, glycine, and glutamate in umbilical cord plasma and found that elevated acetaminophen levels were associated with an increased risk of ADHD that paralleled the rise in 8-hydroxy-deoxyguanosine levels in umbilical cord blood. An increase in methionine, glycine, serine, and 8-hydroxy-deoxyguanosine levels in umbilical cord blood correlated with a significantly higher likelihood of ADHD in childhood. Methionine and glycine each accounted for 22% of the association between elevated acetaminophen levels and subsequent ADHD.463
The adverse effects of acetaminophen on fetal development during pregnancy appear to be mediated through changes in the endocannabinoid pathway.464
Paracetamol is also suspected of being a possible cause of ASS.170
In any case, the evidence suggesting that acetaminophen increases the risk of ADHD during pregnancy is so strong that pregnant women should be warned against taking it.465
Ibuprofen, on the other hand, is not believed to pose an ADHD risk to the unborn child.
Possible mechanism of action:
1.4.2. SSRIs, Antidepressants During Pregnancy (0% to +63%)
According to two meta-analyses of 18 studies, SSRI use during pregnancy is associated with a significantly increased risk of ADHD (OR = 1.26 = approx. +26%) and ASD (OR = 1.42 = approx. +42%) in children. It is unclear whether this results from the SSRIs themselves or from the inheritance of the mother’s mental health issues—for which she was treated with SSRIs—since even when the mother took SSRIs or SNRIs before pregnancy, but not during pregnancy, the children’s risk of ADHD (OR = 1.63 = approx. +63%) and ASD (OR = 1.39 = approx. +39%) was also elevated.468469 As a precaution, SSRIs should be used with extreme caution during pregnancy.
A meta-analysis found that 7 out of 8 studies on SSRIs during pregnancy showed no increased risk of ADHD in children.470 Another study reached the same conclusion.471 According to one study, antidepressants taken during pregnancy increased the likelihood of ADHD in the child later in life by a factor of 1.81.472
One review found that antidepressants during pregnancy nearly double the risk of ADHD and ASD in newborns in unadjusted studies. In adjusted studies, however—in which, for example, the mother’s ADHD is controlled for as a separate factor—there was barely any statistically significant association. Analyses of discordant sibling pairs suggest that a child’s ADHD is more closely related to whether or not their sibling has a neurodevelopmental disorder (NDD) than to whether or not the child was exposed to an antidepressant in utero.473
1.4.3. Valproic acid during pregnancy (+39%)
Valproic acid increases the risk of ADHD in offspring by 39% (meta-analysis, k = 22)474 In addition, it increased the risk of congenital malformations by 147 to 830%, the risk of autism by 70% to 338%, for impaired motor development by 600%, and for intellectual disability and low IQ by 140% to 338%.
Offspring of mice that received valproic acid during pregnancy exhibited significantly increased hyperactivity and changes in the dentate gyrus.475476 There is also evidence of changes in the histaminergic system and social behavior.477
Valproic acid during pregnancy increases the risk of ADHD, ASD, impaired cognitive abilities, and speech disorders in children.478 In addition, depending on the dose—particularly at doses exceeding 600 mg/day—it causes congenital malformations in 10% of children, such as neural tube defects, heart anomalies, urogenital malformations (e.g., hypospadias, skeletal malformations, and orofacial clefts). High-dose folic acid before and during pregnancy may reduce this risk. Valproic acid concentrations in breast milk appear to be low, so breastfeeding does not pose a risk.
1.4.4. Corticosteroids during pregnancy (+30%)
Glucocorticoid administration during pregnancy increased the risk of ADHD in offspring by 30%.479 The risk of ASD was increased by 30% to 50%, the risk of depression, anxiety, and stress-related disorders by 40% to 50%, and the risk of intellectual disability by 30%.
The administration of corticosteroids during pregnancy leads to long-term changes in the brain of the unborn child and increases the risk of ADHD.480 These children experience lifelong changes in the dopaminergic system and the HPA axis, which appear to be caused by changes in the expression and ratio of MR and GR receptors.481 In our view, the ADHD symptoms described in these children could possibly be the consequences of an alteration in the HPA axis.
⇒ The Corticosteroid Receptor Hypothesis of Depression
High cortisol exposure in the fetus or newborn can lead to methylation of the GAD1 / GAD67 gene, which encodes the key enzyme glutamate decarboxylase 1 (GAD1), responsible for converting glutamate to GABA, and leads to elevated glutamate levels. This epigenetic mechanism may increase children’s risk of ADHD.351
Exposure to betamethasone during pregnancy only marginally increased the risk of ADHD in the offspring.482483
Dexamethasone administered during pregnancy in mice increased spontaneous activity in female offspring, while it decreased it in males. Dexamethasone administered during pregnancy downregulated dopamine signaling and upregulated glutamate and GABA signaling in females.484
1.4.5. β-2-Adrenoreceptor agonists during pregnancy (+30%)
Taking β-2-adrenoreceptor agonists (beta-2 sympathomimetics) during pregnancy increases the child’s risk of ADHD by up to 30%.485
1.4.6. Pregabalin during pregnancy (+29%)
Prenatal exposure to pregabalin increased the risk of ADHD by 29%; however, this effect was attenuated when active comparators were taken into account.486
1.4.7. Antibiotics During Pregnancy (up to +19%)
Several meta-analyses found an increased risk of ADHD associated with the mother’s use of antibiotics during pregnancy:
-
19% (meta-analysis, k = 30, N = 7,047,853)487
-
15% (meta-analysis, k = 9, N = 6,180,434)488
-
14% (meta-analysis)489
-
14% (meta-analysis)490
-
11% during the second trimester (meta-analysis, k = 9, N = 6,180,434)488
-
7% in late pregnancy (meta-analysis, k = 9, N = 6,180,434)488
Repeated use of antibiotics further increased the risk:
- an additional 21% for women who took antibiotics more than three times during pregnancy (meta-analysis, k = 9, N = 6,180,434)488
- an additional 13% for women who took antibiotics twice during pregnancy (meta-analysis, k = 9, N = 6,180,434)488
A mother’s use of penicillin during pregnancy increased the child’s risk of ADHD. The risk of ADHD was increased by penicillin even when taken 2 years before pregnancy. Repeated use of penicillin further increased the risk of ADHD.30
Possible mechanism of action: Alteration of the microbiome.491
The risk of ASS increased by +9% (meta-analysis, k = 30, N = 7,047,853).487
1.4.8. Antiepileptic drugs
1.4.8.1. Valproate during pregnancy (+12%)
A large-scale cohort study found an increased risk of ASD (+110%) and ADHD (+43%) in children whose mothers had taken antiepileptic drugs during pregnancy. The risk was primarily attributable to valproate.492 Compared to mothers with epilepsy who did not take antiepileptic drugs during pregnancy, which increases the risk of ASD by only 38%.
Valproate use during pregnancy is believed to increase the risk of ADHD in the unborn child.493
Valproates are the salts of valproic acid.
A cohort study of children up to age 6 (which is still too early to diagnose all people with ADHD) found an increased risk of neurodevelopmental disorders associated with the use of antiepileptic drugs during pregnancy:
- Sodium valproate in combination with other antipsychotics: 15%
- Sodium valproate as monotherapy: 12%
- Lamotrigine 6.3% (no statistically significant increase due to the small number of participants in this group)
- Carbamazepine 2% (no significant increase)
- Children who were not exposed to any of these medications during pregnancy: 1.8%
ADHD was the most common diagnosis. 2% of children whose mothers were taking medication received an ADHD diagnosis by the age of 6, and 1.5% were diagnosed with dyspraxia. None of the children in the control group had an ADHD diagnosis.494
1.4.8.2. Topiramate During Pregnancy
There is ongoing debate regarding the use of the antiepileptic drug topiramate during pregnancy in relation to a possible increased risk of ADHD in the child.495496
1.4.8.3. Levetiracetam During Pregnancy
In mice, levetiracetam caused hyperactivity and repetitive behavior in the offspring during fertilization and pregnancy.497
1.4.9. Estrogens, progestins
Before they were banned in the 1970s and 1980s, millions of pregnant women worldwide were prescribed synthetic sex hormones such as estrogens or progestins.
Some progestins are still prescribed today.
Children of women who have undergone this treatment are at increased risk for:498
- ADHD
- ASS
- Psychoses
- Schizophrenia
- bipolar disorders
- severe depression
- Anxiety
- Eating Disorders
The descendants of the people with ADHD are also affected (3rd generation: particularly ADHD, ASD, and bipolar disorder). In the 4th generation, which is still very young, the first signs are becoming apparent, such as dyspraxia, which is often a precursor to ADHD
Estrogens and progestins appear to mediate their harmful effects epigenetically through hypermethylation of the ZFP57 and ADAMTS9 genes, which are important for neurological development.
1.5. Congenital Disorders
1.5.1. Congenital atrial septal defect or ventricular septal defect (+275%)
Children with a congenital atrial septal defect or ventricular septal defect are 3 to 4 times more likely to exhibit symptoms of inattention and hyperactivity. One study found a prevalence of SDHS of 15% compared to 4% in the control group (+275%).499
1.6. Other Pregnancy Circumstances (up to +100%)
1.6.1. Firstborn status (+31% to +100%)
See the section on Firstborn status in the article “ : Physical Risk Factors for ADHD”
1.6.2. Particularly short or long intervals since the previous pregnancy (+25% to +30%)
Particularly short or particularly long intervals between the pregnancy and the birth of the preceding sibling increased the risk of ADHD by 30% (less than 6 months) and 12% (60 to 119 months) to 25% (120 months or more), respectively.500
1.6.3. Few green spaces in the surrounding area during pregnancy (+3%)
Exposure to green spaces prior to conception was associated, for each interquartile increase in the green space index within the ZIP code area, with a reduced risk of:501
- ADHD: down 2%
- ASS: down 10%
- Learning difficulties: down 7%
- intellectual disability: minus 9%
- Behavioral disorders: down 8%
1.6.4. Protein Deficiency During Pregnancy and the Postpartum Period
Rats whose mothers were fed a low-protein diet 15 days before conception and then throughout the lactation period were significantly more susceptible to early-life stressors (intraperitoneal injection of deltamethrin, lipopolysaccharide, or both).502
1.6.5. Western Dietary Patterns During the First and Second Trimesters of Pregnancy
A Western diet (high in fat, refined grains, and processed foods; low in fruits and vegetables; also known as the Standard American Diet, or SAD) during the first and second trimesters of pregnancy is associated with an increased risk of ADHD and ASD in the child.503
1.6.6. High Salt Intake During Pregnancy
A high intake of salt through the diet during pregnancy could increase the unborn child’s sensitivity to stress.504
1.7. Pregnancy Factors Not Associated with an Increased Risk of ADHD
The following factors were found to have no effect on the unborn child’s risk of ADHD:
- Iodine-to-creatinine ratio in the mother’s urine during pregnancy
- A large study of three cohorts found no effect on the risk of ADHD or ASD505
- The mother’s migration
- A meta-analysis found no evidence of an increased risk of ADHD associated with the mother’s migration, but the situation was different for ASD.506
- Mother’s iron levels
- A study found that the mother’s iron levels during pregnancy had no effect on the child’s risk of ADHD at age 7507
- Artificial insemination508509 using donor sperm510 or intracytoplasmic sperm injection (ICSI)511
- Non-ionizing magnetic field radiation during pregnancy
- A study that had initially found a higher rate of ADHD among children born to mothers who were exposed to the highest levels of non-ionizing magnetic field radiation (““electrosmog”)512 has been retracted513. The updated version finds no correlation between particularly high levels of non-ionizing magnetic field radiation and ADHD.
- A cohort study found no increased risk of ADHD associated with the use of nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy.514
- Benzodiazepines during pregnancy appear to increase the risk of internalizing problems in children (anxiety, emotional reactivity, somatic complaints), but not of externalizing problems (hyperactivity, aggression).515 A cohort study comparing siblings whose mothers took benzodiazepines during pregnancy with those whose mothers did not found no significant increase in the risk of ADHD or ASD associated with benzodiazepines; the authors suggest instead that a link may exist with the mother’s genetic predisposition.516 A meta-analysis also concluded that, to date, no significant increase in the risk of ADHD in offspring has been found to be associated with benzodiazepine use during pregnancy, although one study suggested a slight increase with benzodiazepine monotherapy in the third trimester.517 One study found a slight 15% increase in the risk of ADHD associated with benzodiazepine use during pregnancy.518
- Prenatal exposure to oxytocin does not appear to affect the risk of ADHD and ASD519
- Organic Foods During Pregnancy520
- Triptans during pregnancy521
- Opioid pain relievers during pregnancy522
This list of medications taken by the mother during pregnancy that may increase the risk of ADHD is merely illustrative and by no means exhaustive.
1.8. Pregnancy Factors Associated with a Reduced Risk of ADHD
1.8.1. Mother’s sports during pregnancy > 20 minutes/day (up to a 56% reduction)
Among N = 4,184 children aged 3 to 6, a reduced risk of ADHD was found when mothers, during pregnancy, did the following every day:523
- Participated in sports for 20 to 40 minutes: 56% decrease
- participated in sports for more than 40 minutes: down 51%
compared to children whose mothers participated in sports for less than 20 minutes a day.
Since ADHD is generally not diagnosed until age 7 or older, the overall impact is likely to be even greater.
1.8.2. The mother’s dietary fiber intake during pregnancy (up to a 20% decrease)
A high-fiber diet during pregnancy reduced the risk of ADHD in children by up to 20%.524
This was independent of genetic predisposition to ADHD, an unhealthy diet, and sociodemographic factors.
Dietary fiber increases short-chain fatty acids in the gut, which generally reduces the risk of mental health problems. For more on this, see the section “Microbiome and Short-Chain Fatty Acids (SCFAs) in ADHD” in the article The Gut-Brain Axis as a Cause of ADHD
1.8.3. Mediterranean diet (up to 64% reduction)
A mother’s adherence to the Mediterranean diet during pregnancy reduced the risk of behavioral problems at age 4:525
- Overall problems (OR = 0.42)
- Externalizing symptoms (OR = 0.29)
- Attention problems (OR = 0.32)
- ADHD (OR = 0.36)
- oppositional defiant behavior (OR = 0.06)
- depressive symptoms (OR = 0.38)
López-Vicente M, Szekely E, Lafaille-Magnan ME, Morton JB, Oberlander TF, Greenwood CMT, Muetzel RL, Tiemeier H, Qiu A, Wazana A, White T (2024): Examining the interaction between prenatal stress and polygenic risk for attention-deficit/hyperactivity disorder on brain growth in childhood: Findings from the DREAM BIG consortium. Dev Psychobiol. 2024 May;66(4):e22481. doi: 10.1002/dev.22481. PMID: 38538956. ↥
Zhi D, Perdomo SA, Arteaga LR, Hughes DE, Dunn EC, Lee PH, Evins AE, Reeder HT, Hadland SE, Doyle AE, Clauss JA, Sui J, Roffman JL, Gilman JM (2025): Association of Adverse Prenatal Exposure Burden with Persistent Psychopathology and Accelerated Cortical Thinning in Youth. medRxiv [Preprint]. 2025 Jul 23:2025.07.23.25331227. doi: 10.1101/2025.07.23.25331227. PMID: 40778183; PMCID: PMC12330414. N = 11.868 ↥
Rice, Langley, Woodford, Smith, Thapar (2018): Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Dev Psychopathol. 2018 Aug;30(3):1107-1128. doi: 10.1017/S0954579418000421. ↥ ↥
Thapar A, Cooper M, Eyre O, Langley K (2013): What have we learnt about the causes of ADHD? J Child Psychol Psychiatry. 2013 Jan;54(1):3-16. doi: 10.1111/j.1469-7610.2012.02611.x. PMID: 22963644; PMCID: PMC3572580. REVIEW ↥ ↥ ↥ ↥
zitiert nach Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1;57(11):1313-23. doi: 10.1016/j.biopsych.2004.11.024. PMID: 15950004. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥
Gizer IR, Ficks C, Waldman ID (2009): Candidate gene studies of ADHD: a meta-analytic review. Hum Genet. 2009 Jul;126(1):51-90. doi: 10.1007/s00439-009-0694-x. PMID: 19506906. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Li D, Sham PC, Owen MJ, He L (2006): Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet. 2006 Jul 15;15(14):2276-84. doi: 10.1093/hmg/ddl152. PMID: 16774975. METASTUDY ↥ ↥ ↥ ↥ ↥ ↥
Smith TF (2010): Meta-analysis of the heterogeneity in association of DRD4 7-repeat allele and AD/HD: stronger association with AD/HD combined type. Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1189-99. doi: 10.1002/ajmg.b.31090. PMID: 20468072. METASTUDY ↥
Gornick MC, Addington A, Shaw P, Bobb AJ, Sharp W, Greenstein D, Arepalli S, Castellanos FX, Rapoport JL (2007): Association of the dopamine receptor D4 (DRD4) gene 7-repeat allele with children with attention-deficit/hyperactivity disorder (ADHD): an update. Am J Med Genet B Neuropsychiatr Genet. 2007 Apr 5;144B(3):379-82. doi: 10.1002/ajmg.b.30460. PMID: 17171657. n = 448 ↥
Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF (2004): Transmission disequilibrium testing of dopamine-related candidate gene polymorphisms in ADHD: confirmation of association of ADHD with DRD4 and DRD5. Mol Psychiatry. 2004 Jul;9(7):711-7. doi: 10.1038/sj.mp.4001466. PMID: 14699430. ↥ ↥ ↥
Gabriela, John, Magdalena, Ariadna, Francisco, Liz, Lino, Josefina, Ernesto, Carlos (2009): Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients. Neurosci Lett. 2009 Feb 27;451(3):257-60. doi: 10.1016/j.neulet.2009.01.004. PMID: 19146920. ↥ ↥
Johansson S, Halleland H, Halmøy A, Jacobsen KK, Landaas ET, Dramsdahl M, Fasmer OB, Bergsholm P, Lundervold AJ, Gillberg C, Hugdahl K, Knappskog PM, Haavik J (2008): Genetic analyses of dopamine related genes in adult ADHD patients suggest an association with the DRD5-microsatellite repeat, but not with DRD4 or SLC6A3 VNTRs. Am J Med Genet B Neuropsychiatr Genet. 2008 Dec 5;147B(8):1470-5. doi: 10.1002/ajmg.b.30662. PMID: 18081165. n = 698 ↥ ↥ ↥
Yang B, Chan RC, Jing J, Li T, Sham P, Chen RY (2007): A meta-analysis of association studies between the 10-repeat allele of a VNTR polymorphism in the 3’-UTR of dopamine transporter gene and attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):541-50. doi: 10.1002/ajmg.b.30453. PMID: 17440978. METASTUDY ↥
Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry. 2005 Jun 1;57(11):1313-23. doi: 10.1016/j.biopsych.2004.11.024. PMID: 15950004. REVIEW ↥
Guan L, Wang B, Chen Y, Yang L, Li J, Qian Q, Wang Z, Faraone SV, Wang Y (2009): A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol Psychiatry. 2009 May;14(5):546-54. doi: 10.1038/sj.mp.4002139. PMID: 18180757. ↥
Liu D, Ren Y, Wu T, Shen H, Yan P, Meng Y, Zhang Q, Zhang J, Bai P, Zhao J (2022): Parental smoking exposure before and during pregnancy and offspring attention-deficit/hyperactivity disorder risk: A Chinese child and adolescent cohort study. Front Public Health. 2022 Oct 10;10:1017046. doi: 10.3389/fpubh.2022.1017046. PMID: 36299741; PMCID: PMC9589153. N = 2.477 Familien ↥
Yohn, Caruso, Blendy (2019): Effects of nicotine and stress exposure across generations in C57BL/6 mice, Stress, 22:1, 142-150, DOI: 10.1080/10253890.2018.1532991 ↥
McCarthy, Zhang, Wilkes, Vaillancourt, Biederman, Bhide (2022): Nicotine and the developing brain: Insights from preclinical models. Pharmacol Biochem Behav. 2022 Feb 14:173355. doi: 10.1016/j.pbb.2022.173355. PMID: 35176350. ↥ ↥
Dai J, Wang Z, Xu W, Zhang M, Zhu Z, Zhao X, Zhang D, Nie D, Wang L, Qiao Z (2017): Paternal nicotine exposure defines different behavior in subsequent generation via hyper-methylation of mmu-miR-15b. Sci Rep. 2017 Aug 4;7(1):7286. doi: 10.1038/s41598-017-07920-3. PMID: 28779169; PMCID: PMC5544724. ↥
Zhang M, Xu W, He G, Zhang D, Zhao X, Dai J, Wu J, Cao Y, Wang Z, Wang L, Qiao Z (2018): Maternal nicotine exposure has severe cross-generational effects on offspring behavior. Behav Brain Res. 2018 Aug 1;348:263-266. doi: 10.1016/j.bbr.2018.04.033. PMID: 29698694. ↥
Deng L, Wang Q, Lou Y (2023): Maternal nicotine intoxication before pregnancy induces depressive- and anxiety-like behaviors as well as cognitive deficits in male offspring and correlates with neurobiological changes. Brain Behav. 2023 Jul;13(7):e3052. doi: 10.1002/brb3.3052. PMID: 37161637; PMCID: PMC10338757. ↥
McCarthy, Morgan, Lowe, Williamson, Spencer, Biederman, Bhide (2018): Nicotine exposure of male mice produces behavioral impairment in multiple generations of descendants. PLoS Biol 16(10): e2006497. https://doi.org/10.1371/journal.pbio.2006497 ↥ ↥ ↥ ↥ ↥ ↥ ↥
Buck, Sanders, Wageman, Knopik, Stitzel, O’Neill (2019): Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice. Neuropharmacology. 2019 May 1;149:66-82. doi: 10.1016/j.neuropharm.2019.02.006. PMID: 30742847; PMCID: PMC7096676. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Zhang M, Zhang D, Dai J, Cao Y, Xu W, He G, Wang Z, Wang L, Li R, Qiao Z. Paternal nicotine exposure induces hyperactivity in next-generation via down-regulating the expression of DAT. Toxicology. 2020 Feb 15;431:152367. doi: 10.1016/j.tox.2020.152367. Epub 2020 Jan 13. PMID: 31945395. ↥ ↥
van Mil, Steegers-Theunissen, Bouwland-Both, Verbiest, Rijlaarsdam, Hofman, Steegers, Heijmans, Jaddoe, Verhulst, Stolk, Eilers, Uitterlinden, Tiemeier (2014): DNA methylation profiles at birth and child ADHD symptoms. J Psychiatr Res. 2014 Feb;49:51-9. doi: 10.1016/j.jpsychires.2013.10.017. PMID: 24290898. ↥
Chen VC, Lee CT, Wu SI, Gossop M (2024): Neurobehavioral disorders among children born to mothers exposed to illicit substances during pregnancy. BMC Med. 2024 Dec 18;22(1):581. doi: 10.1186/s12916-024-03762-9. PMID: 39696283; PMCID: PMC11656950. ↥ ↥
Cadet JL, Jayanthi S (2021): Epigenetic Landscape of Methamphetamine Use Disorder. Curr Neuropharmacol. 2021;19(12):2060-2066. doi: 10.2174/1570159X19666210524111915. PMID: 34030618; PMCID: PMC9185771. REVIEW ↥
Nakano, R., Kaizaki-Mitsumoto, A., & Numazawa, S. (2023). Paternal exposure to methylphenidate induces ADHD-like behavioral phenotypes and altered gene expressions in mouse offspring. Fundamental Toxicological Sciences, 10(1), 7-20. ↥
Nakano R, Ikeda R, Yamazaki Y, Munetomo-Aoki S, Morinaka H, Abe S, Isobe H, Hosonuma M, Kamijo S, Kaizaki-Mitsumoto A, Numazawa S (2025): Paternal exposure to methylphenidate causes behavioral abnormalities in grandchildren. J Toxicol Sci. 2025;50(9):445-457. doi: 10.2131/jts.50.445. PMID: 40887248. ↥
Holmgaard S, Kiilerich P, Borbye-Lorenzen N, Skogstrand K (2024): Maternal pre-pregnancy and prenatal penicillin, neonatal inflammation and growth factors are associated to ADHD in the offspring. Brain Behav Immun Health. 2024 Feb 10;36:100739. doi: 10.1016/j.bbih.2024.100739. PMID: 38425710; PMCID: PMC10901857. N = 553.766 ↥ ↥
Ishido M, Higashi K, Mori H, Ueno M, Kurokawa K (2025): DNA methylation profiles of transgenerational rat hyperactivity primed by silver nanoparticles: Comparison with valproate model rats of autism. Behav Brain Res. 2025 Feb 4;477:115293. doi: 10.1016/j.bbr.2024.115293. PMID: 39419183. ↥
Choi HM, Huybrechts KF, Hernandez-Diaz S, Qiu X, Leung M, James P, Shupler M, Huang W, Wei Y, Zanobetti A, McDougle CJ, Schwartz J, Coull B, Weisskopf M, Papatheodorou S (2025): Preconception, prenatal and early childhood exposure to green space and risk of neurodevelopmental delays: a national cohort study among Medicaid enrollees. Environ Int. 2025 Aug;202:109666. doi: 10.1016/j.envint.2025.109666. PMID: 40639188; PMCID: PMC12380237. n = 1.841.915 mother-child pairs ↥
Koehlmoos TP, Lee E, Wisdahl J, Donaldson T (2023): Fetal alcohol spectrum disorders prevention and clinical guidelines research-workshop report. BMC Proc. 2023 Aug 15;17(Suppl 12):19. doi: 10.1186/s12919-023-00272-z. PMID: 37580722; PMCID: PMC10426045. ↥
Pagnin, Zamboni Grecco, Furtado (2018): Prenatal alcohol use as a risk for attention-deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci. 2018 Oct 23. doi: 10.1007/s00406-018-0946-7. n = 81 ↥
van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3. ↥
Hoang HH, Tran ATN, Nguyen VH, Nguyen TTB, Nguyen TAP, Le DD, Jatho A, Onchonga D, Duong TV, Nguyen MT, Tran BT (2021): Attention Deficit Hyperactivity Disorder (ADHD) and Associated Factors Among First-Year Elementary School Students. J Multidiscip Healthc. 2021 Apr 30;14:997-1005. doi: 10.2147/JMDH.S301091. PMID: 33958873; PMCID: PMC8096448. ↥ ↥
Wang, Martin, Lei, Hausknecht, Ishiwari, Richards, Haj-Dahmane, Shen (2020): Prenatal Ethanol Exposure Leads to Attention Deficits in Both Male and Female Rats. Front Neurosci. 2020 Jan 24;14:12. doi: 10.3389/fnins.2020.00012. PMID: 32038156; PMCID: PMC6992663. ↥
Perkins AE, Dart E, Kaiser D (2024): Prenatal Alcohol Exposure Disrupts Performance in a Differential Reinforcement of Low Rates Task Specifically in Adolescent Male Rats. Dev Psychobiol. 2024 Dec;66(8):e22555. doi: 10.1002/dev.22555. PMID: 39467264. ↥
Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425. REVIEW ↥ ↥ ↥
Gerstner T, Saevareid HI, Johnsen ÅR, Løhaugen G, Skranes J (2023): Sleep disturbances in Norwegian children with fetal alcohol spectrum disorders (FASD) with and without a diagnosis of attention-deficit hyperactivity disorder or epilepsy. Alcohol Clin Exp Res. 2023 Feb 21. doi: 10.1111/acer.15009. Epub ahead of print. PMID: 36811179. n = 53 ↥
Chen CY, Shih PY, Su CT, Cheng CF, Lee MC, Lane HY (2025): Association between infant feeding and ADHD development in childhood: a birth cohort study in Taiwan. J Child Psychol Psychiatry. 2025 Jun;66(6):881-891. doi: 10.1111/jcpp.14100. PMID: 39707757; PMCID: PMC12062847. N = 19.721 ↥
Fransquet, Hutchinson, Olsson, Wilson, Allsop, Najman, Elliott, Mattick, Saffery, Ryan (2016): Triple B Research Consortium. Perinatal maternal alcohol consumption and methylation of the dopamine receptor DRD4 in the offspring: the Triple B study. Environ Epigenet. 2016 Dec 7;2(4):dvw023. doi: 10.1093/eep/dvw023. PMID: 29492300; PMCID: PMC5804537. N = 844 ↥
Schneider, Moore, Barnhart, Larson, DeJesus, Mukherjee, Nickles, Converse, Roberts, Kraemer (2005): Moderate-level prenatal alcohol exposure alters striatal dopamine system function in rhesus monkeys. Alcohol Clin Exp Res. 2005 Sep;29(9):1685-97. doi: 10.1097/01.alc.0000179409.80370.25. PMID: 16205369. ↥
Lee, Park, Ryu, Shin, Ko, Han, Koren, Cho (2015): Changes in the methylation status of DAT, SERT, and MeCP2 gene promoters in the blood cell in families exposed to alcohol during the periconceptional period. Alcohol Clin Exp Res. 2015 Feb;39(2):239-50. doi: 10.1111/acer.12635. PMID: 25656446. ↥
Shabanov, Lebedev, Bychkov (2012): [The effect of ethanol exposure in pregnancy on maturation of monoaminergic systems in the developing rat bran]. Ross Fiziol Zh Im I M Sechenova. 2012 Feb;98(2):202-11. Russian. PMID: 22650063. ↥
Schneider, Moore, Barr, Larson, Kraemer (2011): Moderate prenatal alcohol exposure and serotonin genotype interact to alter CNS serotonin function in rhesus monkey offspring. Alcohol Clin Exp Res. 2011 May;35(5):912-20. doi: 10.1111/j.1530-0277.2010.01421.x. PMID: 21294753; PMCID: PMC3083456. ↥
De Nicolò, Carito, Fiore, Laviola (2014): Aberrant behavioral and neurobiologic profiles in rodents exposed to ethanol or red wine early in development. Curr. Dev. Disord. Rep. 2014;1:173–180. doi: 10.1007/s40474-014-0023-5. ↥
Kazemi, Huang, Avci, Akay, Akay (2021): Investigating the effects of chronic perinatal alcohol and combined nicotine and alcohol exposure on dopaminergic and non-dopaminergic neurons in the VTA. Sci Rep. 2021 Apr 22;11(1):8706. doi: 10.1038/s41598-021-88221-8. PMID: 33888815; PMCID: PMC8062589. ↥
Haan, Sallis, Ystrom, Njølstad, Andreassen, Reichborn-Kjennerud, Munafò, Havdahl, Zuccolo (2021): Maternal and offspring genetic risk score analyses of fetal alcohol exposure and attention-deficit hyperactivity disorder risk in offspring. Alcohol Clin Exp Res. 2021 Sep 6. doi: 10.1111/acer.14692. PMID: 34486127. ↥
Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0. n = 573 ↥
Haan E, Sallis HM, Zuccolo L, Labrecque J, Ystrom E, Reichborn-Kjennerud T, Andreassen O, Havdahl A, Munafò MR (2022): Prenatal smoking, alcohol and caffeine exposure and maternal-reported attention deficit hyperactivity disorder symptoms in childhood: triangulation of evidence using negative control and polygenic risk score analyses. Addiction. 2022 May;117(5):1458-1471. doi: 10.1111/add.15746. PMID: 34791750; PMCID: PMC7613851. ↥ ↥ ↥
Kjaer Weile, Wu, Hegaard, Kesmodel, Henriksen, Nohr (2019: Alcohol intake in early pregnancy and risk of Attention-Deficit Hyperactivity Disorder (ADHD) in children up to 19 years of age: a cohort study. Alcohol Clin Exp Res. 2019 Nov 19. doi: 10.1111/acer.14243. n = 48.072 ↥
Reilhac, Garlantézec, Lacroix, Rouget, Warembourg, Monfort, Le Gléau, Cordier, Viel, Chevrier (2019): Prenatal exposure to glycol ethers and response inhibition in 6-year-old children: The PELAGIE cohort study. Environ Res. 2019 Nov 21:108950. doi: 10.1016/j.envres.2019.108950. ↥
San Martin Porter, Maravilla, Betts, Alati (2019): Low-moderate prenatal alcohol exposure and offspring attention-deficit hyperactivity disorder (ADHD): systematic review and meta-analysis. Arch Gynecol Obstet. 2019 Aug;300(2):269-277. doi: 10.1007/s00404-019-05204-x. REVIEW ↥
O’Neill J, O’Connor MJ, Kalender G, Ly R, Ng A, Dillon A, Narr KL, Loo SK, Alger JR, Levitt JG (2022): Combining neuroimaging and behavior to discriminate children with attention deficit-hyperactivity disorder with and without prenatal alcohol exposure. Brain Imaging Behav. 2022 Feb;16(1):69-77. doi: 10.1007/s11682-021-00477-w. PMID: 34089460; PMCID: PMC8643366. ↥
Hausknecht K, Shen YL, Wang RX, Haj-Dahmane S, Shen RY (2017): Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons. J Neurosci. 2017 Jun 14;37(24):5798-5808. doi: 10.1523/JNEUROSCI.3894-16.2017. PMID: 28476947; PMCID: PMC5473200. ↥
Bosco C, Diaz E (2012): Placental hypoxia and foetal development versus alcohol exposure in pregnancy. Alcohol Alcohol. 2012 Mar-Apr;47(2):109-17. doi: 10.1093/alcalc/agr166. PMID: 22241888. REVIEW ↥
Wells AC, Lotfipour S (2023): Prenatal nicotine exposure during pregnancy results in adverse neurodevelopmental alterations and neurobehavioral deficits. Adv Drug Alcohol Res. 2023 Aug 11;3:11628. doi: 10.3389/adar.2023.11628. PMID: 38389806; PMCID: PMC10880762. REVIEW ↥
Willoughby MT, Pek J, Greenberg MT; Family Life Project Investigators (2012): Parent-reported Attention Deficit/Hyperactivity symptomatology in preschool-aged children: factor structure, developmental change, and early risk factors. J Abnorm Child Psychol. 2012 Nov;40(8):1301-12. doi: 10.1007/s10802-012-9641-8. PMID: 22581375; PMCID: PMC3461245. ↥
Elvin ÖD, Aydan ÇV, Güzel EÇ, Topçu B (2024): Evaluation of the relationship between the frequency of attention deficit, hyperactivity disorder symptoms and nutritional habits in children. Med J Malaysia. 2024 Sep;79(5):538-546. PMID: 39352155. ↥
Zhang Z, Yu J, Li Q, Zhao Y, Tang L, Peng Y, Liu Y, Gan C, Liu K, Wang J, Chen L, Luo Q, Qiu H, Ren H, Jiang C (2025): Unraveling the causal pathways of maternal smoking and breastfeeding in the development of neuropsychiatric disorders: A Mendelian randomization perspective. J Affect Disord. 2025 Mar 15;373:35-43. doi: 10.1016/j.jad.2024.12.075. PMID: 39716673. n = 397.732 ↥
Sourander A, Sucksdorff M, Chudal R, Surcel HM, Hinkka-Yli-Salomäki S, Gyllenberg D, Cheslack-Postava K, Brown AS (2019): Prenatal Cotinine Levels and ADHD Among Offspring. Pediatrics. 2019 Mar;143(3):e20183144. doi: 10.1542/peds.2018-3144. PMID: 30804074; PMCID: PMC6398365. ↥ ↥
Banerjee TD, Middleton F, Faraone SV (2007): Environmental risk factors for attention-deficit hyperactivity disorder. Acta Pædiatrica 2007;96, 1269–74. Zitiert nach Philipsen, Heßlinger, Tebartz van Elst (2008): AufmerksamkeitsdefizitHyperaktivitätsstörung im Erwachsenenalter – Diagnostik, Ätiologie und Therapie (ÜBERSICHTSARBEIT), Deutsches Ärzteblatt, Jg. 105, Heft 17, 25. April 2008, Seite 311 – 317, 313 ↥
Braun JM, Kahn RS, Froehlich T, Auinger P, Lanphear BP (2006): Exposures to environmental toxicants and attention deficit hyperactivity disorder in U.S. children. Environ Health Perspect. 2006 Dec;114(12):1904-9. doi: 10.1289/ehp.9478. PMID: 17185283; PMCID: PMC1764142. n = 4.704) ↥
Lebeña A, Faresjö Å, Jones MP, Bengtsson F, Faresjö T, Ludvigsson J (2024): Early environmental predictors for attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder (ASD) and their co-occurrence: The prospective ABIS-Study. Sci Rep. 2024 Jun 26;14(1):14759. doi: 10.1038/s41598-024-65067-4. PMID: 38926504; PMCID: PMC11208583. ↥ ↥ ↥ ↥
He B, Peng J, Wu M, Deng Y, Zhang Y (2025): Association between maternal smoking during pregnancy and attention-deficit/hyperactivity disorder (ADHD) in children aged 4-15 years: A secondary data analysis from the NHANES dataset. Tob Induc Dis. 2025 Aug 8;23. doi: 10.18332/tid/207094. PMID: 40785796; PMCID: PMC12332854. ↥
Huang L, Wang Y, Zhang L, Zheng Z, Zhu T, Qu Y, Mu D (2018): Maternal Smoking and Attention-Deficit/Hyperactivity Disorder in Offspring: A Meta-analysis. Pediatrics. 2018 Jan;141(1):e20172465. doi: 10.1542/peds.2017-2465. PMID: 29288161. REVIEW ↥ ↥ ↥
He Y, Chen J, Zhu LH, Hua LL, Ke FF (2017): Maternal Smoking During Pregnancy and ADHD: Results From a Systematic Review and Meta-Analysis of Prospective Cohort Studies. J Atten Disord. 2020 Oct;24(12):1637-1647. doi: 10.1177/1087054717696766. PMID: 29039728. METASTUDY, N = 17.304 ↥
Minatoya, Araki, Itoh, Yamazaki, Kobayashi, Miyashita, Sasaki, Kishi (2019): Prenatal tobacco exposure and ADHD symptoms at pre-school age: the Hokkaido Study on Environment and Children’s Health. Environ Health Prev Med. 2019 Dec 7;24(1):74. doi: 10.1186/s12199-019-0834-4. ↥ ↥ ↥
Itoh M, Kobayashi S, Nishihara S, Miyashita C, Yamazaki K, Tamura N, Suyama S, Ikeda A, Itoh S, Ait Bamai Y, Yamaguchi T, Masuda H, Hanley S, Kishi R (2024): Association between prenatal tobacco exposure and attention-deficit/hyperactivity disorder related characteristics at 6 and 8 years: a birth cohort in Japan. BMJ Open. 2024 Dec 26;14(12):e087406. doi: 10.1136/bmjopen-2024-087406. PMID: 39725438; PMCID: PMC11683938. N = 7.217 ↥ ↥
Zhang YL, Yang WK, Strodl E, Zhang ML, Chen WQ (2025): Association Between Environmental Smoke Exposure in Early Life and ADHD-like Behaviors in Chinese Preschoolers: Findings from Population Survey in Shenzhen. Toxics. 2025 Jun 26;13(7):534. doi: 10.3390/toxics13070534. PMID: 40710979; PMCID: PMC12300800. n = 64.472 ↥
Godleski S, Shisler S, Colton K, Leising M (2024): Prenatal Tobacco Exposure and Behavioral Disorders in Children and Adolescents: Systematic Review and Meta-Analysis. Pediatr Rep. 2024 Aug 31;16(3):736-752. doi: 10.3390/pediatric16030062. PMID: 39311325; PMCID: PMC11417955. REVIEW ↥
Jansone K, Eichler A, Fasching PA, Kornhuber J, Kaiser A, Millenet S, Banaschewski T, Nees F, On Behalf Of The Imac-Mind Consortium (2023): Association of Maternal Smoking during Pregnancy with Neurophysiological and ADHD-Related Outcomes in School-Aged Children. Int J Environ Res Public Health. 2023 Mar 7;20(6):4716. doi: 10.3390/ijerph20064716. PMID: 36981624; PMCID: PMC10048892. ↥
Schwenke, Fasching, Faschingbauer, Pretscher, Kehl, Peretz, Keller, Häberle, Eichler, Irlbauer-Müller, Dammer, Beckmann, Schneider (2018): Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. Arch Gynecol Obstet. 2018 Sep 8. doi: 10.1007/s00404-018-4888-0. ↥ ↥
Wang, Hu, Chen, Xue, Du (2019): Prenatal Tobacco Exposure Modulated the Association of Genetic variants with Diagnosed ADHD and its symptom domain in children: A Community Based Case-Control Study. Sci Rep. 2019 Mar 12;9(1):4274. doi: 10.1038/s41598-019-40850-w. ↥
Zambrano-Sánchez, Martínez-Cortés, Poblano, Dehesa-Moreno, Vázquez-Urbano, Del Río-Carlos (2019): Maternal smoking during pregnancy and physiological anxiety in children with attention deficit hyperactivity disorder. Appl Neuropsychol Child. 2019 Jul 3:1-8. doi: 10.1080/21622965.2019.1632708. ↥
McIntosh DE, Mulkins RS, Dean RS (1995): Utilization of maternal perinatal risk indicators in the differential diagnosis of ADHD and UADD children. Int J Neurosci. 1995 Mar;81(1-2):35-46. doi: 10.3109/00207459509015297. PMID: 7775071. n = 265 ↥
Xavier J, Singh S, Kumari P, Ravichandiran V (2022): Neurological repercussions of neonatal nicotine exposure: A review. Int J Dev Neurosci. 2022 Feb;82(1):3-18. doi: 10.1002/jdn.10163. PMID: 34913189. REVIEW ↥
Xie T, Mao Y (2024): The causal impact of maternal smoking around birth on offspring ADHD: A two-sample Mendelian randomization study. J Affect Disord. 2024 Jan 22:S0165-0327(24)00215-5. doi: 10.1016/j.jad.2024.01.196. Epub ahead of print. PMID: 38266926. n = 246.888 ↥
Fleming M, Fitton CA, Steiner MFC, McLay JS, Clark D, King A, Mackay DF, Pell JP (2017): Educational and Health Outcomes of Children Treated for Attention-Deficit/Hyperactivity Disorder. JAMA Pediatr. 2017 Jul 3;171(7):e170691. doi: 10.1001/jamapediatrics.2017.0691. PMID: 28459927; PMCID: PMC6583483. n = 766.244 ↥
Lipińska, Słopień, Pytlińska, Słopień, Wolańczyk, Bryńska (2021): The role of factors associated with the course of pregnancy and childbirth in attention deficit hyperactivity disorder (ADHD). Psychiatr Pol. 2021 Jun 30;55(3):659-673. English, Polish. doi: 10.12740/PP/OnlineFirst/110686. PMID: 34460889. n = 311 ↥ ↥ ↥ ↥
Deng, Yang, Wang, Zhou, Wang, Zhang, Niu (2022): Identification and Characterization of Influential Factors in Susceptibility to Attention Deficit Hyperactivity Disorder Among Preschool-Aged Children. Front Neurosci. 2022 Jan 31;15:709374. doi: 10.3389/fnins.2021.709374. PMID: 35173570; PMCID: PMC8841729. n = 7.938 ↥
Thapar, Rice (2020): Family-Based Designs that Disentangle Inherited Factors from Pre- and Postnatal Environmental Exposures: In Vitro Fertilization, Discordant Sibling Pairs, Maternal versus Paternal Comparisons, and Adoption Designs. Cold Spring Harb Perspect Med. 2020 Mar 9:a038877. doi: 10.1101/cshperspect.a038877.. PMID: 32152247. ↥
Zakariyah A, Al Qutub S, Kazim S, Alharbi R, Alharthi H, Alharbi H, Albassami M, Hanbazazh M, Mahnashi M (2024): Exposure to Smoking as a Predictor of ADHD Subtypes Among Children Within Saudi Arabia: An Observational Study. Tob Use Insights. 2024 Sep 9;17:1179173X241283765. doi: 10.1177/1179173X241283765. PMID: 39258266; PMCID: PMC11384971. N = 217 ↥ ↥
{Haan, Westmoreland, Schellhas, Sallis, Taylor, Zuccolo, Munafò (2022): Prenatal smoking, alcohol and caffeine exposure and offspring externalizing disorders: a systematic review and meta-analysis. Addiction. 2022 Apr 6. doi: 10.1111/add.15858. PMID: 35385887. ↥
Fuemmeler BF, Glasgow TE, Schechter JC, Maguire R, Sheng Y, Bidopia T, Barsell DJ, Ksinan A, Zhang J, Lin Y, Hoyo C, Murphy S, Qin J, Wang X, Kollins S (2022): Prenatal and Childhood Smoke Exposure Associations with Cognition, Language, and Attention-Deficit/Hyperactivity Disorder. J Pediatr. 2022 Dec 10:S0022-3476(22)01115-5. doi: 10.1016/j.jpeds.2022.11.041. PMID: 36513211. ↥
Rice, Langley, Woodford, Smith, Thapar (2018): Identifying the contribution of prenatal risk factors to offspring development and psychopathology: What designs to use and a critique of literature on maternal smoking and stress in pregnancy. Dev Psychopathol. 2018 Aug;30(3):1107-1128. doi: 10.1017/S0954579418000421. REVIEW ↥ ↥
Contreras D, Piña R, Carvallo C, Godoy F, Ugarte G, Zeise M, Rozas C, Morales B (2022): Methylphenidate Restores Behavioral and Neuroplasticity Impairments in the Prenatal Nicotine Exposure Mouse Model of ADHD: Evidence for Involvement of AMPA Receptor Subunit Composition and Synaptic Spine Morphology in the Hippocampus. Int J Mol Sci. 2022 Jun 26;23(13):7099. doi: 10.3390/ijms23137099. PMID: 35806103; PMCID: PMC9266648. ↥
Zhu J, Fan F, McCarthy DM, Zhang L, Cannon EN, Spencer TJ, Biederman J, Bhide PG (2017): A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes. Int J Dev Neurosci. 2017 May;58:26-34. doi: 10.1016/j.ijdevneu.2017.01.014. PMID: 28179105. ↥
Alkam, Mamiya, Kimura, Yoshida, Kihara, Tsunoda, Aoyama, Hiramatsu, Kim, Nabeshima (2017): Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice. Psychopharmacology (Berl). 2017 Jun;234(12):1853-1869. doi: 10.1007/s00213-017-4591-z. ↥ ↥
Bryden DW, Burton AC, Barnett BR, Cohen VJ, Hearn TN, Jones EA, Kariyil RJ, Kunin A, Kwak SI, Lee J, Lubinski BL, Rao GK, Zhan A, Roesch MR (2016): Prenatal Nicotine Exposure Impairs Executive Control Signals in Medial Prefrontal Cortex. Neuropsychopharmacology. 2016 Feb;41(3):716-25. doi: 10.1038/npp.2015.197. PMID: 26189451; PMCID: PMC4707818. ↥
Aoyagi Y, Momoi N, Kanai Y, Go H, Abe Y, Miyazaki K, Tomita Y, Hayashi M, Endo K, Mitomo M, Hosoya M (2020): Prenatal nicotine exposure affects cardiovascular function and growth of the developing fetus. J Obstet Gynaecol Res. 2020 Jul;46(7):1044-1054. doi: 10.1111/jog.14294. PMID: 32428988. ↥ ↥
Neuman, Lobos, Reich, Henderson, Sun, Todd (2007): Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol Psychiatry. 2007 Jun 15;61(12):1320-8. ↥
Dryden (2007): Prenatal smoking increases ADHD risk in some children. Erläuterung zu Neuman et al. ↥
Sánchez-Mora, Richarte, Garcia-Martínez, Pagerols, Corrales, Bosch, Vidal, Viladevall, Casas, Cormand, Ramos-Quiroga, Ribasés (2015): Dopamine receptor DRD4 gene and stressful life events in persistent attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):480-491. doi: 10.1002/ajmg.b.32340. ↥
Li Q, Cai X, Zhou H, Ma D, Li N (2024): Maternal smoking cessation in the first trimester still poses an increased risk of attention-deficit/hyperactivity disorder and learning disability in offspring. Front Public Health. 2024 Jul 16;12:1386137. doi: 10.3389/fpubh.2024.1386137. PMID: 39081356; PMCID: PMC11286595. ↥
RKI: Rauchen in der Schwangerschaft – Querschnittergebnisse aus KiGGS Welle 2 und Trends - Fact sheet - JoHM 1/2018 german ↥
RKI: Smoking during pregnancy. Results of the cross-sectional KiGGS Wave 2 study and trends english ↥
Tong VT, Jones JR, Dietz PM, D’Angelo D, Bombard JM; Centers for Disease Control and Prevention (CDC). Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. MMWR Surveill Summ (2009): 2009 May 29;58(4):1-29. PMID: 19478726. ↥ ↥
Allen H, Daw J (2025): Perinatal Smoking Patterns From Preconception to 1-Year Post Partum. JAMA Netw Open. 2025 Jan 2;8(1):e2454974. doi: 10.1001/jamanetworkopen.2024.54974. Erratum in: JAMA Netw Open. 2025 Feb 3;8(2):e253405. doi: 10.1001/jamanetworkopen.2025.3405. PMID: 39821402; PMCID: PMC11742529. ↥
Kipling L, Bombard J, Wang X, Cox S (2024): Cigarette Smoking Among Pregnant Women During the Perinatal Period: Prevalence and Health Care Provider Inquiries - Pregnancy Risk Assessment Monitoring System, United States, 2021. MMWR Morb Mortal Wkly Rep. 2024 May 2;73(17):393-398. doi: 10.15585/mmwr.mm7317a2. PMID: 38696343; PMCID: PMC11065467. ↥ ↥
Gilman SE, Breslau J, Subramanian SV, Hitsman B, Koenen KC (2008): Social factors, psychopathology, and maternal smoking during pregnancy. Am J Public Health. 2008 Mar;98(3):448-53. doi: 10.2105/AJPH.2006.102772. PMID: 17600245; PMCID: PMC2253564. ↥
Polli, Ipsen, Caballero-Puntiverio, Østerbøg, Aznar, Andreasen, Kohlmeier (2020): Cellular and Molecular Changes in Hippocampal Glutamate Signaling and Alterations in Learning, Attention, and Impulsivity Following Prenatal Nicotine Exposure. Mol Neurobiol. 2020 Jan 8. doi: 10.1007/s12035-019-01854-9. ↥ ↥
Collishaw S, Maughan B, Natarajan L, Pickles A (2010): Trends in adolescent emotional problems in England: a comparison of two national cohorts twenty years apart. J Child Psychol Psychiatry. 2010 Aug;51(8):885-94. doi: 10.1111/j.1469-7610.2010.02252.x. PMID: 20497281. ↥
Murphy JM, Horton NJ, Monson RR, Laird NM, Sobol AM, Leighton AH (2003): Cigarette smoking in relation to depression: historical trends from the Stirling County Study. Am J Psychiatry. 2003 Sep;160(9):1663-9. doi: 10.1176/appi.ajp.160.9.1663. PMID: 12944343. ↥
Polli, Kohlmeier (2019): Prenatal nicotine exposure in rodents: why are there so many variations in behavioral outcomes? Nicotine Tob Res. 2019 Oct 9. pii: ntz196. doi: 10.1093/ntr/ntz196. ↥
Robinson DM, Peebles KC, Kwok H, Adams BM, Clarke LL, Woollard GA, Funk GD (2002): Prenatal nicotine exposure increases apnoea and reduces nicotinic potentiation of hypoglossal inspiratory output in mice. J Physiol. 2002 Feb 1;538(Pt 3):957-73. doi: 10.1113/jphysiol.2001.012705. PMID: 11826179; PMCID: PMC2290085. ↥
Al-Hachim GM, Mahmoud FA (1985): Prenatal nicotine and CNS development. Epilepsia. 1985 Nov-Dec;26(6):661-5. doi: 10.1111/j.1528-1157.1985.tb05708.x. PMID: 4076070. ↥
Balsevich G, Poon A, Goldowitz D, Wilking JA (2014): The effects of pre- and post-natal nicotine exposure and genetic background on the striatum and behavioral phenotypes in the mouse. Behav Brain Res. 2014 Jun 1;266:7-18. doi: 10.1016/j.bbr.2014.02.038. PMID: 24607511. ↥
Pauly JR, Sparks JA, Hauser KF, Pauly TH (2004): In utero nicotine exposure causes persistent, gender-dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int J Dev Neurosci. 2004 Aug-Oct;22(5-6):329-37. doi: 10.1016/j.ijdevneu.2004.05.009. PMID: 15380832. ↥
Polli, Kohlmeier (2019): Alterations in NMDAR-mediated signaling within the laterodorsal tegmental nucleus are associated with prenatal nicotine exposure. Neuropharmacology. 2019 Aug 19;158:107744. doi: 10.1016/j.neuropharm.2019.107744. ↥
Buck, O’Neill, Stitzel (2019): Developmental nicotine exposure elicits multigenerational disequilibria in proBDNF proteolysis and glucocorticoid signaling in the frontal cortices, striata, and hippocampi of adolescent mice. Biochem Pharmacol. 2019 Aug 9;168:438-451. doi: 10.1016/j.bcp.2019.08.003. ↥
Buck, O’Neill, Stitzel (2020): Developmental nicotine exposure engenders intergenerational downregulation and aberrant posttranslational modification of cardinal epigenetic factors in the frontal cortices, striata, and hippocampi of adolescent mice. Epigenetics Chromatin. 2020 Mar 5;13(1):13. doi: 10.1186/s13072-020-00332-0. PMID: 32138755; PMCID: PMC7059320. ↥
Rizwan S, Manning JT, Brabin BJ (2007): Maternal smoking during pregnancy and possible effects of in utero testosterone: evidence from the 2D:4D finger length ratio. Early Hum Dev. 2007 Feb;83(2):87-90. doi: 10.1016/j.earlhumdev.2006.05.005. PMID: 16814493. ↥
Kalkbrenner AE, Zheng C, Yu J, Jenson TE, Kuhlwein T, Ladd-Acosta C, Grove J, Schendel D (2024): Method for Testing Etiologic Heterogeneity Among Non-Competing Diagnoses, Applied to Impact of Perinatal Exposures on Autism and Attention Deficit Hyperactivity Disorder. Epidemiology. 2024 Jul 18. doi: 10.1097/EDE.0000000000001760. PMID: 39024025. ↥
Batstra L, Neeleman J, Hadders-Algra M (2003): Can breast feeding modify the adverse effects of smoking during pregnancy on the child’s cognitive development? J Epidemiol Community Health. 2003 Jun;57(6):403-4. doi: 10.1136/jech.57.6.403. PMID: 12775783; PMCID: PMC1732491. ↥
Guedria A, Guedria M, Ben Fredj M, Ayoub R, Ben Abid H, Mhalla A, Slama H (2025): Factors associated with attention-deficit/hyperactivity disorder among Tunisian children. Front Psychiatry. 2025 Feb 7;16:1462099. doi: 10.3389/fpsyt.2025.1462099. PMID: 39990169; PMCID: PMC11842382. N = 154 ↥ ↥ ↥
Mahlberg, James, Bulten, Rodriguez, Kwan, Cairney (2019): Investigating the Association Between Exposure to Second Hand Smoke in utero and Developmental Coordination Disorder. Front Pediatr. 2019 Nov 5;7:438. doi: 10.3389/fped.2019.00438. eCollection 2019. ↥
Greenwood PB, DeSerisy M, Koe E, Rodriguez E, Salas L, Pereir FP, Herbstman J, Pagliaccio D, Margolis AE (2024): Combined and sequential exposure to prenatal second hand smoke and postnatal maternal distress is associated with cingulo-opercular global efficiency and attention problems in school-age children. Neurotoxicol Teratol. 2024 Feb 29:107338. doi: 10.1016/j.ntt.2024.107338. PMID: 38431065. ↥
Kaur S, Morales-Hidalgo P, Arija V, Canals J. Prenatal Exposure to Air Pollutants and Attentional Deficit Hyperactivity Disorder Development in Children: A Systematic Review. Int J Environ Res Public Health. 2023 Apr 7;20(8):5443. doi: 10.3390/ijerph20085443. PMID: 37107725; PMCID: PMC10138804. REVIEW ↥ ↥ ↥ ↥
Perera FP, Tang D, Wang S, Vishnevetsky J, Zhang B, Diaz D, Camann D, Rauh V (2012): Prenatal polycyclic aromatic hydrocarbon (PAH) exposure and child behavior at age 6-7 years. Environ Health Perspect. 2012 Jun;120(6):921-6. doi: 10.1289/ehp.1104315. PMID: 22440811; PMCID: PMC3385432. ↥ ↥
Perera FP, Chang HW, Tang D, Roen EL, Herbstman J, Margolis A, Huang TJ, Miller RL, Wang S, Rauh V (2014): Early-life exposure to polycyclic aromatic hydrocarbons and ADHD behavior problems. PLoS One. 2014 Nov 5;9(11):e111670. doi: 10.1371/journal.pone.0111670. PMID: 25372862; PMCID: PMC4221082. ↥ ↥
Pagliaccio D, Herbstman JB, Perera F, Tang D, Goldsmith J, Peterson BS, Rauh V, Margolis AE (2020): Prenatal exposure to polycyclic aromatic hydrocarbons modifies the effects of early life stress on attention and Thought Problems in late childhood. J Child Psychol Psychiatry. 2020 Nov;61(11):1253-1265. doi: 10.1111/jcpp.13189. Epub 2020 Jan 7. PMID: 31907931; PMCID: PMC7338249. ↥
Peterson, Bansal, Sawardekar, Nati, Elgabalawy, Hoepner, Garcia, Hao, Margolis, Perera, Rauh (2022): Prenatal exposure to air pollution is associated with altered brain structure, function, and metabolism in childhood. J Child Psychol Psychiatry. 2022 Feb 14. doi: 10.1111/jcpp.13578. PMID: 35165899. ↥ ↥
Perera FP, Wheelock K, Wang Y, Tang D, Margolis AE, Badia G, Cowell W, Miller RL, Rauh V, Wang S, Herbstman JB (2018): Combined effects of prenatal exposure to polycyclic aromatic hydrocarbons and material hardship on child ADHD behavior problems. Environ Res. 2018 Jan;160:506-513. doi: 10.1016/j.envres.2017.09.002. PMID: 28987706; PMCID: PMC5724364. ↥
Rezaei Kalantary, Jaffarzadeh, Rezapour, Hesami Arani (2020): Association between exposure to polycyclic aromatic hydrocarbons and attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2020 Apr;27(11):11531-11540. doi: 10.1007/s11356-020-08134-3. PMID: 32124297. n = 2.799, 6 Studien, REVIEW ↥
Emecheta EE, Borda DB, Pfohl PM, Wohlleben W,Hutzler C, Haase A, Roloff A (2022): A comparative investigation of the sorption of polycyclic aromatic hydrocarbons to various polydisperse micro- and nanoplastics using a novel third-phase partition method. Micropl.&Nanopl. 2, 29 (2022). https://doi.org/10.1186/s43591-022-00049-9 ↥
Peters, Frühgeborene und Schule – Ermutigt oder ausgebremst? Kapitel 2: Das Aufmerksamkeitsdefizitsyndrom (AD(H)S), Seite 126 ↥
http://www.adhs.org/genese/ mit weiteren Nachweisen ↥ ↥
van de Bor (2019): Fetal toxicology. Handb Clin Neurol. 2019;162:31-55. doi: 10.1016/B978-0-444-64029-1.00002-3. ↥
RÍsovÁ (2020): The pathway of lead through the mother’s body to the child. Interdiscip Toxicol. 2019 Sep;12(1):1-6. doi: 10.2478/intox-2019-0001. PMID: 32189981; PMCID: PMC7061448. REVIEW ↥
Cory-Slechta, Virgolini, Thiruchelvam, Weston, Bauter (2004): Maternal stress modulates the effects of developmental lead exposure. Environ Health Perspect. 2004 May;112(6):717-30. ↥
Cory-Slechta, Stern, Weston, Allen, Liu (2010): Enhanced learning deficits in female rats following lifetime pb exposure combined with prenatal stress. Toxicol Sci. 2010 Oct;117(2):427-38. doi: 10.1093/toxsci/kfq221. ↥
Sioen I, Den Hond E, Nelen V, Van de Mieroop E, Croes K, Van Larebeke N, Nawrot TS, Schoeters G (2013): Prenatal exposure to environmental contaminants and behavioural problems at age 7-8years. Environ Int. 2013 Sep;59:225-31. doi: 10.1016/j.envint.2013.06.014. PMID: 23845936. n = 270 ↥ ↥ ↥
Virgolini, Rossi-George, Lisek, Weston, Thiruchelvam, Cory-Slechta (2008): CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress. Neurotoxicology. 2008 Sep;29(5):812-27. doi: 10.1016/j.neuro.2008.03.003. ↥
Weston, Weston, Allen, Cory-Slechta (2014): Sex-dependent impacts of low-level lead exposure and prenatal stress on impulsive choice behavior and associated biochemical and neurochemical manifestations. Neurotoxicology. 2014 Sep;44:169-83. doi: 10.1016/j.neuro.2014.06.013. ↥
Austin, Curtin, Curtin, Gennings, Arora, Tammimies, Isaksson, Willfors, Bölte (2019): Dynamical properties of elemental metabolism distinguish attention deficit hyperactivity disorder from autism spectrum disorder. Transl Psychiatry. 2019 Sep 25;9(1):238. doi: 10.1038/s41398-019-0567-6. ↥
Markovac, Goldstein (1988): Picomolar concentrations of lead stimulate brain protein kinase C. Nature volume 334, pages 71–3, 1988 ↥
Arnsten (2009): Stress signalling pathways that impair prefrontal cortex structure and function. Nat Rev Neurosci. 2009 Jun;10(6):410-22. doi: 10.1038/nrn2648. ↥
Gedeon, Ramesh, Wellman, Jadhav (2001): Changes in mesocorticolimbic dopamine and D1/D2 receptor levels after low level lead exposure: a time course study, Toxicology Letters, Volume 123, Issues 2–3, 2001, Pages 217-226, ISSN 0378-4274, https://doi.org/10.1016/S0378-4274(01)00408-8 ↥ ↥
Morgan, Garavan, Smith, Driscoll, Levitsky, Strupp (2001): Early lead exposure produces lasting changes in sustained attention, response initiation, and reactivity to errors, Neurotoxicology and Teratology, Volume 23, Issue 6, 2001, Pages 519-531, ISSN 0892-0362, https://doi.org/10.1016/S0892-0362(01)00171-4. ↥ ↥
Lidsky, Schneider (2003): Lead neurotoxicity in children: basic mechanisms and clinical correlates, Brain, Volume 126, Issue 1, January 2003, Pages 5–19, https://doi.org/10.1093/brain/awg014 ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Cecil, Brubaker, Adler, Dietrich, Altaye, Egelhoff, Wessel, Elangovan, Hornung, Jarvis, Lanphear (2008) Decreased Brain Volume in Adults with Childhood Lead Exposure. PLoS Med 5(5): e112. https://doi.org/10.1371/journal.pmed.0050112. ↥
Nevin (2000): How Lead Exposure Relates to Temporal Changes in IQ, Violent Crime, and Unwed Pregnancy, Environmental Research, Volume 83, Issue 1, 2000, Pages 1-22, ISSN 0013-9351, https://doi.org/10.1006/enrs.1999.4045. ↥ ↥ ↥ ↥
Wright, Dietrich, Ris, Hornung, Wessel, Lanphear, Ho, Rae (2008): Association of Prenatal and Childhood Blood Lead Concentrations with Criminal Arrests in Early Adulthood. PLoS Med 5(5): e101. https://doi.org/10.1371/journal.pmed.0050101 ↥ ↥ ↥ ↥
Xi, Wu (2021): A Review on the Mechanism Between Different Factors and the Occurrence of Autism and ADHD. Psychol Res Behav Manag. 2021 Apr 9;14:393-403. doi: 10.2147/PRBM.S304450. PMID: 33859505; PMCID: PMC8044340. REVIEW ↥
Ribas-Fitó N, Torrent M, Carrizo D, Júlvez J, Grimalt JO, Sunyer J (2007): Exposure to hexachlorobenzene during pregnancy and children’s social behavior at 4 years of age. Environ Health Perspect. 2007 Mar;115(3):447-50. doi: 10.1289/ehp.9314. PMID: 17431497; PMCID: PMC1849941. N = 475 ↥
Forns J, Stigum H, Høyer BB, Sioen I, Sovcikova E, Nowack N, Lopez-Espinosa MJ, Guxens M, Ibarluzea J, Torrent M, Wittsiepe J, Govarts E, Trnovec T, Chevrier C, Toft G, Vrijheid M, Iszatt N, Eggesbø M (2018): Prenatal and postnatal exposure to persistent organic pollutants and attention-deficit and hyperactivity disorder: a pooled analysis of seven European birth cohort studies. Int J Epidemiol. 2018 Aug 1;47(4):1082-1097. doi: 10.1093/ije/dyy052. PMID: 29912347; PMCID: PMC6124627. N = 4.437 ↥ ↥
Kyriklaki A, Vafeiadi M, Kampouri M, Koutra K, Roumeliotaki T, Chalkiadaki G, Anousaki D, Rantakokko P, Kiviranta H, Fthenou E, Bitsios P, Kyrtopoulos SA, Kogevinas M, Chatzi L (2016): Prenatal exposure to persistent organic pollutants in association with offspring neuropsychological development at 4years of age: The Rhea mother-child cohort, Crete, Greece. Environ Int. 2016 Dec;97:204-211. doi: 10.1016/j.envint.2016.09.012. PMID: 27666324. n = 689 ↥ ↥
Vester, Caudle (2016): The Synapse as a Central Target for Neurodevelopmental Susceptibility to Pesticides. Toxics. 2016 Aug 26;4(3):18. doi: 10.3390/toxics4030018. PMID: 29051423; PMCID: PMC5606656. REVIEW ↥ ↥
Slotkin, Seidler (2007): Comparative developmental neurotoxicity of organophosphates in vivo: transcriptional responses of pathways for brain cell development, cell signaling, cytotoxicity and neurotransmitter systems. Brain Res Bull. 2007 May 30;72(4-6):232-74. doi: 10.1016/j.brainresbull.2007.01.005. PMID: 17452286; PMCID: PMC1945108. ↥
Rauh, Arunajadai, Horton, Perera, Hoepner, Barr, Whyatt (2011): Seven-year neurodevelopmental scores and prenatal exposure to chlorpyrifos, a common agricultural pesticide. Environ Health Perspect. 2011 Aug;119(8):1196-201. doi: 10.1289/ehp.1003160. PMID: 21507777; PMCID: PMC3237355. ↥
Bouchard, Chevrier, Harley, Kogut, Vedar, Calderon, Trujillo, Johnson, Bradman, Barr, Eskenazi (2011): Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environ Health Perspect. 2011 Aug;119(8):1189-95. doi: 10.1289/ehp.1003185. PMID: 21507776; PMCID: PMC3237357. ↥
Thistle, Ramos, Roell, Choi, Manley, Hall, Villanger, Cequier, Sakhi, Thomsen, Zeiner, Reichborn-Kjennerud, Øvergaard, Herring, Aase, Engel (2022): Prenatal organophosphorus pesticide exposure and executive function in preschool-aged children in the Norwegian Mother, Father and Child Cohort Study (MoBa). Environ Res. 2022 May 22:113555. doi: 10.1016/j.envres.2022.113555. PMID: 35613628.) ↥
Ho, Hoskins (1990): Dopamine in organophosphate-induced neurotoxicity. J Toxicol Sci . 1990 Dec;15 Suppl 4:159-61. doi: 10.2131/jts.15.supplementiv_159. REVIEW ↥
Manley, Villanger, Thomsen, Cequier, Sakhi, Reichborn-Kjennerud, Herring, Øvergaard, Zeiner, Roell, Engel, Kamai, Thistle, Hall, Aase, Engel (2022): Prenatal Exposure to Organophosphorus Pesticides and Preschool ADHD in the Norwegian Mother, Father and Child Cohort Study. Int J Environ Res Public Health. 2022 Jul 2;19(13):8148. doi: 10.3390/ijerph19138148. PMID: 35805806. ↥
Hall AM, Ramos AM, Drover SS, Choi G, Keil AP, Richardson DB, Martin CL, Olshan AF, Villanger GD, Reichborn-Kjennerud T, Zeiner P, Øvergaard KR, Sakhi AK, Thomsen C, Aase H, Engel SM (2022): Gestational organophosphate ester exposure and preschool attention-deficit/hyperactivity disorder in the Norwegian Mother, Father, and Child cohort study. Int J Hyg Environ Health. 2022 Nov 28;248:114078. doi: 10.1016/j.ijheh.2022.114078. PMID: 36455478. ↥
Zhou W, Deng Y, Zhang C, Dai H, Guan L, Luo X, He W, Tian J, Zhao L (2022): Chlorpyrifos residue level and ADHD among children aged 1-6 years in rural China: A cross-sectional study. Front Pediatr. 2022 Oct 14;10:952559. doi: 10.3389/fped.2022.952559. PMID: 36313880; PMCID: PMC9616114. ↥
Li H, Tong J, Wang X, Lu M, Yang F, Gao H, Gan H, Yan S, Gao G, Huang K, Cao Y, Tao F (2024): Associations of prenatal exposure to individual and mixed organophosphate esters with ADHD symptom trajectories in preschool children: The modifying effects of maternal Vitamin D. J Hazard Mater. 2024 Oct 5;478:135541. doi: 10.1016/j.jhazmat.2024.135541. PMID: 39154480. ↥
Carr RL, Alugubelly N, de Leon K, Loyant L, Mohammed AN, Patterson ME, Ross MK, Rowbotham NE (2020): Inhibition of fatty acid amide hydrolase by chlorpyrifos in juvenile rats results in altered exploratory and social behavior as adolescents. Neurotoxicology. 2020 Mar;77:127-136. doi: 10.1016/j.neuro.2020.01.002. PMID: 31931040; PMCID: PMC7986983. ↥
Hall AM, Thistle JE, Manley CK, Roell KR, Ramos AM, Villanger GD, Reichborn-Kjennerud T, Zeiner P, Cequier E, Sakhi AK, Thomsen C, Aase H, Engel SM (2022): Organophosphorus Pesticide Exposure at 17 Weeks’ Gestation and Odds of Offspring Attention-Deficit/Hyperactivity Disorder Diagnosis in the Norwegian Mother, Father, and Child Cohort Study. Int J Environ Res Public Health. 2022 Dec 15;19(24):16851. doi: 10.3390/ijerph192416851. PMID: 36554732; PMCID: PMC9778918. N = 849 ↥
Dalsager, Fage-Larsen, Bilenberg, Jensen, Nielsen, Kyhl, Grandjean, Andersen (2019): Maternal urinary concentrations of pyrethroid and chlorpyrifos metabolites and attention deficit hyperactivity disorder (ADHD) symptoms in 2-4-year-old children from the Odense Child Cohort. Environ Res. 2019 Sep;176:108533. doi: 10.1016/j.envres.2019.108533. ↥ ↥ ↥
Pitzer, Williams, Vorhees (2021) Effects of pyrethroids on brain development and behavior: Deltamethrin. Neurotoxicol Teratol. 2021 Apr 20;87:106983. doi: 10.1016/j.ntt.2021.106983. PMID: 33848594. REVIEW ↥ ↥
Koff L, Di Re J, Chand S, Avchalumov Y, Nguyen NM, Baumgartner TJ, Singh AK, Goode NA, Marosi M, Hallberg LM, Ameredes BT, Green TA, Yelamanchili SV, Pendyala G, Laezza F (2025): Early Life Exposure to Deltamethrin Impairs Synaptic Function by Altering the Brain-Derived Extracellular Vesicle Proteome. Mol Cell Proteomics. 2025 Feb;24(2):100902. doi: 10.1016/j.mcpro.2024.100902. PMID: 39746543; PMCID: PMC11847076. ↥
Xi, Yang, Yu, Li, He, El-Aziz, Zhao, Cao (2022): Influence of perinatal deltamethrin exposure at distinct developmental stages on motor activity, learning and memory. Ecotoxicol Environ Saf. 2022 Apr 1;236:113460. doi: 10.1016/j.ecoenv.2022.113460. PMID: 35378399. ↥
Nguyen JH, Curtis MA, Imami AS, Ryan WG, Alganem K, Neifer KL, Saferin N, Nawor CN, Kistler BP, Miller GW, Shukla R, McCullumsmith RE, Burkett JP (2025): Developmental pyrethroid exposure disrupts molecular pathways for MAP kinase and circadian rhythms in mouse brain. Physiol Genomics. 2025 Apr 1;57(4):240-253. doi: 10.1152/physiolgenomics.00033.2024. PMID: 39961078. ↥
Wang T, Wang B, Chen HR, Xu LH, Wang M, Li JJ, Shao J, Qi XM, Zhu QL, Xu DX, Meng XH (2025): Gestational exposure to fenvalerate induces attention-deficit hyperactivity disorder-like behaviors partially through altered DNA hydroxymethylation in the fetal midbrain of weaning offspring. Ecotoxicol Environ Saf. 2025 Sep 15;303:118812. doi: 10.1016/j.ecoenv.2025.118812. PMID: 40782536. ↥
Luo T, Xiao X, Li J, Chen S, Gui T, Song X, Li Y (2025): Effects of children exposure to pyrethroid pesticides during infancy and toddlerhood on their ADHD symptoms at preschool age: A prospective study in Southwestern China. Psychiatry Res. 2025 Oct;352:116659. doi: 10.1016/j.psychres.2025.116659. PMID: 40849996. ↥
Buchenauer L, Haange SB, Bauer M, Rolle-Kampczyk UE, Wagner M, Stucke J, Elter E, Fink B, Vass M, von Bergen M, Schulz A, Zenclussen AC, Junge KM, Stangl GI, Polte T (2023): Maternal exposure of mice to glyphosate induces depression- and anxiety-like behavior in the offspring via alterations of the gut-brain axis. Sci Total Environ. 2023 Sep 12;905:167034. doi: 10.1016/j.scitotenv.2023.167034. PMID: 37709081. ↥
Shaw W (2024): Hypothesis: 2 Major Environmental and Pharmaceutical Factors-Acetaminophen Exposure and Gastrointestinal Overgrowth of Clostridia Bacteria Induced By Ingestion of Glyphosate-Contaminated Foods-Dysregulate the Developmental Protein Sonic Hedgehog and Are Major Causes of Autism. Integr Med (Encinitas). 2024 Jul;23(3):12-23. PMID: 39114279; PMCID: PMC11302971. ↥ ↥
Sass JB, Donley N, Freese W (2024): Neonicotinoid pesticides: evidence of developmental neurotoxicity from regulatory rodent studies. Front Toxicol. 2024 Oct 2;6:1438890. doi: 10.3389/ftox.2024.1438890. PMID: 39415959; PMCID: PMC11480014. ↥
Barrett (2019): Attention Worthy: Prenatal Phthalate Exposure and Subsequent ADHD Diagnosis Science Selection; CID: 034001https://doi.org/10.1289/EHP3815 ↥
Almeida-Toledano L, Navarro-Tapia E, Sebastiani G, Ferrero-Martínez S, Ferrer-Aguilar P, García-Algar Ó, Andreu-Fernández V, Gómez-Roig MD (2024): Effect of prenatal phthalate exposure on fetal development and maternal/neonatal health consequences: A systematic review. Sci Total Environ. 2024 Nov 10;950:175080. doi: 10.1016/j.scitotenv.2024.175080. PMID: 39079634. REVIEW ↥
Kougias DG, Sellinger EP, Willing J, Juraska JM (2018): Perinatal Exposure to an Environmentally Relevant Mixture of Phthalates Results in a Lower Number of Neurons and Synapses in the Medial Prefrontal Cortex and Decreased Cognitive Flexibility in Adult Male and Female Rats. J Neurosci. 2018 Aug 1;38(31):6864-6872. doi: 10.1523/JNEUROSCI.0607-18.2018. PMID: 30012688; PMCID: PMC6070669. ↥
Radke, Braun, Nachman, Cooper (2020): Phthalate exposure and neurodevelopment: A systematic review and meta-analysis of human epidemiological evidence. Environ Int. 2020 Feb 8;137:105408. doi: 10.1016/j.envint.2019.105408. PMID: 32045779. REVIEW ↥
Minatoya, Kishi (2021): A Review of Recent Studies on Bisphenol A and Phthalate Exposures and Child Neurodevelopment. Int J Environ Res Public Health. 2021 Mar 30;18(7):3585. doi: 10.3390/ijerph18073585. PMID: 33808331. REVIEW ↥ ↥
Salazar, Villaseca, Cisternas, Inestrosa (2021). Neurodevelopmental impact of the offspring by thyroid hormone system-disrupting environmental chemicals during pregnancy. Environ Res. 2021 Jun 1;200:111345. doi: 10.1016/j.envres.2021.111345. PMID: 34087190. ↥
Elagali A, Eisner A, Tanner S, Drummond K, Symeonides C, Love C, Tang ML, Mansell T, Burgner D, Collier F, Sly PD, O’Hely M, Dunlop S, Vuillermin P, Ponsonby AL (2025): A pathway-based genetic score for inflammation: An indicator of vulnerability to phthalate-induced adverse neurodevelopment outcomes. Int J Hyg Environ Health. 2025 Mar;264:114514. doi: 10.1016/j.ijheh.2024.114514. PMID: 39721371. ↥ ↥
Ku, Tsai, Wang, Su, Sun, Wang, Wang (2019): Prenatal and childhood phthalate exposure and attention deficit hyperactivity disorder traits in child temperament: A 12-year follow-up birth cohort study. Sci Total Environ. 2019 Aug 29;699:134053. doi: 10.1016/j.scitotenv.2019.134053. ↥
Choi G, Villanger GD, Drover SSM, Sakhi AK, Thomsen C, Nethery RC, Zeiner P, Knudsen GP, Reichborn-Kjennerud T, Øvergaard KR, Herring AH, Skogan AH, Biele G, Aase H, Engel SM (2021): Prenatal phthalate exposures and executive function in preschool children. Environ Int. 2021 Apr;149:106403. doi: 10.1016/j.envint.2021.106403. PMID: 33524667; PMCID: PMC7945722. ↥
Ko MY, Park H, Chon SH, Lee BS, Cha SW, Hyun SA, Ka M (2023): Prenatal Di-methoxyethyl phthalate exposure impairs cortical neurogenesis and synaptic activity in the mice. Brain Pathol. 2023 Oct 30:e13221. doi: 10.1111/bpa.13221. PMID: 37903655. ↥
Yu ZX, Mo HY, Shan CH, Zhao YM, Zhou JX, Wang YF, Liu Y, Tong J, Geng ML, Wu X, Zhang Y, Zhu BB, Huang K, Tao FB, Gao H (2025): Risk of Neurodevelopmental Disorders in Preschool Children Associated with the Longitudinal Trajectory of Phthalates during Pregnancy: Potential Mechanisms Based on Metabonomics of Cord Blood. Environ Sci Technol. 2025 Aug 12;59(31):16180-16192. doi: 10.1021/acs.est.5c00115. PMID: 40720638. ↥ ↥ ↥ ↥
Zhang R, Manza P, Volkow ND (2022): Prenatal caffeine exposure: association with neurodevelopmental outcomes in 9- to 11-year-old children. J Child Psychol Psychiatry. 2022 May;63(5):563-578. doi: 10.1111/jcpp.13495. PMID: 34318489; PMCID: PMC9291501. ↥
Silva Bdel P, Anselmi L, Schmidt V, Santos IS (2015): Consumo de cafeína durante a gestação e transtorno de déficit de atenção e hiperatividade (TDAH): uma revisão sistemática da literatura [Caffeine consumption during pregnancy and attention deficit hyperactivity disorder (ADHD): a systematic literature review]. Cad Saude Publica. 2015 Apr;31(4):682-90. Portuguese. doi: 10.1590/0102-311x00142314. PMID: 25945978. REVIEW ↥
Linnet KM, Wisborg K, Secher NJ, Thomsen PH, Obel C, Dalsgaard S, Henriksen TB (2009): Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study. Acta Paediatr. 2009 Jan;98(1):173-9. doi: 10.1111/j.1651-2227.2008.00980.x. PMID: 18764862. ↥
Bekkhus M, Skjøthaug T, Nordhagen R, Borge AI (2010): Intrauterine exposure to caffeine and inattention/overactivity in children. Acta Paediatr. 2010 Jun;99(6):925-8. doi: 10.1111/j.1651-2227.2010.01744.x. PMID: 20219037. ↥
Cortés-Albornoz, García-Guáqueta, Velez-van-Meerbeke, Talero-Gutiérrez (2021): Maternal Nutrition and Neurodevelopment: A Scoping Review. Nutrients. 2021 Oct 8;13(10):3530. doi: 10.3390/nu13103530. PMID: 34684531; PMCID: PMC8538181. REVIEW ↥
Linnet KM, Dalsgaard S, Obel C, Wisborg K, Henriksen TB, Rodriguez A, Kotimaa A, Moilanen I, Thomsen PH, Olsen J, Jarvelin MR (2003): Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am J Psychiatry. 2003 Jun;160(6):1028-40. doi: 10.1176/appi.ajp.160.6.1028. PMID: 12777257. REVIEW ↥
Del-Ponte B, Santos IS, Tovo-Rodrigues L, Anselmi L, Munhoz TN, Matijasevich A (2016): Caffeine consumption during pregnancy and ADHD at the age of 11 years: a birth cohort study. BMJ Open. 2016 Dec 5;6(12):e012749. doi: 10.1136/bmjopen-2016-012749. PMID: 27920084; PMCID: PMC5168652. ↥
Loomans EM, Hofland L, van der Stelt O, van der Wal MF, Koot HM, Van den Bergh BR, Vrijkotte TG (2012): Caffeine intake during pregnancy and risk of problem behavior in 5- to 6-year-old children. Pediatrics. 2012 Aug;130(2):e305-13. doi: 10.1542/peds.2011-3361. PMID: 22778296. ↥
Modi H, Baranger DAA, Paul SE, Gorelik AJ, Hornstein A, Balbona JV, Agrawal A, Bijsterbosch JD, Bogdan R (2025): Associations between prenatal caffeine exposure and child development: Longitudinal results from the Adolescent Brain Cognitive Development (ABCD) Study. Neurotoxicol Teratol. 2025 Jan-Feb;107:107404. doi: 10.1016/j.ntt.2024.107404. PMID: 39592017. ↥ ↥
D’Urso S, Wootton RE, Ask H, Brito Nunes C, Andreassen OA, Hwang LD, Moen GH, Evans DM, Havdahl A (2024): Mendelian randomization analysis of maternal coffee consumption during pregnancy on offspring neurodevelopmental difficulties in the Norwegian Mother, Father and Child Cohort Study (MoBa). Psychol Med. 2024 Oct 9;54(12):1-14. doi: 10.1017/S0033291724002216. PMID: 39382486; PMCID: PMC11496242. ↥
Ouyang J, Wu P, Chen L, Tong J, Yan S, Li J, Tao F, Huang K (2025): Impact of tea and coffee consumption during pregnancy on children’s cognitive development. Sci Rep. 2025 Mar 14;15(1):8832. doi: 10.1038/s41598-025-91982-1. PMID: 40087371; PMCID: PMC11909266. ↥
Papadopoulou E, Botton J, Brantsæter AL, Haugen M, Alexander J, Meltzer HM, Bacelis J, Elfvin A, Jacobsson B, Sengpiel V (2018): Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study. BMJ Open. 2018 Apr 23;8(3):e018895. doi: 10.1136/bmjopen-2017-018895. PMID: 29685923; PMCID: PMC5914784. ↥
Jin F, Qiao C (2021): Association of maternal caffeine intake during pregnancy with low birth weight, childhood overweight, and obesity: a meta-analysis of cohort studies. Int J Obes (Lond). 2021 Feb;45(2):279-287. doi: 10.1038/s41366-020-0617-4. PMID: 32518355. REVIEW ↥
Nygaard, Slinning, Moe, Fjell, Walhovd (2019): Mental health in youth prenatally exposed to opioids and poly-drugs and raised in permanent foster/adoptive homes: A prospective longitudinal study. Early Hum Dev. 2019 Oct 29;140:104910. doi: 10.1016/j.earlhumdev.2019.104910. ↥
Bassalov H, Yakirevich-Amir N, Reuveni I, Monk C, Florentin S, Bonne O, Matok I (2024): Prenatal Cannabis Exposure and The Risk for Neuropsychiatric Anomalies in the Offspring: A Systematic Review and Meta-Analysis. Am J Obstet Gynecol. 2024 Jun 20:S0002-9378(24)00682-3. doi: 10.1016/j.ajog.2024.06.014. PMID: 38908654. METASTUDY ↥ ↥
Roncero, Valriberas-Herrero, Mezzatesta-Gava, Villegas, Aguilar, Grau-López (2020): Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod Health. 2020 Feb 17;17(1):25. doi: 10.1186/s12978-020-0880-9. PMID: 32066469; PMCID: PMC7027300. REVIEW ↥
Andrade C (2025): Maternal Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes During Childhood and Early Adult Life. J Clin Psychiatry. 2025 Jan 6;86(1):24f15753. doi: 10.4088/JCP.24f15753. PMID: 39832340. REVIEW ↥
Azubuike CD, Grundmann O, Goodin AJ (2025): Neurodevelopmental effects of perinatal exposure to cannabis on progeny: A narrative review. Drug Alcohol Depend Rep. 2025 Aug 19;16:100372. doi: 10.1016/j.dadr.2025.100372. PMID: 40896776; PMCID: PMC12396393. REVIEW ↥
Young-Wolff KC, Kong K, Alexeeff SE, Croen LA, Oberman N, Kirane H, Ansley D, Davignon M, Adams SR, Avalos LA (2025): Prenatal Cannabis Use and Offspring Attention Deficit Hyperactivity Disorder and Disruptive Behavior Disorders: A Retrospective Cohort Study. J Dev Behav Pediatr. 2025 Jan-Feb 01;46(1):e25-e32. doi: 10.1097/DBP.0000000000001323. PMID: 39400201; PMCID: PMC11832326. ↥
Baranger DA, Miller AP, Gorelik AJ, Paul SE, Hatoum AS, Johnson EC, Colbert SM, Smyser CD, Rogers CE, Bijsterbosch JD, Agrawal A, Bogdan R (2024): Prenatal cannabis exposure, the brain, and psychopathology during early adolescence. Nat Ment Health. 2024 Aug;2(8):975-986. doi: 10.1038/s44220-024-00281-7. PMID: 40836962; PMCID: PMC12363474. ↥
Zhou J, Tong J, Liang C, Wu P, Ouyang J, Cai W, Sheng J, Gao G, Yan S, Tao F, Huang K (2025): Prenatal placental metal accumulation and its association with child attention deficit/hyperactivity disorder and autism spectrum disorder symptom at 3 years of age: The role of psychosocial-environmental support in infancy. Environ Res. 2025 Mar 7;274:121294. doi: 10.1016/j.envres.2025.121294. PMID: 40058545. ↥ ↥ ↥
Kim, Jang, Lim, Kim, Shin, Lee, Kim, Hong (2020): The Effect of Prenatal Cadmium Exposure on Attention-deficit/Hyperactivity Disorder in 6-Year-old Children in Korea. J Prev Med Public Health. 2020 Jan;53(1):29-36. doi: 10.3961/jpmph.19.175. PMID: 32023672; PMCID: PMC7002990. ↥
Ibiwoye MO, Snyder EA, Lyons J, Vasauskas AA, Hernandez MJ, Summerlin AR, Foster JD (2022): The Effect of Short-Term Exposure to Cadmium on the Expression of Vascular Endothelial Barrier Antigen in the Developing Rat Forebrain and Cerebellum: A Computerized Quantitative Immunofluorescent Study. Cureus. 2022 Apr 5;14(4):e23848. doi: 10.7759/cureus.23848. PMID: 35402117; PMCID: PMC8986507. ↥
Shih, Zeng, Lin, Chen, Chen, Wu, Tseng, Wu (2018): Association between peripheral manganese levels and attention-deficit/hyperactivity disorder: a preliminary meta-analysis. Neuropsychiatr Dis Treat. 2018 Jul 18;14:1831-1842. doi: 10.2147/NDT.S165378. eCollection 2018. ↥
Schildroth S, Bauer JA, Friedman A, Austin C, Coull BA, Placidi D, White RF, Smith D, Wright RO, Lucchini RG, Arora M, Horton M, Claus Henn B (2023): Early life manganese exposure and reported attention-related behaviors in Italian adolescents. Environ Epidemiol. 2023 Oct 19;7(6):e274. doi: 10.1097/EE9.0000000000000274. PMID: 38912396; PMCID: PMC11189689. ↥
Smith DR, Strupp BJ. Animal Models of Childhood Exposure to Lead or Manganese: Evidence for Impaired Attention, Impulse Control, and Affect Regulation and Assessment of Potential Therapies. Neurotherapeutics. 2023 Feb 28. doi: 10.1007/s13311-023-01345-9. PMID: 36853434. ↥
Cowell, Wright (2017): Sex-Specific Effects of Combined Exposure to Chemical and Non-chemical Stressors on Neuroendocrine Development: a Review of Recent Findings and Putative Mechanisms. Current environmental health reports, 4(4), 415-425. ↥
Fang, Strodl, Liu, Liu, Yin, Wen, Sun, Xian, Jiang, Jing, Jin, Wu, Chen (2019): Association between prenatal exposure to household inhalants exposure and ADHD-like behaviors at around 3 years of age: Findings from Shenzhen Longhua Child Cohort Study. Environ Res. 2019 Jul 26;177:108612. doi: 10.1016/j.envres.2019.108612. ↥
Forns, Sunyer, Garcia-Esteban, Porta, Ghassabian, Giorgis-Allemand, Gong, Gehring, Sørensen, Standl, Sugiri, Almqvist, Andiarena, Badaloní, Beelen, Berdel, Cesaroni, Charles, Eriksen, Estarlich, Fernandez, Forhan, Jaddoe, Korek, Lichtenstein, Lertxundi, Lopez-Espinosa, Markevych, de Nazelle, Raaschou-Nielsen, Nieuwenhuijsen, Pérez-Lobato, Philippat, Slama, Tiesler, Verhulst, von Berg, Vrijkotte, Nybo Andersen, Heude, Krämer, Heinrich, Tiemeier, Forastiere, Pershagen, Brunekreef, Guxens (2018): Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe. Epidemiology. 2018 Jun 19. doi: 10.1097/EDE.0000000000000874.; n = 29.127 ↥
Aghaei, Janjani, Yousefian, Jamal, Yunesian (2019): Association between ambient gaseous and particulate air pollutants and attention deficit hyperactivity disorder (ADHD) in children; a systematic review. Environ Res. 2019 Mar 15;173:135-156. doi: 10.1016/j.envres.2019.03.030. REVIEW ↥
Chang YC, Chen WT, Su SH, Jung CR, Hwang BF (2022): PM2.5 exposure and incident attention-deficit/hyperactivity disorder during the prenatal and postnatal periods: A birth cohort study. Environ Res. 2022 Jun 28:113769. doi: 10.1016/j.envres.2022.113769. PMID: 35777438. n = 425.736 ↥
Mortamais, Pujol, Martínez-Vilavella, Fenoll, Reynes, Sabatier, Rivas, Forns, Vilor-Tejedor, Alemany, Cirach, Alvarez-Pedrerol, Nieuwenhuijsen, Sunyer (2019): Effects of prenatal exposure to particulate matter air pollution on corpus callosum and behavioral problems in children. Environ Res. 2019 Nov;178:108734. doi: 10.1016/j.envres.2019.108734. ↥
Carll, Salatini, Pirela, Wang, Xie, Lorkiewicz, Naeem, Qian, Castranova, Godleski, Demokritou (2020): Inhalation of printer-emitted particles impairs cardiac conduction, hemodynamics, and autonomic regulation and induces arrhythmia and electrical remodeling in rats. Part Fibre Toxicol. 2020 Jan 29;17(1):7. doi: 10.1186/s12989-019-0335-z. PMID: 31996220; PMCID: PMC6990551. ↥
Weitekamp, Hofmann (2021): Effects of air pollution exposure on social behavior: a synthesis and call for research. Environ Health. 2021 Jun 25;20(1):72. doi: 10.1186/s12940-021-00761-8. PMID: 34187479; PMCID: PMC8243425. REVIEW ↥ ↥ ↥ ↥
Emam, Shahsavani, Khodagholi, Zarandi, Hopke, Hadei, Behbahani, Yarahmadi (2020): Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring. Part Fibre Toxicol. 2020 Jan 29;17(1):8. doi: 10.1186/s12989-020-0336-y. PMID: 31996222; PMCID: PMC6990481. ↥
Win-Shwe, Fujitani, Kyi-Tha-Thu, Furuyama, Michikawa, Tsukahara, Nitta, Hirano (2014): Effects of diesel engine exhaust origin secondary organic aerosols on novel object recognition ability and maternal behavior in BALB/c mice. Int J Environ Res Public Health. 2014 Oct 30;11(11):11286-307. doi: 10.3390/ijerph111111286. PMID: 25361045; PMCID: PMC4245613. ↥
Patisaul (2017): Endocrine Disruption of Vasopressin Systems and Related Behaviors. Front Endocrinol (Lausanne). 2017 Jun 19;8:134. doi: 10.3389/fendo.2017.00134. PMID: 28674520; PMCID: PMC5475378. ↥
Fuertes E, Standl M, Forns J, Berdel D, Garcia-Aymerich J, Markevych I, Schulte-Koerne G, Sugiri D, Schikowski T, Tiesler CM, Heinrich J (2016): Traffic-related air pollution and hyperactivity/inattention, dyslexia and dyscalculia in adolescents of the German GINIplus and LISAplus birth cohorts. Environ Int. 2016 Dec;97:85-92. doi: 10.1016/j.envint.2016.10.017. PMID: 27835751. METASTUDIE ↥
Liu B, Fang X, Strodl E, He G, Ruan Z, Wang X, Liu L, Chen W (2022): Fetal Exposure to Air Pollution in Late Pregnancy Significantly Increases ADHD-Risk Behavior in Early Childhood. Int J Environ Res Public Health. 2022 Aug 23;19(17):10482. doi: 10.3390/ijerph191710482. PMID: 36078201; PMCID: PMC9518584. N = 26.052 ↥ ↥ ↥ ↥
Yorifuji T, Kashima S, Diez MH, Kado Y, Sanada S, Doi H (2017): Prenatal exposure to outdoor air pollution and child behavioral problems at school age in Japan. Environ Int. 2017 Feb;99:192-198. doi: 10.1016/j.envint.2016.11.016. PMID: 27890345. ↥ ↥ ↥ ↥ ↥ ↥
McGuinn LA, Bellinger DC, Colicino E, Coull BA, Just AC, Kloog I, Osorio-Valencia E, Schnaas L, Wright RJ, Téllez-Rojo MM, Wright RO, Horton MK (2020): Prenatal PM2.5 exposure and behavioral development in children from Mexico City. Neurotoxicology. 2020 Dec;81:109-115. doi: 10.1016/j.neuro.2020.09.036. Epub 2020 Sep 17. PMID: 32950567; PMCID: PMC7708408. ↥
Gong T, Almqvist C, Bölte S, Lichtenstein P, Anckarsäter H, Lind T, Lundholm C, Pershagen G (2014): Exposure to air pollution from traffic and neurodevelopmental disorders in Swedish twins. Twin Res Hum Genet. 2014 Dec;17(6):553-62. doi: 10.1017/thg.2014.58. PMID: 25229653. ↥ ↥
Forns J, Sunyer J, Garcia-Esteban R, Porta D, Ghassabian A, Giorgis-Allemand L, Gong T, Gehring U, Sørensen M, Standl M, Sugiri D, Almqvist C, Andiarena A, Badaloní C, Beelen R, Berdel D, Cesaroni G, Charles MA, Eriksen KT, Estarlich M, Fernandez MF, Forhan A, Jaddoe VWV, Korek M, Lichtenstein P, Lertxundi A, Lopez-Espinosa MJ, Markevych I, de Nazelle A, Raaschou-Nielsen O, Nieuwenhuijsen M, Pérez-Lobato R, Philippat C, Slama R, Tiesler CMT, Verhulst FC, von Berg A, Vrijkotte T, Nybo Andersen AM, Heude B, Krämer U, Heinrich J, Tiemeier H, Forastiere F, Pershagen G, Brunekreef B, Guxens M (2018): Air Pollution Exposure During Pregnancy and Symptoms of Attention Deficit and Hyperactivity Disorder in Children in Europe. Epidemiology. 2018 Sep;29(5):618-626. doi: 10.1097/EDE.0000000000000874. PMID: 29923866. METASTUDIE ↥
Shih P, Huang CC, Pan SC, Chiang TL, Guo YL (2020): Hyperactivity disorder in children related to traffic-based air pollution during pregnancy. Environ Res. 2020 Sep;188:109588. doi: 10.1016/j.envres.2020.109588. PMID: 32504847. ↥ ↥ ↥
Tartaglione AM, Camoni L, Calamandrei G, Chiarotti F, Venerosi A (2024): The contribution of environmental pollutants to the risk of autism and other neurodevelopmental disorders: A systematic review of case-control studies. Neurosci Biobehav Rev. 2024 Sep;164:105815. doi: 10.1016/j.neubiorev.2024.105815. PMID: 39053787. METASTUDY ↥
Chen G, Jin Z, Li S, Jin X, Tong S, Liu S, Yang Y, Huang H, Guo Y (2018): Early life exposure to particulate matter air pollution (PM1, PM2.5 and PM10) and autism in Shanghai, China: A case-control study. Environ Int. 2018 Dec;121(Pt 2):1121-1127. doi: 10.1016/j.envint.2018.10.026. PMID: 30409451. ↥
Bae HJ, Mony TJ, Park SJ (2025): Association between Prenatal Particulate Matter Exposure and Neuropsychiatric Disorders Development. Biomol Ther (Seoul). 2025 Jul 1;33(4):557-571. doi: 10.4062/biomolther.2025.031. PMID: 40494647; PMCID: PMC12215041. REVIEW ↥
Sentís A, Sunyer J, Dalmau-Bueno A, Andiarena A, Ballester F, Cirach M, Estarlich M, Fernández-Somoano A, Ibarluzea J, Íñiguez C, Lertxundi A, Tardón A, Nieuwenhuijsen M, Vrijheid M, Guxens M; INMA Project (2017). Prenatal and postnatal exposure to NO2 and child attentional function at 4-5years of age. Environ Int. 2017 Sep;106:170-177. doi: 10.1016/j.envint.2017.05.021. PMID: 28689118. ↥
Fuertes E, Standl M, Forns J, Berdel D, Garcia-Aymerich J, Markevych I, Schulte-Koerne G, Sugiri D, Schikowski T, Tiesler CM, Heinrich J (2016): Traffic-related air pollution and hyperactivity/inattention, dyslexia and dyscalculia in adolescents of the German GINIplus and LISAplus birth cohorts. Environ Int. 2016 Dec;97:85-92. doi: 10.1016/j.envint.2016.10.017. PMID: 27835751. METASTUDY ↥
Forns J, Sunyer J, Garcia-Esteban R, Porta D, Ghassabian A, Giorgis-Allemand L, Gong T, Gehring U, Sørensen M, Standl M, Sugiri D, Almqvist C, Andiarena A, Badaloní C, Beelen R, Berdel D, Cesaroni G, Charles MA, Eriksen KT, Estarlich M, Fernandez MF, Forhan A, Jaddoe VWV, Korek M, Lichtenstein P, Lertxundi A, Lopez-Espinosa MJ, Markevych I, de Nazelle A, Raaschou-Nielsen O, Nieuwenhuijsen M, Pérez-Lobato R, Philippat C, Slama R, Tiesler CMT, Verhulst FC, von Berg A, Vrijkotte T, Nybo Andersen AM, Heude B, Krämer U, Heinrich J, Tiemeier H, Forastiere F, Pershagen G, Brunekreef B, Guxens M (2018): Air Pollution Exposure During Pregnancy and Symptoms of Attention Deficit and Hyperactivity Disorder in Children in Europe. Epidemiology. 2018 Sep;29(5):618-626. doi: 10.1097/EDE.0000000000000874. PMID: 29923866. METASTUDY ↥
Oudin, Frondelius, Haglund, Källén, Forsberg, Gustafsson, Malmqvist (2019): Prenatal exposure to air pollution as a potential risk factor for autism and ADHD. Environ Int. 2019 Oct 16;133(Pt A):105149. doi: 10.1016/j.envint.2019.105149. ↥
Umweltbundesamt, abgerufen 30.11.23 ↥
Eubig PA, Aguiar A, Schantz SL (2010): Lead and PCBs as risk factors for attention deficit/hyperactivity disorder. Environ Health Perspect. 2010 Dec;118(12):1654-67. doi: 10.1289/ehp.0901852. PMID: 20829149; PMCID: PMC3002184. REVIEW ↥
Lopez-Garcia M, Martinez-Bebia M, Lopez-Moro A, Gimenez-Blasi N, Latorre JA, Mariscal-Arcas M (2025): Endocrine Disruptors and Attention Deficit Hyperactivity Disorder: A Systematic Review. Arch Med Res. 2025 Jun 21;56(7):103260. doi: 10.1016/j.arcmed.2025.103260. PMID: 40544787. REVIEW ↥ ↥
Chishti, Fisher, Seegal (1996): Aroclors 1254 and 1260 reduce dopamine concentrations in rat striatal slices. Neurotoxicology. 1996 Fall-Winter;17(3-4):653-60. ↥
Jones, Miller (2008): The effects of environmental neurotoxicants on the dopaminergic system: A possible role in drug addiction. Biochem Pharmacol. 2008 Sep 1;76(5):569-81. doi: 10.1016/j.bcp.2008.05.010. PMID: 18555207. REVIEW ↥ ↥
Grønnestad, Schlenk, Krøkje, Jaspers, Jenssen, Coffin, Bertotto, Giroux, Lyche, Arukwe (2021): Alteration of neuro-dopamine and steroid hormone homeostasis in wild Bank voles in relation to tissue concentrations of PFAS at a Nordic skiing area. Sci Total Environ. 2021 Feb 20;756:143745. doi: 10.1016/j.scitotenv.2020.143745. PMID: 33250251. ↥
Sammi, Foguth, Nieves, De Perre, Wipf, McMurray, Lee, Cannon (2019): Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegans. Toxicol Sci. 2019 Dec 1;172(2):417-434. doi: 10.1093/toxsci/kfz191. PMID: 31428778; PMCID: PMC6876260.) ↥
Foguth, Hoskins, Clark, Nelson, Flynn, de Perre, Hoverman, Lee, Sepúlveda, Cannon (2020): Single and mixture per- and polyfluoroalkyl substances accumulate in developing Northern leopard frog brains and produce complex neurotransmission alterations. Neurotoxicol Teratol. 2020 Sep-Oct;81:106907. doi: 10.1016/j.ntt.2020.106907. PMID: 32561179. ↥
Hmila I, Hill J, Shalaby KE, Ouararhni K, Abedsselem H, Modaresi SMS, Bihaqi SW, Marques E, Sondhi A, Slitt AL, Zawia NH (2024): Perinatal exposure to PFOS and sustained high-fat diet promote neurodevelopmental disorders via genomic reprogramming of pathways associated with neuromotor development. Ecotoxicol Environ Saf. 2024 Mar 1;272:116070. doi: 10.1016/j.ecoenv.2024.116070. PMID: 38340603. ↥ ↥
Symeonides C, Aromataris E, Mulders Y, Dizon J, Stern C, Barker TH, Whitehorn A, Pollock D, Marin T, Dunlop S (2024): An Umbrella Review of Meta-Analyses Evaluating Associations between Human Health and Exposure to Major Classes of Plastic-Associated Chemicals. Ann Glob Health. 2024 Aug 19;90(1):52. doi: 10.5334/aogh.4459. PMID: 39183960; PMCID: PMC11342836. ↥
Ames JL, Sharma V, Lyall K (2025): Effects of Early-life PFAS Exposure on Child Neurodevelopment: A Review of the Evidence and Research gaps. Curr Environ Health Rep. 2025 Jan 31;12(1):9. doi: 10.1007/s40572-024-00464-5. PMID: 39888511; PMCID: PMC11785707. REVIEW ↥
Skogheim, Villanger, Weyde, Engel, Surén, Øie, Skogan, Biele, Zeiner, Øvergaard, Haug, Sabaredzovic, Aase (2019): Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children. Int J Hyg Environ Health. 2019 Oct 22. pii: S1438-4639(19)30570-X. doi: 10.1016/j.ijheh.2019.10.003. ↥
Qu, Cao, Li, Wang, Liu, Wang, Nie, Sun, Liu, Zhang (2021): The association between maternal perfluoroalkyl substances exposure and early attention deficit hyperactivity disorder in children: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2021 Jul 9. doi: 10.1007/s11356-021-15136-2. PMID: 34244930. ↥
Yao H, Fu Y, Weng X, Zeng Z, Tan Y, Wu X, Zeng H, Yang Z, Li Y, Liang H, Wu Y, Wen L, Jing C (2023): The Association between Prenatal Per- and Polyfluoroalkyl Substances Exposure and Neurobehavioral Problems in Offspring: A Meta-Analysis. Int J Environ Res Public Health. 2023 Jan 17;20(3):1668. doi: 10.3390/ijerph20031668. PMID: 36767045. REVIEW ↥
Kim JI, Kim BN, Lee YA, Shin CH, Hong YC, Døssing LD, Hildebrandt G, Lim YH (2023): Association between early-childhood exposure to perfluoroalkyl substances and ADHD symptoms: A prospective cohort study. Sci Total Environ. 2023 Mar 25:163081. doi: 10.1016/j.scitotenv.2023.163081. PMID: 36972880. ↥
Tong, Liang, Huang, Xiang, Qi, Feng, Lai, Shao, Wu, Tao (2020): Prenatal serum thallium exposure and 36-month-old children’s attention-deficit/hyperactivity disorder symptoms: Ma’anshan birth cohort study. Chemosphere. 2020 Apr;244:125499. doi: 10.1016/j.chemosphere.2019.125499. PMID: 32050328. ↥
Zhang J, Yuan M, Liu Y, Zhong X, Wu J, Chen W (2025): Bisphenol A exposure and neurodevelopmental disorders and problems in children under 12 years of age: A systematic review and meta-analysis. J Hazard Mater. 2025 Jun 15;490:137731. doi: 10.1016/j.jhazmat.2025.137731. PMID: 40054188. METASTUDY ↥ ↥
Vian Matias de Oliveira I, Martins de Albuquerque F, de Jesus Fernandes A, Berti Zanella P, Alves Silva M (2025): Prenatal exposure to bisphenol-A and neurocognitive changes in children aged 2 to 5 years: a systematic review. Rev Environ Health. 2025 Aug 5;40(4):820-833. doi: 10.1515/reveh-2024-0161. PMID: 40760858. REVIEW ↥
Costa HE, Cairrao E (2024): Effect of bisphenol A on the neurological system: a review update. Arch Toxicol. 2024 Jan;98(1):1-73. doi: 10.1007/s00204-023-03614-0. PMID: 37855918; PMCID: PMC10761478. REVIEW ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD (2010): Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol. 2010 Apr;202(4):393.e1-7. doi: 10.1016/j.ajog.2010.01.025. PMID: 20350650. ↥
Corbel T, Gayrard V, Puel S, Lacroix MZ, Berrebi A, Gil S, Viguié C, Toutain PL, Picard-Hagen N (2014): Bidirectional placental transfer of Bisphenol A and its main metabolite, Bisphenol A-Glucuronide, in the isolated perfused human placenta. Reprod Toxicol. 2014 Aug;47:51-8. doi: 10.1016/j.reprotox.2014.06.001. PMID: 24933518. ↥
Grandin FC, Lacroix MZ, Gayrard V, Viguié C, Mila H, de Place A, Vayssière C, Morin M, Corbett J, Gayrard C, Gely CA, Toutain PL, Picard-Hagen N (2019): Is bisphenol S a safer alternative to bisphenol A in terms of potential fetal exposure? Placental transfer across the perfused human placenta. Chemosphere. 2019 Apr;221:471-478. doi: 10.1016/j.chemosphere.2019.01.065. PMID: 30654261. ↥
Ye X, Kuklenyik Z, Needham LL, Calafat AM (2006): Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography-isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):110-5. doi: 10.1016/j.jchromb.2005.11.050. PMID: 16377264. ↥
Ni Y, Hu L, Yang S, Ni L, Ma L, Zhao Y, Zheng A, Jin Y, Fu Z (2021): Bisphenol A impairs cognitive function and 5-HT metabolism in adult male mice by modulating the microbiota-gut-brain axis. Chemosphere. 2021 Nov;282:130952. doi: 10.1016/j.chemosphere.2021.130952. PMID: 34082316. ↥
Feng D, Zhang H, Jiang X, Zou J, Li Q, Mai H, Su D, Ling W, Feng X (2020): Bisphenol A exposure induces gut microbiota dysbiosis and consequent activation of gut-liver axis leading to hepatic steatosis in CD-1 mice. Environ Pollut. 2020 Oct;265(Pt A):114880. doi: 10.1016/j.envpol.2020.114880. PMID: 32540565. ↥
Lai KP, Chung YT, Li R, Wan HT, Wong CK (2016): Bisphenol A alters gut microbiome: Comparative metagenomics analysis. Environ Pollut. 2016 Nov;218:923-930. doi: 10.1016/j.envpol.2016.08.039. PMID: 27554980. ↥
Engdahl E, van Schijndel MDM, Voulgaris D, Di Criscio M, Ramsbottom KA, Rigden DJ, Herland A, Rüegg J (2021): Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP). Int J Mol Sci. 2021 May 24;22(11):5534. doi: 10.3390/ijms22115534. PMID: 34073890; PMCID: PMC8197233. ↥
Suresh S, Singh S A, Vellapandian C (2022): Bisphenol A exposure links to exacerbation of memory and cognitive impairment: A systematic review of the literature. Neurosci Biobehav Rev. 2022 Dec;143:104939. doi: 10.1016/j.neubiorev.2022.104939. PMID: 36328120. METASTUDY ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Stein TP (2024): Does Bisphenol A (BPA) Exposure Cause Human Diseases? Biomedicines. 2024 Nov 25;12(12):2678. doi: 10.3390/biomedicines12122678. PMID: 39767585; PMCID: PMC11727305. REVIEW ↥ ↥ ↥ ↥ ↥ ↥
Zoppé H, Xavier J, Dupuis A, Migeot V, Bioulac S, Hary R, Bonnet-Brilhault F, Albouy M (2024): Is exposure to Bisphenol A associated with Attention-deficit hyperactivity disorder (ADHD) and associated executive or behavioral problems in children? A comprehensive systematic review. Neurosci Biobehav Rev. 2024 Dec;167:105938. doi: 10.1016/j.neubiorev.2024.105938. PMID: 39551456. REVIEW ↥
Panagiotidou, Zerva, Mitsiou, Alexis, Kitraki (2014): Perinatal exposure to low-dose bisphenol A affects the neuroendocrine stress response in rats. J Endocrinol. 2014 Jan 27;220(3):207-18. doi: 10.1530/JOE-13-0416. ↥
Mao, Jain, Denslow, Nouri, Chen, Wang, Zhu, Koh, Sarma, Sumner, Lei, Sumner, Bivens, Roberts, Tuteja, Rosenfeld (2020): Bisphenol A and bisphenol S disruptions of the mouse placenta and potential effects on the placenta-brain axis. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4642-4652. doi: 10.1073/pnas.1919563117. Epub 2020 Feb 18. PMID: 32071231; PMCID: PMC7060676. ↥
Pham-The T, Nishijo M, Pham TN, Vu HT, Tran NN, Tran AH, Hoang LV, Do Q, Nishino Y, Nishijo H. (2022): Perinatal Dioxin Exposure and Attention Deficit Hyperactivity Disorder (ADHD) Symptoms in Children Living in a Dioxin Contamination Hotspot in Vietnam. Toxics. 2022 Apr 24;10(5):212. doi: 10.3390/toxics10050212. PMID: 35622626; PMCID: PMC9143824. ↥
Choi YJ, Cho J, Hong YC, Lee DW, Moon S, Park SJ, Lee KS, Shin CH, Lee YA, Kim BN, Kaminsky Z, Kim JI, Lim YH (2023): DNA methylation is associated with prenatal exposure to sulfur dioxide and childhood attention-deficit hyperactivity disorder symptoms. Sci Rep. 2023 Mar 1;13(1):3501. doi: 10.1038/s41598-023-29843-y. PMID: 36859453; PMCID: PMC9977725. N = 329 ↥
Yorifuji T, Kashima S, Higa Diez M, Kado Y, Sanada S, Doi H (2016)_ Prenatal Exposure to Traffic-related Air Pollution and Child Behavioral Development Milestone Delays in Japan. Epidemiology. 2016 Jan;27(1):57-65. doi: 10.1097/EDE.0000000000000361. PMID: 26247490. ↥
Park S, Cowell W, Margolis AE, Sjodin A, Jones R, Rauh V, Wang S, Herbstman JB (2023): Prenatal exposure to polybrominated diphenyl ethers and inattention/hyperactivity symptoms in mid to late adolescents. Front Epidemiol. 2023 Jun 21;3:1061234. doi: 10.3389/fepid.2023.1061234. PMID: 38455925; PMCID: PMC10910905. ↥
Ibarluzea J, Subiza-Pérez M, Arregi A, Molinuevo A, Arranz-Freijo E, Sánchez-de Miguel M, Jiménez A, Andiarena A, Santa-Marina L, Lertxundi A. Association of maternal prenatal urinary fluoride levels with ADHD symptoms in childhood. Environ Res. 2023 Jul 19;235:116705. doi: 10.1016/j.envres.2023.116705. PMID: 37479215. ↥
Wang A, Duan L, Huang H, Ma J, Zhang Y, Ma Q, Guo Y, Li Z, Cheng X, Zhu J, Zhou G, Ba Y (2022): Association between fluoride exposure and behavioural outcomes of school-age children: a pilot study in China. Int J Environ Health Res. 2022 Jan;32(1):232-241. doi: 10.1080/09603123.2020.1747601. PMID: 32281876. ↥
Riddell JK, Malin AJ, Flora D, McCague H, Till C (2019): Association of water fluoride and urinary fluoride concentrations with attention deficit hyperactivity disorder in Canadian youth. Environ Int. 2019 Dec;133(Pt B):105190. doi: 10.1016/j.envint.2019.105190. Erratum in: Environ Int. 2022 Mar;161:107091. PMID: 31654913; PMCID: PMC8118663. ↥
Chen S, Ahlqvist VH, Sjöqvist H, Stephansson O, Magnusson C, Dalman C, Karlsson H, Lee BK, Gardner RM (2024): Maternal intrahepatic cholestasis of pregnancy and neurodevelopmental conditions in offspring: A population-based cohort study of 2 million Swedish children. PLoS Med. 2024 Jan 16;21(1):e1004331. doi: 10.1371/journal.pmed.1004331. PMID: 38227577; PMCID: PMC10790993. ↥
Tsai MM, Chang JC, Lu HY, Gau SS, Chien YH, Hwu WL, Ni YH, Chen HL, Lee NC (2025): Long-term follow-up of neurocognitive function in patients with citrin deficiency and cholestasis. Clin Exp Pediatr. 2025 Mar;68(3):257-265. doi: 10.3345/cep.2024.01102. PMID: 39608367; PMCID: PMC11884951. ↥
Tamayo JM, Osman HC, Schwartzer JJ, Ashwood P (2023): The influence of asthma on neuroinflammation and neurodevelopment: From epidemiology to basic models. Brain Behav Immun. 2023 Dec 8;116:218-228. doi: 10.1016/j.bbi.2023.12.003. PMID: 38070621. REVIEW ↥
Brown AA, Widdowson M, Brandt S, Mohammadzadeh P, Rosenberg JB, Jepsen JRM, Ebdrup BH, Hernández-Lorca M, Bønnelykke K, Chawes B, Stokholm J, Thorsen J, Ibrahimi P, Li X, Sørensen SJ, Rasmussen MA (2025): Associations of the gut microbiome and inflammatory markers with mental health symptoms: a cross-sectional study on Danish adolescents. Sci Rep. 2025 Mar 26;15(1):10378. doi: 10.1038/s41598-025-94687-7. PMID: 40140473; PMCID: PMC11947166. ↥
Kemppainen M, Gissler M, Kirjavainen T (2025): Maternal asthma during pregnancy and the likelihood of neurodevelopmental disorders in offspring. Acta Obstet Gynecol Scand. 2025 Jan;104(1):235-244. doi: 10.1111/aogs.15008. PMID: 39540656; PMCID: PMC11683540. ↥ ↥
Walle KM, Gustavson K, Mjaaland S, Askeland RB, Magnus P, Susser E, Lipkin WI, Stoltenberg C, Bresnahan M, Reichborn-Kjennerud T, Hornig M, Ask H (2025): Maternal immune-mediated conditions and ADHD risk in offspring. BMC Med. 2025 Jul 1;23(1):348. doi: 10.1186/s12916-025-04227-3. PMID: 40597162; PMCID: PMC12210767. N = 104.270 mother-child pairs ↥ ↥ ↥ ↥
Zheng J, Chen J, Zhang Q, Ying L, Huang H, Yang J, Chen Z (2025): Association between maternal asthma and ASD/ADHD in offspring: A meta-analysis based on observational studies. NPJ Prim Care Respir Med. 2025 Jul 8;35(1):32. doi: 10.1038/s41533-025-00440-y. PMID: 40624093; PMCID: PMC12234711. METASTUDY ↥
Liu, Dalsgaard, Olsen, Li, Wright, Momen (2019): Parental asthma occurrence, exacerbations and risk of attention-deficit/hyperactivity disorder. Brain Behav Immun. 2019 Aug 30. pii: S0889-1591(19)30738-X. doi: 10.1016/j.bbi.2019.08.198. n = 961.202 ↥ ↥ ↥ ↥
Cowell, Bellinger, Wright, Wright (2019): Antenatal active maternal asthma and other atopic disorders is associated with ADHD behaviors among school-aged children. Brain Behav Immun. 2019 Aug;80:871-878. doi: 10.1016/j.bbi.2019.05.040. ↥
Bernal J. Action of thyroid hormone in brain. J Endocrinol Invest. 2002 Mar;25(3):268-88. doi: 10.1007/BF03344003. PMID: 11936472. REVIEW ↥
Thompson CC, Potter GB (2000): Thyroid hormone action in neural development. Cereb Cortex. 2000 Oct;10(10):939-45. doi: 10.1093/cercor/10.10.939. PMID: 11007544. REVIEW ↥
König S, Moura Neto V (2002): Thyroid hormone actions on neural cells. Cell Mol Neurobiol. 2002 Dec;22(5-6):517-44. doi: 10.1023/a:1021828218454. PMID: 12585678. REVIEW ↥
Evans IM, Sinha AK, Pickard MR, Edwards PR, Leonard AJ, Ekins RP (1999): Maternal hypothyroxinemia disrupts neurotransmitter metabolic enzymes in developing brain. J Endocrinol. 1999 May;161(2):273-9. doi: 10.1677/joe.0.1610273. PMID: 10320825. ↥
Klein RZ, Sargent JD, Larsen PR, Waisbren SE, Haddow JE, Mitchell ML. Relation of severity of maternal hypothyroidism to cognitive development of offspring. J Med Screen. 2001;8(1):18-20. doi: 10.1136/jms.8.1.18. PMID: 11373843. ↥
Downing S, Halpern L, Carswell J, Brown RS (2012): Severe maternal hypothyroidism corrected prior to the third trimester is associated with normal cognitive outcome in the offspring. Thyroid. 2012 Jun;22(6):625-30. doi: 10.1089/thy.2011.0257. PMID: 22574629. ↥
Idris I, Srinivasan R, Simm A, Page RC (2006): Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf). 2005 Nov;63(5):560-5. doi: 10.1111/j.1365-2265.2005.02382.x. PMID: 16268809. ↥
Siesser WB, Zhao J, Miller LR, Cheng SY, McDonald MP (2006): Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav. 2006 Apr;5(3):282-97. doi: 10.1111/j.1601-183X.2005.00161.x. Erratum in: Genes Brain Behav. 2006 Apr;5(3):298. PMID: 16594981. ↥
Feng Y, Li J, Lok KYW, Chau PH, Lu D, Kwok JYY (2025): Maternal thyroid dysfunction and stress during pregnancy on ADHD risk in preschoolers: a retrospective study. Eur Child Adolesc Psychiatry. 2025 Jun 23. doi: 10.1007/s00787-025-02792-9. PMID: 40549175. n = 5.602 ↥ ↥ ↥ ↥
Modesto, Tiemeier, Peeters, Jaddoe, Hofman, Verhulst, Ghassabian (2015): Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children. JAMA Pediatr. 2015 Sep;169(9):838-45. doi: 10.1001/jamapediatrics.2015.0498. PMID: 26146876. ↥
Hales, Taylor, Channon, McEwan, Thapar, Langley, Muller, Draman, Dayan, Gregory, Okosieme, Lazarus, Rees, Ludgate (2019): Controlled Antenatal Thyroid Screening II: effect of treating maternal sub-optimal thyroid function on child behaviour. J Clin Endocrinol Metab. 2019 Oct 29. pii: dgz098. doi: 10.1210/clinem/dgz098. ↥
Demeneix (2019): Evidence for Prenatal Exposure to Thyroid Disruptors and Adverse Effects on Brain Development. Eur Thyroid J. 2019 Dec;8(6):283-292. doi: 10.1159/000504668. PMID: 31934553; PMCID: PMC6944944. ↥
Levie, Korevaar, Mulder, Bath, Dineva, Lopez-Espinosa, Basterrechea, Santa Marina, Rebagliato, Sunyer, Rayman, Tiemeier, Peeters, Guxens (2019): Maternal Thyroid Function in Early Pregnancy and Child Attention-Deficit Hyperactivity Disorder: An Individual-Participant Meta-Analysis. Thyroid. 2019 Aug 20. doi: 10.1089/thy.2018.0794. ↥
Engel SM, Villanger GD, Herring A, Nethery RC, Drover SSM, Zoeller RT, Meltzer HM, Zeiner P, Knudsen GP, Reichborn-Kjennerud T, Longnecker MP, Aase H (2022): Gestational thyroid hormone concentrations and risk of attention-deficit hyperactivity disorder in the Norwegian Mother, Father and Child Cohort Study. Paediatr Perinat Epidemiol. 2022 Dec 8. doi: 10.1111/ppe.12941. PMID: 36482860. ↥
Umezu, Kita, Morita (2019): Hyperactive behavioral phenotypes and an altered brain monoaminergic state in male offspring mice with perinatal hypothyroidism. Toxicol Rep. 2019 Oct 7;6:1031-1039. doi: 10.1016/j.toxrep.2019.10.005. eCollection 2019. ↥
Andersen SL, Laurberg P, Wu CS, Olsen J (2014): Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG. 2014 Oct;121(11):1365-74. doi: 10.1111/1471-0528.12681. PMID: 24605987. ↥
Lin HY, Liang CS, Tsai SJ, Hsu JW, Huang KL, Su TP, Chen TJ, Bai YM, Hsu TW, Chen MH (2024): Congenital hypothyroidism and risk of subsequent autism spectrum disorder and attention-deficit/hyperactivity disorder in Taiwan. Psychiatry Clin Neurosci. 2024 Nov;78(11):721-725. doi: 10.1111/pcn.13733. PMID: 39254145. ↥
Villanger, Ystrom, Engel, Longnecker, Pettersen, Rowe, Reichborn-Kjennerud, Aase (2020): Neonatal thyroid-stimulating hormone and association with attention-deficit/hyperactivity disorder. Paediatr Perinat Epidemiol. 2020 Sep;34(5):590-596. doi: 10.1111/ppe.12643. PMID: 32072662; PMCID: PMC7431377. N = 1.497 ↥
Khan JY, Rajakumar RA, Devaskar UP, Weissfeld LA, Devaskar SU (1999): Effect of primary congenital hypothyroidism upon expression of genes mediating murine brain glucose uptake. Pediatr Res. 1999 May;45(5 Pt 1):718-25. doi: 10.1203/00006450-199905010-00019. PMID: 10231871. ↥
Buss, Entringer, Davis, Hobel, Swanson, Wadhwa, Sandman (2012): Impaired Executive Function Mediates the Association between Maternal Pre-Pregnancy Body Mass Index and Child ADHD Symptoms https://doi.org/10.1371/journal.pone.0037758 ↥
Sanchez CE, Barry C, Sabhlok A, Russell K, Majors A, Kollins SH, Fuemmeler BF (2018): Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis. Obes Rev. 2018 Apr;19(4):464-484. doi: 10.1111/obr.12643. PMID: 29164765; PMCID: PMC6059608. Meta-Analysis ↥
Duko B, Mengistu TS, Stacey D, Moran LJ, Tessema G, Pereira G, Bedaso A, Gebremedhin AT, Alati R, Ayonrinde OT, Benyamin B, Lee SH, Hyppönen E (2024): Associations between maternal preconception and pregnancy adiposity and neuropsychiatric and behavioral outcomes in the offspring: A systematic review and meta-analysis. Psychiatry Res. 2024 Dec;342:116149. doi: 10.1016/j.psychres.2024.116149. PMID: 39278191. REVIEW, n = 3.680.937 ↥
Nivins S, Kumar P, Chen X, Gissler M, Lavebratt C (2025): Prenatal exposure to maternal hypertension and higher body mass index and risks of neurodevelopmental and psychiatric disorders during childhood. Acta Obstet Gynecol Scand. 2025 Feb;104(2):319-330. doi: 10.1111/aogs.15021. PMID: 39611242; PMCID: PMC11782093. ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥ ↥
Eleftheriades A, Koulouraki S, Belegrinos A, Eleftheriades M, Pervanidou P (2025): Maternal Obesity and Neurodevelopment of the Offspring. Nutrients. 2025 Mar 2;17(5):891. doi: 10.3390/nu17050891. PMID: 40077761; PMCID: PMC11901708. REVIEW ↥
Nilsson IAK, Ozsvar J, Gissler M, Lavebratt C (2024): Maternal Eating Disorders, Body Mass Index, and Offspring Psychiatric Diagnoses. JAMA Netw Open. 2024 Oct 1;7(10):e2440517. doi: 10.1001/jamanetworkopen.2024.40517. PMID: 39436646; PMCID: PMC11581519. ↥ ↥
Kerri A, Heude B, Zoumenou R, Boivin MJ, Cot M, Massougbodji A, Bodeau-Livinec F (2026): Maternal anthropometric measurements in pregnancy and child neurocognitive and behavioral development at 1 and 6 years of age: A cohort study in Benin, Sub-Saharan Africa. Nutrition. 2026 Jan;141:112914. doi: 10.1016/j.nut.2025.112914. PMID: 40957183. N = 1.323 ↥
Jenabi, Bashirian, Khazaei, Basiri (2019): The maternal pre-pregnancy BMI and the risk of ADHD among children and adolescents: A systematic review and meta-Analysis. Korean J Pediatr. 2019 Jun 14. doi: 10.3345/kjp.2019.00185. REVIEW ↥
Robinson, Ghassabian, Sundaram, Trinh, Lin, Bell, Yeung (2020): Parental Weight Status and Offspring Behavioral Problems and Psychiatric Symptoms. J Pediatr. 2020 May;220:227-236.e1. doi: 10.1016/j.jpeds.2020.01.016. PMID: 32067780; PMCID: PMC7186145. ↥
Naef L, Srivastava L, Gratton A, Hendrickson H, Owens SM, Walker CD (2008): Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl). 2008 Mar;197(1):83-94. doi: 10.1007/s00213-007-1008-4. PMID: 18004547. ↥
Hughes AM, Sanderson E, Morris T, Ayorech Z, Tesli M, Ask H, Reichborn-Kjennerud T, Andreassen OA, Magnus P, Helgeland Ø, Johansson S, Njølstad P, Davey Smith G, Havdahl A, Howe LD, Davies NM (2022): Body mass index and childhood symptoms of depression, anxiety, and attention-deficit hyperactivity disorder: A within-family Mendelian randomization study. Elife. 2022 Dec 20;11:e74320. doi: 10.7554/eLife.74320. PMID: 36537070; PMCID: PMC9767454. N = 40.949 Familien ↥
Zhang H, Lin J, Zhao H (2024): Impacts of Maternal Preeclampsia Exposure on Offspring Neuronal Development: Recent Insights and Interventional Approaches. Int J Mol Sci. 2024 Oct 15;25(20):11062. doi: 10.3390/ijms252011062. PMID: 39456854; PMCID: PMC11508320. REVIEW ↥
Böhm S, Curran EA, Kenny LC, O’Keeffe GW, Murray D, Khashan AS (2019): The Effect of Hypertensive Disorders of Pregnancy on the Risk of ADHD in the Offspring. J Atten Disord. 2019 May;23(7):692-701. doi: 10.1177/1087054717690230. PMID: 28162026. ↥ ↥
Dachew BA, Scott JG, Mamun A, Alati R (2019): Pre-eclampsia and the risk of attention-deficit/hyperactivity disorder in offspring: Findings from the ALSPAC birth cohort study. Psychiatry Res. 2019 Feb;272:392-397. doi: 10.1016/j.psychres.2018.12.123. PMID: 30605798. ↥
Getahun, Rhoads, Demissie, Lu, Quinn, Fassett, Wing. Jacobsen (2013): In utero exposure to ischemic-hypoxic conditions and attention-deficit/hyperactivity disorder. Pediatrics 131 1 (2013): e53-61. ↥
Maher, Dalman, O’Keeffe, Kearney, McCarthy, Kenny, Khashan (2020): Association between preeclampsia and attention-deficit hyperactivity disorder: a population-based and sibling-matched cohort study. Acta Psychiatr Scand. 2020 Feb 13. doi: 10.1111/acps.13162. PMID: 32056200. n = 2.047.619 ↥
Zhen Lim TX, Pickering TA, Lee RH, Hauptman I, Wilson ML (2023): Hypertensive disorders of pregnancy and occurrence of ADHD, ASD, and epilepsy in the child: A meta-analysis. Pregnancy Hypertens. 2023 Sep;33:22-29. doi: 10.1016/j.preghy.2023.06.002. PMID: 37356382. METASTUDY ↥ ↥ ↥
Mann JR, McDermott S (2011): Are maternal genitourinary infection and pre-eclampsia associated with ADHD in school-aged children? J Atten Disord. 2011 Nov;15(8):667-73. doi: 10.1177/1087054710370566. PMID: 20837984. n = 84.721 ↥ ↥ ↥ ↥
Wang H, László KD, Gissler M, Li F, Zhang J, Yu Y, Li J (2021): Maternal hypertensive disorders and neurodevelopmental disorders in offspring: a population-based cohort in two Nordic countries. Eur J Epidemiol. 2021 May;36(5):519-530. doi: 10.1007/s10654-021-00756-2. PMID: 33948753; PMCID: PMC8159819. ↥ ↥ ↥ ↥ ↥
Qian L, Xin T, Xu W, Zhu J (2025): Effect of maternal gestational diabetes mellitus on neurodevelopment in late preterm infants at the corrected age of 12 months. Sci Rep. 2025 Apr 23;15(1):14139. doi: 10.1038/s41598-025-98987-w. PMID: 40269066; PMCID: PMC12019377. n = 205 ↥
Gumusoglu, Chilukuri, Santillan, Santillan, Stevens (2020): Neurodevelopmental Outcomes of Prenatal Preeclampsia Exposure. Trends Neurosci. 2020 Apr;43(4):253-268. doi: 10.1016/j.tins.2020.02.003. PMID: 32209456; PMCID: PMC7170230. REVIEW ↥
Zhao J, Xia L.(2022): Association between hypertensive disorders of pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring: a systematic review and meta-analysis. Hypertens Pregnancy. 2022 May 28:1-10. doi: 10.1080/10641955.2022.2079674. PMID: 35634947. REVIEW ↥ ↥
Ramos, de Mattos Hungria, Camerini, Suiama, Calzavara (2020): Potential beneficial effects of caffeine administration in the neonatal period of an animal model of schizophrenia. Behav Brain Res. 2020 Aug 5;391:112674. doi: 10.1016/j.bbr.2020.112674. PMID: 32417274. ↥
Triche, Grosso, Belanger, Darefsky, Benowitz, Bracken (2008): Chocolate consumption in pregnancy and reduced likelihood of preeclampsia. Epidemiology. 2008 May;19(3):459-64. doi: 10.1097/EDE.0b013e31816a1d17. PMID: 18379424; PMCID: PMC2782959. ↥
Assaf M, Rouphael M, Bou Sader Nehme S, Soufia M, Alameddine A, Hallit S, Landry M, Bitar T, Hleihel W (2024): Correlational Insights into Attention-Deficit/Hyperactivity Disorder in Lebanon. Int J Environ Res Public Health. 2024 Aug 5;21(8):1027. doi: 10.3390/ijerph21081027. PMID: 39200638; PMCID: PMC11353674. ↥ ↥
Li J, Olsen J, Vestergaard M, Obel C (2010): Attention-deficit/hyperactivity disorder in the offspring following prenatal maternal bereavement: a nationwide follow-up study in Denmark. Eur Child Adolesc Psychiatry. 2010 Oct;19(10):747-53. doi: 10.1007/s00787-010-0113-9. PMID: 20495989. ↥ ↥ ↥
Kacharava, Nemsadze, Inasaridze (2022): PRESENCE OF PRENATAL MATERNAL STRESS INCREASES THE RISK OF THE DEVELOPMENT OF ADHD SYMPTOMS IN YOUNG CHILDREN. Georgian Med News. 2022 Mar;(324):92-101. PMID: 35417868. ↥
Jallow J, Hurtig T, Kerkelä M, Miettunen J, Halt AH (2024): Prenatal maternal stress, breastfeeding and offspring ADHD symptoms. Eur Child Adolesc Psychiatry. 2024 Nov;33(11):4003-4011. doi: 10.1007/s00787-024-02451-5. PMID: 38691181; PMCID: PMC11588867. N = 7.910 ↥
Manzari, Matvienko-Sikar, Baldoni, O’Keeffe, Khashan (2019): Prenatal maternal stress and risk of neurodevelopmental disorders in the offspring: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol. 2019 Jul 20. doi: 10.1007/s00127-019-01745-3. REVIEW ↥
Class QA, Abel KM, Khashan AS, Rickert ME, Dalman C, Larsson H, Hultman CM, Långström N, Lichtenstein P, D’Onofrio BM (2014): Offspring psychopathology following preconception, prenatal and postnatal maternal bereavement stress. Psychol Med. 2014 Jan;44(1):71-84. doi: 10.1017/S0033291713000780. PMID: 23591021; PMCID: PMC3766407. ↥
Kim HJ, Ko EA, Kwon OB, Jung SC (2024): Prenatal treatment with corticosterone via maternal injection induces learning and memory impairments via delaying postsynaptic development in hippocampal CA1 neurons of rats. J Neurosci Res. 2024 Apr;102(4):e25323. doi: 10.1002/jnr.25323. PMID: 38553948. ↥
Wurmser, Rieger, Domogalla, Kahnt, Buchwald, Kowatsch, Kuehnert, Buske-Kirschbaum, Papousek, Pirke, von Voss (2006): Assiciation between life stress durcing prengnancy and infant crying in the first six months postpartum: A prospective longitudinal study. Early Human Development 82, 341-349 ↥
Talge, Neal, Glover (2007): Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):245-61. ↥
von Lüpke: Die ADHS-Problematik hat eine lange Geschichte, Seite 4 ↥
Bolea-Alamañac, Davies, Evans, Joinson, Pearson, Skapinakis, Emond (2019): Does maternal somatic anxiety in pregnancy predispose children to hyperactivity? Eur Child Adolesc Psychiatry. 2019 Mar 13. doi: 10.1007/s00787-019-01289-6. ↥
Lautarescu, Craig, Glover (2020): Prenatal stress: Effects on fetal and child brain development. Int Rev Neurobiol. 2020;150:17-40. doi: 10.1016/bs.irn.2019.11.002. PMID: 32204831. REVIEW ↥
Kacharava T, Nemsadze K, Inasaridze K (2024): Elevated level of prenatal testosterone and vitamin D3 deficiency during pregnancy, in the presence of prenatal maternal stress, and their association with the development of attention deficit hyperactivity disorder (ADHD)-like symptoms in toddlers. Pediatr Endocrinol Diabetes Metab. 2024;30(2):69-73. doi: 10.5114/pedm.2024.136278. PMID: 39026483; PMCID: PMC11249814. ↥ ↥ ↥
Rosenqvist, Sjölander, Ystrom, Larsson, Reichborn-Kjennerud (2018): Adverse family life events during pregnancy and ADHD symptoms in five-year-old offspring. J Child Psychol Psychiatry. 2018 Oct 27. doi: 10.1111/jcpp.12990. n = 34.751 ↥
Agapaki, Papagianni, Metallinou, Valavani, Mantzou, Kanelli, Eleftheriades, Spyropoulou, Zervas, Chrousos, Pervanidou (2022): Associations between Maternal and Offspring Hair Cortisol Concentrations and Child Behavioral Symptoms in Mother-Child Pairs with Perinatal Mental Disorders. Children (Basel). 2022 May 31;9(6):810. doi: 10.3390/children9060810. PMID: 35740747; PMCID: PMC9221619. ↥
Barzilay, Lawrence, Berliner, Gur, Leventer-Roberts, Weizman, Feldman (2019): Association between prenatal exposure to a 1-month period of repeated rocket attacks and neuropsychiatric outcomes up through age 9: a retrospective cohort study. Eur Child Adolesc Psychiatry. 2019 Nov 4. doi: 10.1007/s00787-019-01426-1. n = 14.053 ↥
Grizenko, Shayan, Polotskaia, Ter-Stepanian, Joober (2008): Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD; J Psychiatry Neurosci. 2008 Jan; 33(1): 10–16. PMCID: PMC2186370 ↥
Glover (2015): Prenatal stress and its effects on the fetus and the child: possible underlying biological mechanisms. Adv Neurobiol. 2015;10:269-83. doi: 10.1007/978-1-4939-1372-5_13. ↥
Van den Bergh, B. R.H. and Marcoen, A. (2004), High Antenatal Maternal Anxiety Is Related to ADHD Symptoms, Externalizing Problems, and Anxiety in 8- and 9-Year-Olds. Child Development, 75: 1085–1097. doi:10.1111/j.1467-8624.2004.00727.x ↥
Andreasen JJ, Tobiasen BB, Jensen RC, Boye H, Jensen TK, Bilenberg N, Andersen MS, Glintborg D (2023): Maternal cortisol in 3rd trimester is associated with traits of neurodevelopmental disorder in offspring. Odense Child Cohort. Psychoneuroendocrinology. 2023 Aug;154:106293. doi: 10.1016/j.psyneuen.2023.106293. PMID: 37207405. n = 717 Mutter-Kind-Paare ↥
O’Donnell, Glover, Lahti, Lahti, Edgar, Räikkönen, O’Connor (2017): Maternal prenatal anxiety and child COMT genotype predict working memory and symptoms of ADHD. PLoS One. 2017 Jun 14;12(6):e0177506. doi: 10.1371/journal.pone.0177506. eCollection 2017. ↥
Choudhry, Sengupta, Grizenko, Fortier, Thakur, Bellingham, Joober (2012): LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy. J Child Psychol Psychiatry. 2012 Aug;53(8):892-902. doi: 10.1111/j.1469-7610.2012.02551.x. PMID: 22486528. ↥
Grizenko N, Paci M, Joober R (2010): Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? J Atten Disord. 2010 May;13(6):649-57. doi: 10.1177/1087054709347200. PMID: 19767592. ↥
Grizenko N, Shayan YR, Polotskaia A, Ter-Stepanian M, Joober R (2008): Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J Psychiatry Neurosci. 2008 Jan;33(1):10-6. PMID: 18197267; PMCID: PMC2186370. ↥
Bronson, Bale (2014): Prenatal stress-induced increases in placental inflammation and offspring hyperactivity are male-specific and ameliorated by maternal antiinflammatory treatment. Endocrinology. 2014 Jul;155(7):2635-46. doi: 10.1210/en.2014-1040. ↥
Shaw, Crombie, Zakar, Palliser, Hirst (2019): Perinatal compromise contributes to programming of GABAergic and glutamatergic systems leading to long-term effects on offspring behaviour. J Neuroendocrinol. 2019 Nov 23:e12814. doi: 10.1111/jne.12814. ↥ ↥
Provençal, Arloth, Cattaneo, Anacker, Cattane, Wiechmann, Röh, Ködel, Klengel, Czamara, Müller, Lahti; PREDO team, Räikkönen, Pariante, Binder (2019): Glucocorticoid exposure during hippocampal neurogenesis primes future stress response by inducing changes in DNA methylation. Proc Natl Acad Sci U S A. 2019 Aug 9. pii: 201820842. doi: 10.1073/pnas.1820842116. ↥
Finik, Buthmann, Zhang, Go, Nomura (2020): Placental Gene Expression and Offspring Temperament Trajectories: Predicting Negative Affect in Early Childhood. J Abnorm Child Psychol. 2020 Jun;48(6):783-795. doi: 10.1007/s10802-020-00632-9. PMID: 32185610; PMCID: PMC7242121. ↥
Stonawski, Frey, Golub, Moll, Heinrich, Eichler (2018): [Epigenetic modifications in children associated with maternal emotional stress during pregnancy]. [Article in German] Z Kinder Jugendpsychiatr Psychother. 2018 Mar;46(2):155-167. doi: 10.1024/1422-4917/a000515. ↥
Suarez, Lahti, Lahti-Pulkkinen, Girchenko, Czamara, Arloth, Malmberg, Hämäläinen, Kajantie, Laivuori, Villa, Reynolds, Provençal, Binder, Räikkönen (2020): A polyepigenetic glucocorticoid exposure score at birth and childhood mental and behavioral disorders. Neurobiol Stress. 2020 Nov 21;13:100275. doi: 10.1016/j.ynstr.2020.100275. PMID: 33344728; PMCID: PMC7739178. N = 814 Kinder / childs von / of N = 408 Müttern / mothers ↥
Hanć, Gomula, Nowak-Szczepanska, Chakraborty, Kozieł (2022): Prenatal and early postnatal exposure to a natural disaster and Attention-Deficit/Hyperactivity Disorder symptoms in Indian children. Sci Rep. 2022 Sep 28;12(1):16235. doi: 10.1038/s41598-022-20609-6. PMID: 36171270. ↥
Bronson SL, Bale TL (2016): The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming. Neuropsychopharmacology. 2016 Jan;41(1):207-18. doi: 10.1038/npp.2015.231. PMID: 26250599; PMCID: PMC4677129. REVIEW ↥
Zucchi FC, Yao Y, Ward ID, Ilnytskyy Y, Olson DM, Benzies K, Kovalchuk I, Kovalchuk O, Metz GA (2013): Maternal stress induces epigenetic signatures of psychiatric and neurological diseases in the offspring. PLoS One. 2013;8(2):e56967. doi: 10.1371/journal.pone.0056967. PMID: 23451123; PMCID: PMC3579944. ↥
Oberlander TF, Weinberg J, Papsdorf M, Grunau R, Misri S, Devlin AM (2008): Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics. 2008 Mar-Apr;3(2):97-106. doi: 10.4161/epi.3.2.6034. PMID: 18536531. ↥ ↥
Álvarez-Mejía D, Rodas JA, Leon-Rojas JE (2025): From Womb to Mind: Prenatal Epigenetic Influences on Mental Health Disorders. Int J Mol Sci. 2025 Jun 25;26(13):6096. doi: 10.3390/ijms26136096. PMID: 40649875; PMCID: PMC12250387. REVIEW ↥
Dy, Guan, Sampath-Kumar, Richardson, Yang (2008): Placental 11beta-hydroxysteroid dehydrogenase type 2 is reduced in pregnancies complicated with idiopathic intrauterine growth Restriction: evidence that this is associated with an attenuated ratio of cortisone to cortisol in the umbilical artery. Placenta. 2008 Feb;29(2):193-200. doi: 10.1016/j.placenta.2007.10.010. PMID: 18061258. ↥
Zhu, Wang, Zuo, Sun (2019): Mechanisms for establishment of the placental glucocorticoid barrier, a guard for life. Cell Mol Life Sci. 2019 Jan;76(1):13-26. doi: 10.1007/s00018-018-2918-5. PMID: 30225585. REVIEW ↥ ↥ ↥
Doi, Usui, Shimada (2022): Prenatal Environment and Neurodevelopmental Disorders. Front Endocrinol (Lausanne). 2022 Mar 15;13:860110. doi: 10.3389/fendo.2022.860110. PMID: 35370942; PMCID: PMC8964779., REVIEW ↥
Babenko, Kovalchuk, Metz (2015): Stress-induced perinatal and transgenerational epigenetic programming of brain development and mental health. Neurosci Biobehav Rev. 2015 Jan;48:70-91. doi: 10.1016/j.neubiorev.2014.11.013. PMID: 25464029. REVIEW ↥
Doi, Oka, Taniguchi, Sato (2021): Transient expansion of the expression region of Hsd11b1, encoding 11β-hydroxysteroid dehydrogenase type 1, in the developing mouse neocortex. J Neurochem. 2021 Nov;159(4):778-788. doi: 10.1111/jnc.15505. PMID: 34490902. ↥
Mittal VA, Ellman LM, Cannon TD (2008): Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull. 2008 Nov;34(6):1083-94. doi: 10.1093/schbul/sbn080. PMID: 18635675; PMCID: PMC2632505. REVIEW ↥ ↥
Gustavson, Ask, Ystrom, Stoltenberg, Lipkin, Surén, Håberg, Magnus, Knudsen, Eilertsen, Bresnahan, Aase, Mjaaland, Susser, Hornig, Reichborn-Kjennerud (2019): Maternal fever during pregnancy and offspring attention deficit hyperactivity disorder. Sci Rep. 2019 Jul 2;9(1):9519. doi: 10.1038/s41598-019-45920-7. ↥ ↥
Borgert M, Melin A, Hollander AC, Rahman S (2024): Prenatal maternal PTSD as a risk factor for offspring ADHD: A register-based Swedish cohort study of 553 766 children and their mothers. Eur Psychiatry. 2024 Mar 1:1-19. doi: 10.1192/j.eurpsy.2024.21. PMID: 38425211. ↥
Heilbrun LP, Palmer RF, Jaen CR, Svoboda MD, Perkins J, Miller CS (2015): Maternal Chemical and Drug Intolerances: Potential Risk Factors for Autism and Attention Deficit Hyperactivity Disorder (ADHD). J Am Board Fam Med. 2015 Jul-Aug;28(4):461-70. doi: 10.3122/jabfm.2015.04.140192. PMID: 26152436. n = 694 ↥
Palmer RF, Kattari D, Rincon R, Miller CS (2024): Assessing Chemical Intolerance in Parents Predicts the Risk of Autism and ADHD in Their Children. J Xenobiot. 2024 Mar 5;14(1):350-367. doi: 10.3390/jox14010022. PMID: 38535497; PMCID: PMC10970846. N = 6.746 ↥
Şair, Sevinçok, Kutlu, Çakaloz, Sevinçok (2019): The affective temperament traits and pregnancy-related depression in mothers may constitute risk factors for their children with attention deficit and hyperactivity disorder. J Obstet Gynaecol. 2019 Dec 8:1-6. doi: 10.1080/01443615.2019.1679741. ↥
Lin YH, Tsai SJ, Bai YM, Chen TJ, Chen MH (2024): Risk of Neurodevelopmental Disorders in Offspring of Parents with Major Depressive Disorder: A Birth Cohort Study. J Autism Dev Disord. 2024 Aug 1. doi: 10.1007/s10803-024-06502-3. PMID: 39088144. ↥
Tusa BS, Alati R, Ayano G, Betts K, Weldesenbet AB, Dachew B (2024): The risk of attention deficit hyperactivity disorder symptoms in offspring of mothers with perinatal depression: A systematic review and meta-analysis. Asian J Psychiatr. 2024 Dec;102:104261. doi: 10.1016/j.ajp.2024.104261. PMID: 39405772. METASTUDY ↥
Hope H, Pierce M, Gabr H, Radojčić MR, Swift E, Taxiarchi VP, Abel KM (2024): The causal association between maternal depression, anxiety, and infection in pregnancy and neurodevelopmental disorders among 410 461 children: a population study using quasi-negative control cohorts and sibling analysis. Psychol Med. 2024 Jan 11:1-9. doi: 10.1017/S0033291723003604. PMID: 38205522. n = 410.461 ↥
Maleki, Bashirian, Soltanian, Jenabi, Farhadinasab (2021): Association between polycystic ovary syndrome and risk of attention-deficit/hyperactivity disorder in offspring: a meta-analysis. Clin Exp Pediatr. 2021 Apr 15. doi: 10.3345/cep.2021.00178. PMID: 33872487. METASTUDIE ↥
Kahn LG, Hipwell AE, Charifson M, Ling R, Cajachagua-Torres KN, Ghassabian A (2025): Maternal polycystic ovarian syndrome and offspring psychopathology and neurodevelopment. Hum Reprod. 2025 Jul 1;40(7):1257-1265. doi: 10.1093/humrep/deaf079. PMID: 40380372; PMCID: PMC12222619. REVIEW ↥
Kasum, Oresković (2010): Treatment of ovarian hyperstimulation syndrome: new insights. Acta Clin Croat. 2010 Dec;49(4):421-7. PMID: 21830453. REVIEW ↥
Bracero, Zacur (2001): Polycystic ovary syndrome and hyperprolactinemia. Obstet Gynecol Clin North Am. 2001 Mar;28(1):77-84. doi: 10.1016/s0889-8545(05)70186-8. PMID: 11293005. REVIEW ↥
Dalgaard, Andersen, Jensen, Larsen, Find, Boye, Jensen, Bilenberg, Glintborg (2021): Maternal polycystic ovary syndrome and attention deficit hyperactivity disorder in offspring at 3 years of age: Odense Child Cohort. Acta Obstet Gynecol Scand. 2021 Sep 6. doi: 10.1111/aogs.14259. PMID: 34490610. n = 1.776 Mütter ↥
Zhang Y, Lu D, Guo VY, Wang Y, Qiu S, Zhang J, Zhang Y, Chen W, Wang B, Yang W (2023): Association between maternal polycystic ovary syndrome and attention-deficit/hyperactivity disorder in offspring aged 3-6 years: A Chinese population-based study. Front Public Health. 2023 Jan 9;10:1032315. doi: 10.3389/fpubh.2022.1032315. PMID: 36699874; PMCID: PMC9868860. ↥
Hergüner S, Harmancı H, Toy H. Attention deficit-hyperactivity disorder symptoms in women with polycystic ovary syndrome. Int J Psychiatry Med. 2015;50(3):317-25. doi: 10.1177/0091217415610311. PMID: 26449924. n = 80 ↥
Brynge, Gardner, Sjöqvist, Karlsson, Dalman (2022): Maternal levels of acute phase proteins in early pregnancy and risk of autism spectrum disorders in offspring. Transl Psychiatry. 2022 Apr 7;12(1):148. doi: 10.1038/s41398-022-01907-z. PMID: 35393396. ↥
Sung JH, Kang D, Hong SY, Park H, Lee YR, Ham S, Cho J, Choi SJ, Roh CR, Oh SY (2025): Short- and Long-Term Neonatal Outcomes According to Cerclage in Nulliparous Singleton Women: A National Cohort Study Over 15 Years. J Korean Med Sci. 2025 Jul 7;40(26):e131. doi: 10.3346/jkms.2025.40.e131. PMID: 40625042; PMCID: PMC12235190. ↥ ↥
Walle KM, Gustavson K, Mjaaland S, Askeland RB, Magnus P, Susser E, Lipkin WI, Stoltenberg C, Bresnahan M, Reichborn-Kjennerud T, Hornig M, Ask H (2025): Maternal immune-mediated conditions and ADHD risk in offspring. BMC Med. 2025 Jul 1;23(1):348. doi: 10.1186/s12916-025-04227-3. PMID: 40597162; PMCID: PMC12210767. N = 104.270 mother-child-pairs ↥ ↥ ↥ ↥
Galera, Heude, Forhan, Bernard, Peyre, Van der Waerden, Pryor, Bouvard, Melchior, Lioret, de Lauzon-Guillain (2018): EDEN Mother-Child Cohort Study Group. Prenatal diet and children’s trajectories of hyperactivity-inattention and conduct problems from 3 to 8 years: the EDEN mother-child cohort. J Child Psychol Psychiatry. 2018 Sep;59(9):1003-1011. doi: 10.1111/jcpp.12898. PMID: 29573342. n = 1.242 Mutter-Kind-Paare / mother-child-pairs ↥
Leccese L, Nisticò L, Culasso M, Pizzi C, Lastrucci V, Gagliardi L, Brescianini S (2025): Maternal Dietary Pattern in Pregnancy and Behavioral Outcomes at 4 Years of Age in the Piccolipiù Cohort: Potential Sex-Related Differences. Nutrients. 2025 Aug 29;17(17):2814. doi: 10.3390/nu17172814. PMID: 40944202; PMCID: PMC12430498. N = 2.006 ↥
Lin PC, Liang CS, Tsai CK, Tsai SJ, Chen TJ, Bai YM, Chen MH (2022): Associations of a family history of lupus with the risks of lupus and major psychiatric disorders in first-degree relatives. QJM. 2022 Jun 27:hcac153. doi: 10.1093/qjmed/hcac153. PMID: 35758635. ↥
Libutzki B, Neukirch B, Reif A, Hartman CA (2024): Somatic burden of attention-deficit/hyperactivity disorder across the lifecourse. Acta Psychiatr Scand. 2024 Aug;150(2):105-117. doi: 10.1111/acps.13694. PMID: 38804256. ↥
Buckley D, Khashan AS, McCarthy FP, O’Connor K, Maher GM (2025): The Association between Threatened Miscarriage and Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder in Offspring by Age 14 Years. J Autism Dev Disord. 2025 Mar;55(3):1057-1066. doi: 10.1007/s10803-024-06251-3. PMID: 38281274; PMCID: PMC11828788. ↥ ↥
Dudukina E, Horváth-Puhó E, Sørensen HT, Ehrenstein V (2021): Long-term risk of epilepsy, cerebral palsy and attention-deficit/hyperactivity disorder in children affected by a threatened abortion in utero. Int J Epidemiol. 2021 Nov 10;50(5):1540-1553. doi: 10.1093/ije/dyab069. Erratum in: Int J Epidemiol. 2022 Jun 13;51(3):1034. doi: 10.1093/ije/dyac077. PMID: 33846731. ↥
Zeng, Tang, Yue, Li, Qiu, Hu, Tang, Wang, Yang, Qu, Mu (2019): Cumulative evidence for association of parental diabetes mellitus and attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2019 Nov 7. pii: S0149-7634(19)30721-3. doi: 10.1016/j.neubiorev.2019.11.003. n = 5 Mio ↥
Pretorius RA, Avraam D, Guxens M, Julvez J, Harris JR, Nader JT, Cadman T, Elhakeem A, Strandberg-Larsen K, Marroun HE, Defina S, Yang TC, McEachan R, Wright J, Ibarluzea J, Santa-Marina L, Delgado JM, Rebagliato M, Charles MA, Vainqueur C, Maritano S, Zugna D, Yuan WL, Heude B, Huang RC (2025): Is maternal diabetes during pregnancy associated with neurodevelopmental, cognitive and behavioural outcomes in children? Insights from individual participant data meta-analysis in ten birth cohorts. BMC Pediatr. 2025 Jan 30;25(1):76. doi: 10.1186/s12887-024-05365-y. PMID: 39885386; PMCID: PMC11783732. METASTUDY, k = 10 ↥
Damtie Y, Dachew BA, Ayano G, Tadesse AW, Betts K, Alati R (2025): The association between maternal diabetes and the risk of attention deficit hyperactivity disorder in offspring: an updated systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2025 Jan 28. doi: 10.1007/s00787-025-02645-5. PMID: 39873760. METASTUDY, k = 17, n = 18.063.336 ↥
Ornoy, Becker, Weinstein-Fudim, Ergaz (2021): Diabetes during Pregnancy: A Maternal Disease Complicating the Course of Pregnancy with Long-Term Deleterious Effects on the Offspring. A Clinical Review. Int J Mol Sci. 2021 Mar 15;22(6):2965. doi: 10.3390/ijms22062965. PMID: 33803995. REVIEW ↥
Rodolaki K, Pergialiotis V, Iakovidou N, Boutsikou T, Iliodromiti Z, Kanaka-Gantenbein C (2023): The impact of maternal diabetes on the future health and neurodevelopment of the offspring: a review of the evidence. Front Endocrinol (Lausanne). 2023 Jul 3;14:1125628. doi: 10.3389/fendo.2023.1125628. PMID: 37469977; PMCID: PMC10352101. REVIEW ↥
Lin, Lin, Chou, Lee, Hong (2019): Infants of Mothers With Diabetes and Subsequent Attention Deficit Hyperactivity Disorder: A Retrospective Cohort Study. Front Pediatr. 2019 Nov 4;7:452. doi: 10.3389/fped.2019.00452. eCollection 2019. ↥
Chen S, Persson M, Wang R, Dalman C, Lee BK, Karlsson H, Gardner RM (2023): Random capillary glucose levels throughout pregnancy, obstetric and neonatal outcomes, and long-term neurodevelopmental conditions in children: a group-based trajectory analysis. BMC Med. 2023 Jul 19;21(1):260. doi: 10.1186/s12916-023-02926-3. PMID: 37468907; PMCID: PMC10354916. ↥
Zeng, Tang, Yue, Li, Qiu, Hu, Tang, Wang, Yang, Qu, Mu (2019): Cumulative evidence for association of parental diabetes mellitus and attention-deficit/hyperactivity disorder. Neurosci Biobehav Rev. 2019 Nov 7. pii: S0149-7634(19)30721-3. doi: 10.1016/j.neubiorev.2019.11.003. METASTUDY ↥ ↥ ↥
Kong, Nilsson, Brismar, Gissler, Lavebratt (2020): Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA Netw Open. 2020 Feb 5;3(2):e1920787. doi: 10.1001/jamanetworkopen.2019.20787. PMID: 32031649. n = 649.043 ↥
Damtie Y, Betts K, Dachew BA, Ayano G, Alati R (2025): The association between maternal diabetes, antidiabetic medication use, and severe ADHD requiring inpatient care: A registry-based cohort study. J Psychosom Res. 2025 Aug;195:112167. doi: 10.1016/j.jpsychores.2025.112167. PMID: 40466253. ↥
Li DJ, Tsai SJ, Chen TJ, Liang CS, Chen MH (2024): Risk of major mental disorders in the offspring of parents with migraine. Ann Gen Psychiatry. 2024 Jun 22;23(1):23. doi: 10.1186/s12991-024-00508-y. PMID: 38909222; PMCID: PMC11193281. ↥
Wiegersma, Dalman, Lee, Karlsson, Gardner (2019): Association of Prenatal Maternal Anemia With Neurodevelopmental Disorders. JAMA Psychiatry. 2019 Sep 18:1-12. doi: 10.1001/jamapsychiatry.2019.2309. ↥
Ayubi E, Mansori K (2023): Maternal Infection during Pregnancy and Attention-Deficit Hyperactivity Disorder in Children: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022 Dec;51(12):2674-2687. doi: 10.18502/ijph.v51i12.11458. PMID: 36742242; PMCID: PMC9874197. ↥
Lin MC, Pan YJ, Wu CS, Liu CL, Chen PC, Thompson WK, Fan CC, Wang SH (2025): Prenatal and early childhood infections requiring hospitalization and risk of neurodevelopmental disorders in offspring: a population-based birth cohort study in Taiwan. Mol Psychiatry. 2025 May;30(5):1791-1800. doi: 10.1038/s41380-024-02787-z. PMID: 39390224. ↥
Borbye-Lorenzen N, Holmgaard S, Ottosson F, Nudel R, Appadurai V, Laursen TM, Bækvad-Hansen M, Bybjerg-Grauholm J, Nordentoft M, Børglum AD, Mortensen PB, Werge T, Benros ME, Hougaard DM, Skogstrand K (2025): High level of immunoglobulin G targeting mycoplasma or cytomegalovirus in the newborn increases risk of ADHD. Brain Behav Immun. 2025 Jan;123:99-107. doi: 10.1016/j.bbi.2024.09.009. PMID: 39260764. ↥ ↥
Yates EF, Mulkey SB (2024): Viral infections in pregnancy and impact on offspring neurodevelopment: mechanisms and lessons learned. Pediatr Res. 2024 Mar 20. doi: 10.1038/s41390-024-03145-z. PMID: 38509227. REVIEW ↥
Verlaet, Noriega, Hermans, Savelkoul (2014): Nutrition, immunological mechanisms and dietary immunomodulation in ADHD. Eur Child Adolesc Psychiatry. 2014 Jul;23(7):519-29. doi: 10.1007/s00787-014-0522-2. PMID: 24493267. REVIEW ↥
Hutton J (2023): Developmental Outcomes in Children Born to Women with Possible Subclinical Rubella Exposures During Pregnancy. J Med Virol. 2023 Jan 21. doi: 10.1002/jmv.28517. PMID: 36680415. ↥
Simanek AM, Meier HC (2015): Association Between Prenatal Exposure to Maternal Infection and Offspring Mood Disorders: A Review of the Literature. Curr Probl Pediatr Adolesc Health Care. 2015 Nov;45(11):325-64. doi: 10.1016/j.cppeds.2015.06.008. PMID: 26476880. REVIEW ↥ ↥
Flinkkilä E, Keski-Rahkonen A, Marttunen M, Raevuori A (2016): Prenatal Inflammation, Infections and Mental Disorders. Psychopathology. 2016;49(5):317-333. doi: 10.1159/000448054. PMID: 27529630. REVIEW ↥
Silva D, Colvin L, Hagemann E, Bower C (2014): Environmental risk factors by gender associated with attention-deficit/hyperactivity disorder. Pediatrics. 2014 Jan;133(1):e14-22. doi: 10.1542/peds.2013-1434. PMID: 24298003. ↥
Gibson B, Goodfriend E, Zhong Y, Melhem NM (2023): Fetal inflammatory response and risk for psychiatric disorders. Transl Psychiatry. 2023 Jun 24;13(1):224. doi: 10.1038/s41398-023-02505-3. PMID: 37355708; PMCID: PMC10290670. ↥
Atkinson JA, Gordon HG, Tong S, Walker SP, Mehdipour P, Lindquist AC, Hastie RM (2025): Hypertensive disorders of pregnancy and childhood neurodevelopment: A systematic review and meta-analysis. PLoS Med. 2025 Sep 10;22(9):e1004558. doi: 10.1371/journal.pmed.1004558. PMID: 40929171; PMCID: PMC12422451. METASTUDY ↥ ↥ ↥ ↥
Dachew BA, Scott JG, Betts K, Mamun A, Alati R (2020): Hypertensive disorders of pregnancy and the risk of offspring depression in childhood: Findings from the Avon Longitudinal Study of Parents and Children. Dev Psychopathol. 2020 Aug;32(3):845-851. doi: 10.1017/S0954579419000944. PMID: 31345273. ↥
Nijsten, Jansen, Limpens, Finken, Koot, Grooten, Roseboom, Painter (2022): Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022 Mar 30:S0002-9378(22)00249-6. doi: 10.1016/j.ajog.2022.03.052. PMID: 35367190. ↥
Eyles, Burne, McGrath (2013): Vitamin D, effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Front Neuroendocrinol. 2013 Jan;34(1):47-64. doi: 10.1016/j.yfrne.2012.07.001. PMID: 22796576. REVIEW ↥
Kesby, Eyles, Burne, McGrath (2011): The effects of vitamin D on brain development and adult brain function. Mol Cell Endocrinol. 2011 Dec 5;347(1-2):121-7. doi: 10.1016/j.mce.2011.05.014. PMID: 21664231. REVIEW ↥
Eyles, Feron, Cui, Kesby, Harms, Ko, McGrath, Burne (2009): Developmental vitamin D deficiency causes abnormal brain development, Psychoneuroendocrinology, Volume 34, Supplement 1, 2009, Pages S247-S257, ISSN 0306-4530, https://doi.org/10.1016/j.psyneuen.2009.04.015. ↥
Almeras, Eyles, Benech, Laffite, Villard, Patatian, Boucraut, Mackay‐Sim, McGrath, Féron (2007): Developmental vitamin D deficiency alters brain protein expression in the adult rat: Implications for neuropsychiatric disorders. Proteomics, 7: 769-780. https://doi.org/10.1002/pmic.200600392 ↥
Chien MC, Huang CY, Wang JH, Shih CL, Wu P (2024): Effects of vitamin D in pregnancy on maternal and offspring health-related outcomes: An umbrella review of systematic review and meta-analyses. Nutr Diabetes. 2024 May 30;14(1):35. doi: 10.1038/s41387-024-00296-0. PMID: 38816412; PMCID: PMC11139885. ↥
Upadhyaya S, Ståhlberg T, Silwal S, Arrhenius B, Sourander A (2022): Maternal Vitamin D Levels during Pregnancy and Offspring Psychiatric Outcomes: A Systematic Review. Int J Mol Sci. 2022 Dec 21;24(1):63. doi: 10.3390/ijms24010063. PMID: 36613505; PMCID: PMC9820292. ↥ ↥
Kesby JP, Cui X, Ko P, McGrath JJ, Burne TH, Eyles DW (2009): Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci Lett. 2009 Sep 18;461(2):155-8. doi: 10.1016/j.neulet.2009.05.070. PMID: 19500655. ↥
Pertile RA, Cui X, Eyles DW (2016): Vitamin D signaling and the differentiation of developing dopamine systems. Neuroscience. 2016 Oct 1;333:193-203. doi: 10.1016/j.neuroscience.2016.07.020. PMID: 27450565. ↥
van Rooij D, Mou Y, White T, Voortman T, Jansen PW, Buitelaar JK (2025): Prenatal Vitamin D, Multivitamin, and Folic Acid Supplementation and Brain Structure in Children with ADHD and ASD Traits: The Generation R Study. Nutrients. 2025 Sep 17;17(18):2979. doi: 10.3390/nu17182979. PMID: 41010504; PMCID: PMC12472298. ↥
Sucksdorff, Brown, Chudal, Surcel, Hinkka-Yli-Salomäki, Cheslack-Postava, Gyllenberg, Sourander (2019): Maternal Vitamin D Levels and the Risk of Offspring Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2019 Dec 18. pii: S0890-8567(19)32232-4. doi: 10.1016/j.jaac.2019.11.021. n = 2.124 ↥
Morales E, Julvez J, Torrent M, Ballester F, Rodríguez-Bernal CL, Andiarena A, Vegas O, Castilla AM, Rodriguez-Dehli C, Tardón A, Sunyer J (2015): Vitamin D in Pregnancy and Attention Deficit Hyperactivity Disorder-like Symptoms in Childhood. Epidemiology. 2015 Jul;26(4):458-65. doi: 10.1097/EDE.0000000000000292. PMID: 25867115. ↥
Aagaard K, Møllegaard Jepsen JR, Sevelsted A, Horner D, Vinding R, Rosenberg JB, Brustad N, Eliasen A, Mohammadzadeh P, Følsgaard N, Hernández-Lorca M, Fagerlund B, Glenthøj BY, Rasmussen MA, Bilenberg N, Stokholm J, Bønnelykke K, Ebdrup BH, Chawes B (2023): High-dose vitamin D3 supplementation in pregnancy and risk of neurodevelopmental disorders in the children at age 10: A randomized clinical trial. Am J Clin Nutr. 2023 Dec 9:S0002-9165(23)66298-7. doi: 10.1016/j.ajcnut.2023.12.002. PMID: 38072183. N = 496 ↥
Sucksdorff M, Brown AS, Chudal R, Surcel HM, Hinkka-Yli-Salomäki S, Cheslack-Postava K, Gyllenberg D, Sourander A (2021): Maternal Vitamin D Levels and the Risk of Offspring Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry. 2021 Jan;60(1):142-151.e2. doi: 10.1016/j.jaac.2019.11.021. PMID: 31863882; PMCID: PMC8330061. ↥
Thinggaard CM, Dalgård C, Möller S, Christesen HBT, Bilenberg N (2024): Vitamin D status in pregnancy and cord blood is associated with symptoms of attention-deficit hyperactivity disorder at age 5 years: Results from Odense Child Cohort. Aust N Z J Psychiatry. 2024 Aug 16:48674241272018. doi: 10.1177/00048674241272018. PMID: 39152569. ↥
Ye X, Zhou Q, Ren P, Xiang W, Xiao L. The Synaptic and Circuit Functions of Vitamin D in Neurodevelopment Disorders. Neuropsychiatr Dis Treat. 2023 Jul 3;19:1515-1530. doi: 10.2147/NDT.S407731. PMID: 37424961; PMCID: PMC10327924. REVIEW ↥
Strøm, Halldorsson, Hansen, Granström, Maslova, Petersen, Cohen, Olsen (2014): Vitamin D measured in maternal serum and offspring neurodevelopmental outcomes: a prospective study with long-term follow-up. Ann Nutr Metab. 2014;64(3-4):254-61. doi: 10.1159/000365030. n = 850 ↥
López-Vicente, Sunyer, Lertxundi, González, Rodríguez-Dehli, Espada Sáenz-Torre, Vrijheid, Tardón, Llop, Torrent, Ibarluzea, Guxens (2019): Maternal circulating Vitamin D3 levels during pregnancy and behaviour across childhood. Sci Rep. 2019 Oct 15;9(1):14792. doi: 10.1038/s41598-019-51325-3. ↥
Wootton RE, Dack K, Jones HJ, Riglin L, Madley-Dowd P, Borges C, Pagoni P, Roth C, Brantsæter AL, Corfield EC, Stoltenberg C, Øyen AS, Davey Smith G, Ask H, Thapar A, Stergiakouli E, Havdahl A (2024): Testing maternal effects of vitamin-D and omega-3 levels on offspring neurodevelopmental traits in the Norwegian Mother, Father and Child Cohort Study. Psychol Med. 2024 Sep 9;54(12):1-11. doi: 10.1017/S0033291724001466. PMID: 39248077; PMCID: PMC11496238. ↥
Martins, Bandarra, Figueiredo-Braga (2019): The role of marine omega-3 in human neurodevelopment, including Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder – a review. Crit Rev Food Sci Nutr. 2019 Mar 18:1-16. doi: 10.1080/10408398.2019.1573800. REVIEW ↥
López-Vicente M, Ribas Fitó N, Vilor-Tejedor N, Garcia-Esteban R, Fernández-Barrés S, Dadvand P, Murcia M, Rebagliato M, Ibarluzea J, Lertxundi A, Fernández-Somoano A, Tardón A, López-Sabater MC, Romaguera D, Vrijheid M, Sunyer J, Julvez J (2019): Prenatal Omega-6:Omega-3 Ratio and Attention Deficit and Hyperactivity Disorder Symptoms. J Pediatr. 2019 Jun;209:204-211.e4. doi: 10.1016/j.jpeds.2019.02.022. PMID: 30929929. ↥
Koutra, Margetaki, Kampouri, Kyriklaki, Roumeliotaki, Vafeiadi, Bitsios, Kogevinas, Chatzi (2022) Maternal sleep disturbances during late pregnancy and child neuropsychological and behavioral development in early childhood. Eur Child Adolesc Psychiatry. 2022 Aug 4. doi: 10.1007/s00787-022-02053-z. PMID: 35927528. n = 638 Mutter-Kind-Paare / mother-child-pairs ↥
Lugo-Candelas C, Hwei T, Lee S, Lucchini M, Smaniotto Aizza A, Kahn LG, Buss C, O’Connor TG, Ghassabian A, Padula AM, Aschner J, Deoni S, Margolis AE, Canino G, Monk C, Posner J, Duarte CS (2023): Prenatal sleep health and risk of offspring ADHD symptomatology and associated phenotypes: a prospective analysis of timing and sex differences in the ECHO cohort. Lancet Reg Health Am. 2023 Oct 9;27:100609. doi: 10.1016/j.lana.2023.100609. PMID: 38106969; PMCID: PMC10725065. N = 794 Mutter-Kind-Paare / mother-child-pairs ↥
Bitsko RH, Holbrook JR, O’Masta B, Maher B, Cerles A, Saadeh K, Mahmooth Z, MacMillan LM, Rush M, Kaminski JW (2022): A Systematic Review and Meta-analysis of Prenatal, Birth, and Postnatal Factors Associated with Attention-Deficit/Hyperactivity Disorder in Children. Prev Sci. 2022 Mar 18:10.1007/s11121-022-01359-3. doi: 10.1007/s11121-022-01359-3. PMID: 35303250; PMCID: PMC9482663. METASTUDY ↥
Takahashi N, Nishimura T, Harada T, Okumura A, Iwabuchi T, Rahman MS, Kuwabara H, Takagai S, Usui N, Makinodan M, Matsuzaki H, Ozaki N, Itoh H, Nomura Y, Newcorn JH, Tsuchiya KJ (2023): Interaction of genetic liability for attention deficit hyperactivity disorder (ADHD) and perinatal inflammation contributes to ADHD symptoms in children. Brain Behav Immun Health. 2023 May 18;30:100630. doi: 10.1016/j.bbih.2023.100630. PMID: 37251547; PMCID: PMC10213186. ↥
Gustafsson HC, Sullivan EL, Battison EAJ, Holton KF, Graham AM, Karalunas SL, Fair DA, Loftis JM, Nigg JT (2020): Evaluation of maternal inflammation as a marker of future offspring ADHD symptoms: A prospective investigation. Brain Behav Immun. 2020 Oct;89:350-356. doi: 10.1016/j.bbi.2020.07.019. PMID: 32707260; PMCID: PMC7703804. ↥
Feleder, Tseng, Calhoon, O’Donnell (2010): Neonatal intrahippocampal immune challenge alters dopamine modulation of prefrontal cortical interneurons in adult rats. Biol Psychiatry. 2010 Feb 15;67(4):386-92. doi: 10.1016/j.biopsych.2009.09.028. PMID: 19914600; PMCID: PMC2900781. ↥
Velloso FJ, Zaritsky R, Houbeika RY, Rios N, Levison SW (2025): Interleukin-6 produces behavioral deficits in pre-pubescent mice independent of neuroinflammation. Brain Behav Immun. 2025 May;126:275-288. doi: 10.1016/j.bbi.2025.02.009. PMID: 39984136. ↥
Ferreira LL, Nardi AE, Quagliato LA (2025): Are parents with bipolar disorder at higher risk of having offspring with ADHD? A systematic review. Trends Psychiatry Psychother. 2025 Jan 3. doi: 10.47626/2237-6089-2024-0797. Epub ahead of print. PMID: 39752609. REVIEW ↥
Nilsen K, Staff AC, Krogsrud SK. Paracetamol use in pregnancy: Not as safe as we may think? Acta Obstet Gynecol Scand. 2023 Mar 20. doi: 10.1111/aogs.14557. PMID: 36941046. ↥
Prada D, Ritz B, Bauer AZ, Baccarelli AA (2025): Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health. 2025 Aug 14;24(1):56. doi: 10.1186/s12940-025-01208-0. PMID: 40804730; PMCID: PMC12351903. METASTUDY ↥
Brandlistuen RE, Ystrom E, Nulman I, Koren G, Nordeng H. Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study. Int J Epidemiol. 2013 Dec;42(6):1702-13. doi: 10.1093/ije/dyt183. PubMed PMID: 24163279; PubMed Central PMCID: PMC3887567. n = 48.631 ↥
Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J. Acetaminophen Use During Pregnancy, Behavioral Problems, and Hyperkinetic Disorders. JAMA Pediatr. 2014 Feb 24. doi: 10.1001/jamapediatrics.2013.4914. PubMed PMID:24566677. n = 64.322 ↥
Woodbury ML, Geiger SD, Schantz SL (2024): The relationship of prenatal acetaminophen exposure and attention-related behavior in early childhood. Neurotoxicol Teratol. 2024 Jan-Feb;101:107319. doi: 10.1016/j.ntt.2024.107319. PMID: 38199313. ↥
Liew, Kioumourtzoglou, Roberts, O’Reilly, Ascherio, Weisskopf (2019): Use of Negative Control Exposure Analysis to Evaluate Confounding: An Example of Acetaminophen Exposure and Attention-Deficit/Hyperactivity Disorder in Nurses’ Health Study II. Am J Epidemiol. 2019 Apr 1;188(4):768-775. doi: 10.1093/aje/kwy288. ↥
Masarwa, Levine, Gorelik, Reif, Perlman, Matok (2019): Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies. Am J Epidemiol. 2018 Aug 1;187(8):1817-1827. doi: 10.1093/aje/kwy086. REVIEW ↥
Gilman, Hornig (2019): The Disillusionment of DOHaD Epidemiology. Am J Epidemiol. 2019 Oct 2. pii: kwz214. doi: 10.1093/aje/kwz214. ↥
Ji, Azuine, Zhang, Hou, Hong, Wang, Riley, Pearson, Zuckerman, Wang (2019): Association of Cord Plasma Biomarkers of In Utero Acetaminophen Exposure With Risk of Attention-Deficit/Hyperactivity Disorderand Autism Spectrum Disorder in Childhood. JAMA Psychiatry. 2019 Oct 30:1-11. doi: 10.1001/jamapsychiatry.2019.3259. ↥
Chen, Pan, Wang, Hsu, Huang, Su, Li, Lin, Tsai, Chen, Bai (2019): Prenatal Exposure to Acetaminophen and the Risk of Attention-Deficit/Hyperactivity Disorder: A Nationwide Study in Taiwan. J Clin Psychiatry. 2019 Sep 10;80(5). pii: 18m12612. doi: 10.4088/JCP.18m12612. n = 950 Mutter-Kind-Paare ↥
Khan, Kabiraj, Ahmed, Adam, Mannuru, Ramesh, Shahzad, Chaduvula, Khan (2022): A Systematic Review of the Link Between Autism Spectrum Disorder and Acetaminophen: A Mystery to Resolve. Cureus. 2022 Jul 18;14(7):e26995. doi: 10.7759/cureus.26995. PMID: 35989852; PMCID: PMC9385573. ↥
Baker BH, Bammler TK, Barrett ES, Bush NR, Collett BR, Derefinko KJ, Enquobahrie DA, Karr CJ, LeWinn KZ, Liu J, Loftus CT, MacDonald JW, Swan SH, Zhao Q, Paquette AG, Sathyanarayana S (2025): Associations of maternal blood biomarkers of prenatal APAP exposure with placental gene expression and child attention deficit hyperactivity disorder. Nat Ment Health. 2025 Mar;3(3):318-331. doi: 10.1038/s44220-025-00387-6. PMID: 40964537; PMCID: PMC12439753. N = 307 ↥
Ricci C, Albanese CM, Pablo LA, Li J, Fatima M, Barrett K, Levis B, Brown HK (2023): In utero acetaminophen exposure and child neurodevelopmental outcomes: Systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2023 Mar 20. doi: 10.1111/ppe.12963. PMID: 36939050. Metaanalyse, N = 367.775 ↥
Masarwa, Platt, Filion (2020): Acetaminophen use during pregnancy and the risk of attention deficit hyperactivity disorder: A causal association or bias? Paediatr Perinat Epidemiol. 2020 Jan 9. doi: 10.1111/ppe.12615. ↥
Damkier (2020): Simple twist of fate: In utero exposure to acetaminophen and risk of childhood Attention Deficit Hyperactivity Disorder. Paediatr Perinat Epidemiol. 2020 May;34(3):230-232. doi: 10.1111/ppe.12654. PMID: 32107788. ↥
Damkier P, Gram EB, Ceulemans M, Panchaud A, Cleary B, Chambers C, Weber-Schoendorfer C, Kennedy D, Hodson K, Grant KS, Diav-Citrin O, Običan SG, Shechtman S, Alwan S (2025): Acetaminophen in Pregnancy and Attention-Deficit and Hyperactivity Disorder and Autism Spectrum Disorder. Obstet Gynecol. 2025 Feb 1;145(2):168-176. doi: 10.1097/AOG.0000000000005802. PMID: 39637384. REVIEW ↥
Worringer E, Rowland K (2024): Acetaminophen use during pregnancy was not linked to autism, ADHD, or intellectual disability in offspring. Ann Intern Med. 2024 Aug;177(8):JC95. doi: 10.7326/ANNALS-24-00960-JC. PMID: 39102714. ↥
Kougias DG, Atillasoy E, Southall MD, Scialli AR, Ejaz S, Chu C, Jeminiwa BO, Massarsky A, Unice KM, Schaeffer TH, Kovochich M (2025): A quantitative weight-of-evidence review of preclinical studies examining the potential developmental neurotoxicity of acetaminophen. Crit Rev Toxicol. 2025 Feb 21:1-55. doi: 10.1080/10408444.2024.2442344. PMID: 39982125. REVIEW ↥
Okubo Y, Hayakawa I, Sugitate R, Nariai H (2025): Maternal Acetaminophen Use and Offspring’s Neurodevelopmental Outcome: A Nationwide Birth Cohort Study. Paediatr Perinat Epidemiol. 2025 Sep 2. doi: 10.1111/ppe.70071. PMID: 40898607. n = 217.602 ↥
Anand, Raghavan, Wang, Hong, Azuine, Pearson, Zuckerman, Xie, Wang (2021): Perinatal Acetaminophen Exposure and Childhood Attention-Deficit/Hyperactivity Disorder (ADHD): Exploring the Role of Umbilical Cord Plasma Metabolites in Oxidative Stress Pathways. Brain Sci. 2021 Sep 30;11(10):1302. doi: 10.3390/brainsci11101302. PMID: 34679367; PMCID: PMC8533963. N = 568 ↥
Klein RM, Motomura VN, Debiasi JD, Moreira EG (2023): Gestational paracetamol exposure induces core behaviors of neurodevelopmental disorders in infant rats and modifies response to a cannabinoid agonist in females. Neurotoxicol Teratol. 2023 Jun 29;99:107279. doi: 10.1016/j.ntt.2023.107279. Epub ahead of print. PMID: 37391024. ↥
Spillers NJ, Talbot NC, Luther PM, Ly GH, Roberts CJ, Ahmadzadeh S, Shekoohi S, Viswanath O, Kaye AD (2024): Prenatal Acetaminophen Exposure and its Associated Risk for Attention Deficit Hyperactivity Disorder. Health Psychol Res. 2024 Nov 12;12:125267. doi: 10.52965/001c.125267. PMID: 39944717; PMCID: PMC11820131. REVIEW ↥
Klinger-Gratz PP, Ralvenius WT, Neumann E, Kato A, Nyilas R, Lele Z, Katona I, Zeilhofer HU (2018): Acetaminophen Relieves Inflammatory Pain through CB1 Cannabinoid Receptors in the Rostral Ventromedial Medulla. J Neurosci. 2018 Jan 10;38(2):322-334. doi: 10.1523/JNEUROSCI.1945-17.2017. PMID: 29167401; PMCID: PMC6596108. ↥
Chu S, Woodfin S, Bayliss E, Smith M, Fulp A, Mirabelli E, Moore W (2025): Acetaminophen’s Role in Autism and ADHD: A Mitochondrial Perspective. Int J Mol Sci. 2025 Sep 3;26(17):8585. doi: 10.3390/ijms26178585. PMID: 40943505; PMCID: PMC12429359. REVIEW ↥
Halvorsen, Hesel, Østergaard, Danielsen (2019): In Utero Exposure to SSRIs and Development of Mental Disorders: A Systematic Review and Meta-analysis. Acta Psychiatr Scand. 2019 Apr 2. doi: 10.1111/acps.13030. METASTUDY ↥
Leshem R, Bar-Oz B, Diav-Citrin O, Gbaly S, Soliman J, Renoux C, Matok I (2021). Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs) During Pregnancy and the Risk for Autism spectrum disorder (ASD) and Attention deficit hyperactivity disorder (ADHD) in the Offspring: A True Effect or a Bias? A Systematic Review & Meta-Analysis. Curr Neuropharmacol. 2021;19(6):896-906. doi: 10.2174/1570159X19666210303121059. PMID: 33655866; PMCID: PMC8686301. METASTUDY ↥
Araujo, Delgado, Paumgartten (2020): Antenatal exposure to antidepressant drugs and the risk of neurodevelopmental and psychiatric disorders: a systematic review. Cad Saude Publica. 2020 Jan 31;36(2):e00026619. doi: 10.1590/0102-311X00026619. PMID: 32022173. REVIEW ↥
Hartwig CAM, Robiyanto R, de Vos S, Bos JHJ, van Puijenbroek EP, Hak E, Schuiling-Veninga CCM (2022): In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design. Front Pharmacol. 2022 Nov 10;13:1000018. doi: 10.3389/fphar.2022.1000018. PMID: 36438827; PMCID: PMC9684082. ↥
Clements, Castro, Blumenthal, Rosenfield, Murphy, Fava, Erb, Churchill, Kaimal, Doyle, Robinson, Smoller, Kohane, Perlis (2015): Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Molecular Psychiatry volume 20, pages 727–734 (2015) n = 3620 ↥
Andrade C (2025): Gestational Exposure to Antidepressants and Neurodevelopmental Disorders in Offspring. J Clin Psychiatry. 2025 Dec 17;87(1):25f16226. doi: 10.4088/JCP.25f16226. PMID: 41405548. REVIEW ↥
Valentino K, Teopiz KM, Kwan ATH, Le GH, Wong S, Rosenblat JD, Mansur RB, Lo HKY, McIntyre RS (2024): Anatomical, behavioral, and cognitive teratogenicity associated with valproic acid: a systematic review. CNS Spectr. 2024 Dec;29(6):604-610. doi: 10.1017/S1092852924002311. PMID: 39727238. METASTUDY ↥
Kinjo, Ito, Seki, Fukuhara, Bolati, Arai, Suzuki (2019): Prenatal exposure to valproic acid is associated with altered neurocognitive function and neurogenesis in the dentate gyrus of male offspring rats. Brain Res. 2019 Aug 22;1723:146403. doi: 10.1016/j.brainres.2019.146403. ↥
Sakade, Yamanaka, Soumiya, Furukawa, Fukumitsu (2019): Exposure to valproic acid during middle to late-stage corticogenesis induces learning and social behavioral abnormalities with attention deficit/hyperactivity in adult mice. Biomed Res. 2019;40(5):179-188. doi: 10.2220/biomedres.40.179. ↥
Baronio D, Puttonen HAJ, Sundvik M, Semenova S, Lehtonen E, Panula P (2018): Embryonic exposure to valproic acid affects the histaminergic system and the social behaviour of adult zebrafish (Danio rerio). Br J Pharmacol. 2018 Mar;175(5):797-809. doi: 10.1111/bph.14124. PMID: 29235100; PMCID: PMC5811620. ↥
Ornoy A, Echefu B, Becker M (2023): Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review. Int J Mol Sci. 2023 Dec 27;25(1):390. doi: 10.3390/ijms25010390. PMID: 38203562; PMCID: PMC10779436. ↥
Laugesen K, Skajaa N, Petersen I, Andersen MS, Feldt-Rasmussen U, Kejlberg Al-Mashhadi S, Stewart P, Jørgensen JOL, Sørensen HT (2025): Mental Disorders Among Offspring Prenatally Exposed to Systemic Glucocorticoids. JAMA Netw Open. 2025 Jan 2;8(1):e2453245. doi: 10.1001/jamanetworkopen.2024.53245. Erratum in: JAMA Netw Open. 2025 Feb 3;8(2):e251744. doi: 10.1001/jamanetworkopen.2025.1744. PMID: 39752154; PMCID: PMC11699534. N = 1.061.548 ↥
Khalife, Glover, Taanila, Ebeling, Järvelin, Rodriguez (2013): Prenatal Glucocorticoid Treatment and Later Mental Health in Children and Adolescents; Plos one, November 22, 2013; https://doi.org/10.1371/journal.pone.0081394, n = 222 ↥
Kapoor, Petropoulos, Matthews (2007): Fetal programming of hypothalamic-pituitary-adrenal (HPA) axis function and behavior by synthetic glucocorticoids. Brain Res Rev. 2008 Mar;57(2):586-95. ↥
Rakers, Schleußner, Muth, Hoyer, Rupprecht, Schiecke, Groten, Dreiling, Kozik, Schwab, Hoyer, Ligges (2022): Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8- to 9-year-old children: A prospective observational study. Acta Obstet Gynecol Scand. 2022 Jun 2. doi: 10.1111/aogs.14386. PMID: 35652410. n = 69 ↥
Rakers F, Schleussner E, Cornelius A, Kluckow S, Muth I, Hoyer D, Rupprecht S, Schultze T, Schiecke K, Ligges C, Schwab M, Hoyer H (2024): Association between prenatal glucocorticoid exposure and adolescent neurodevelopment: An observational follow-up study. Acta Obstet Gynecol Scand. 2024 Aug;103(8):1530-1540. doi: 10.1111/aogs.14885. PMID: 38877646; PMCID: PMC11266634. ↥
Elberling F, Spulber S, Bose R, Keung HY, Ahola V, Zheng Z, Ceccatelli S (2023): Sex Differences in Long-term Outcome of Prenatal Exposure to Excess Glucocorticoids-Implications for Development of Psychiatric Disorders. Mol Neurobiol. 2023 Dec;60(12):7346-7361. doi: 10.1007/s12035-023-03522-5. PMID: 37561236; PMCID: PMC10657788. ↥
Liang, Chen, Miao, Christensen, Dalsgaard, Yuan, Li (2017): In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children. Eur Child Adolesc Psychiatry. 2017 Feb 9. doi: 10.1007/s00787-017-0956-4 n = 672.000 ↥
Dudukina E, Szépligeti SK, Karlsson P, Asomaning K, Daltveit AK, Hakkarainen K, Hoti F, Kieler H, Lunde A, Odsbu I, Rantanen M, Reutfors J, Saarelainen L, Ehrenstein V, Toft G (2023): Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries. Drug Saf. 2023 Apr 26. doi: 10.1007/s40264-023-01307-2. Epub ahead of print. PMID: 37099261. ↥
Green JE, Wrobel A, Todd E, Marx W, Berk M, Lotfaliany M, Castle D, Cryan JF, Athan E, Hair C, Nierenberg AA, Jacka FN, Dawson S (2025): Early antibiotic exposure and risk of psychiatric and neurocognitive outcomes: systematic review and meta-analysis. Br J Psychiatry. 2025 Mar;226(3):171-183. doi: 10.1192/bjp.2024.121. PMID: 39658347. REVIEW ↥ ↥
Fan J, Wu S, Huang C, Xiao D, Tang F (2026): Meta-analysis of the association between prenatal antibiotic exposure and risk of childhood attention-deficit/hyperactivity disorder. J Affect Disord. 2026 Jan 1;392:120168. doi: 10.1016/j.jad.2025.120168. PMID: 40914530. METASTUDY ↥ ↥ ↥ ↥ ↥
Ai, Zhao, Shi, Zhu (2021): Antibiotic exposure and childhood attention-deficit/hyperactivity disorder: systematic review and meta-analysis. Psychopharmacology (Berl). 2021 Oct 23. doi: 10.1007/s00213-021-05989-3. PMID: 34687335. METASTUDY ↥
Tao Q, Shen Y, Li Y, Luo H, Yuan M, Gan J (2022): Prenatal exposure to antibiotics and risk of neurodevelopmental disorders in offspring: A systematic review and meta-analysis. Front Neurol. 2022 Nov 25;13:1045865. doi: 10.3389/fneur.2022.1045865. PMID: 36504646; PMCID: PMC9732381. METASTUDY ↥
Parthasarathy S, Giridharan B, Panigrahi J, Konyak LM, Jamir N, Tharumasivam SV (2025): Abnormal microbiota due to prenatal antibiotic as a possible risk factor for Attention-Deficit / Hyperactivity Disorder (ADHD). Int Rev Neurobiol. 2025;180:299-328. doi: 10.1016/bs.irn.2025.03.007. PMID: 40414636. REVIEW ↥
Xu SC, Zhong Y, Jiang HY, Tang J (2024): Exposure to anti-seizure medication during pregnancy and the risk of autism and ADHD in offspring: a systematic review and meta-analysis. Front Neurol. 2024 Jul 22;15:1440145. doi: 10.3389/fneur.2024.1440145. PMID: 39105059; PMCID: PMC11298387. ↥
Baldwin, Amaro (2019): Prescription of Valproate-Containing Medicines in Women of Childbearing Potential who have Psychiatric Disorders: Is It Worth the Risk? CNS Drugs. 2019 Dec 16. doi: 10.1007/s40263-019-00694-4. ↥
Imhoff-Hasse (2013): Valproatexposition des Fetus I: Risiko für autistische Störungen ist erhöht, Dtsch Arztebl 2013; 110(9): A-386 / B-352 / C-352 unter Verweis auf Bromley, Mawer, Briggs, Cheyne, Clayton-Smith, García-Fiñana, Kneen, Lucas, Shallcross, Baker, Liverpool and Manchester Neurodevelopment Group (2013): The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):637-43. doi: 10.1136/jnnp-2012-304270. ↥
Steele JW, Krishnan V, Finnell RH (2024): Mechanisms of neurodevelopmental toxicity of topiramate. Crit Rev Toxicol. 2024 Aug;54(7):465-475. doi: 10.1080/10408444.2024.2368552. PMID: 38995641; PMCID: PMC11296906. REVIEW ↥
Balasubramanian R, Nallasamy V, Pakkir Maideen NM, Chidambaram K, Amirthalingam P (2025): Clinical insights on the complications of TPM use during pregnancy-enabling expectant mothers to make informed choices for their health and the future of their offspring. Eur J Obstet Gynecol Reprod Biol. 2025 Sep;313:114614. doi: 10.1016/j.ejogrb.2025.114614. PMID: 40716154. REVIEW ↥
Podgorac Kojadinović J, Stojadinović G, Popović S, Sekulić S (2025): ADHD-like behaviors in adolescent mice prenatally exposed to levetiracetam: No safe gestational dose across sexes. Pharmacol Biochem Behav. 2025 Nov;256:174091. doi: 10.1016/j.pbb.2025.174091. PMID: 40858228. ↥
Soyer-Gobillard MO, Gaspari L, Sultan C (2025): In utero exposure to synthetic sex hormones and their multigenerational impact on neurodevelopmental disorders: Endocrine disruptors as neuroendocrine disruptors. J Neurol Sci. 2025 May 15;472:123471. doi: 10.1016/j.jns.2025.123471. PMID: 40187226. REVIEW ↥
Lau-Jensen SH, Asschenfeldt B, Evald L, Hjortdal VE (2021): Hyperactivity and Inattention in Young Patients Born With an Atrial Septal or Ventricular Septal Defect. Front. Pediatr. 9:786638. doi: 10.3389/fped.2021.786638 ↥
Cheslack-Postava, Sourander, Suominen, Jokiranta-Olkoniemi, McKeague, Brown (2020): Increased Risk of ADHD at Short and Long Interpregnancy Intervals in a National Birth Cohort. Paediatr Perinat Epidemiol. 2020 Mar 12. doi: 10.1111/ppe.12657. PMID: 32162359. n = 44.043 ↥
Choi HM, Huybrechts KF, Hernandez-Diaz S, Qiu X, Leung M, James P, Shupler M, Huang W, Wei Y, Zanobetti A, McDougle CJ, Schwartz J, Coull B, Weisskopf M, Papatheodorou S (2025): Preconception, prenatal and early childhood exposure to green space and risk of neurodevelopmental delays: a national cohort study among Medicaid enrollees. Environ Int. 2025 Aug;202:109666. doi: 10.1016/j.envint.2025.109666. PMID: 40639188; PMCID: PMC12380237. N = 1.841.915 mother-child-pairs ↥
Mujtaba S, Patro IK, Patro N (2023): Multiple Early Life Stressors as Risk Factors for Neurodevelopmental Abnormalities in the F1 Wistar Rats. Brain Sci. 2023 Sep 22;13(10):1360. doi: 10.3390/brainsci13101360. PMID: 37891729; PMCID: PMC10605318. ↥
Horner D, Jepsen JRM, Chawes B, Aagaard K, Rosenberg JB, Mohammadzadeh P, Sevelsted A, Vahman N, Vinding R, Fagerlund B, Pantelis C, Bilenberg N, Pedersen CT, Eliasen A, Brandt S, Chen Y, Prince N, Chu SH, Kelly RS, Lasky-Su J, Halldorsson TI, Strøm M, Strandberg-Larsen K, Olsen SF, Glenthøj BY, Bønnelykke K, Ebdrup BH, Stokholm J, Rasmussen MA (2025): A western dietary pattern during pregnancy is associated with neurodevelopmental disorders in childhood and adolescence. Nat Metab. 2025 Mar;7(3):586-601. doi: 10.1038/s42255-025-01230-z. PMID: 40033007. n = 61.237 ↥
Dingess, Thakar, Zhang, Flynn, Brown (2018): High-Salt Exposure During Perinatal Development Enhances Stress Sensitivity. Dev Neurobiol. 2018 Nov;78(11):1131-1145. doi: 10.1002/dneu.22635. ↥
Levie, Bath, Guxens, Korevaar, Dineva, Fano, Ibarluzea, Llop, Murcia, Rayman, Sunyer, Peeters, Tiemeier (2020): Maternal Iodine Status During Pregnancy Is Not Consistently Associated with Attention-Deficit Hyperactivity Disorder or Autistic Traits in Children. J Nutr. 2020 Jun 1;150(6):1516-1528. doi: 10.1093/jn/nxaa051. PMID: 32171006; PMCID: PMC7269752. ↥
Gao X, Zhao Y, Wang N, Yang L. (2022): Migration modulates the prevalence of ASD and ADHD: a systematic review and meta-analysis. BMC Psychiatry. 2022 Jun 13;22(1):395. doi: 10.1186/s12888-022-04037-4. PMID: 35698047; PMCID: PMC9195277. METASTUDIE ↥
Díaz-López A, Sans JC, Julvez J, Fernandez-Bares S, Llop S, Rebagliato M, Lertxundi N, Santa-Marina L, Guxens M, Sunyer J, Arija V (2022): Maternal iron status during pregnancy and attention deficit/hyperactivity disorder symptoms in 7-year-old children: a prospective cohort study. Sci Rep. 2022 Dec 1;12(1):20762. doi: 10.1038/s41598-022-23432-1. PMID: 36456588; PMCID: PMC9715623. N = 1.204 ↥
Angel P, Hermansen M, Ramlau-Hansen CH, Gaml-Sørensen A, Kristensen DM, Lindahl-Jacobsen R (2025): Neurodevelopmental or behavioral disorders in children conceived after assisted reproductive technologies: a nationwide cohort study. Fertil Steril. 2025 Apr;123(4):665-676. doi: 10.1016/j.fertnstert.2024.10.017. PMID: 39426700. ↥
Islam MI, Chaffey OA, Chadwick V, Martiniuk A (2024): Mental health in children conceived by Assisted Reproductive Technologies (ARTs): Insights from a longitudinal study of Australian children. PLoS One. 2024 Jun 27;19(6):e0304213. doi: 10.1371/journal.pone.0304213. PMID: 38935695; PMCID: PMC11210819. ↥
Talbot C, Hodson N, Rose J, Bewley S (2024): Comparing the psychological outcomes of donor and non-donor conceived people: A systematic review. BJOG. 2024 Dec;131(13):1747-1759. doi: 10.1111/1471-0528.17892. PMID: 38936405. ↥
Lo H, Weng SF, Tsai EM (2022): Neurodevelopmental Disorders in Offspring Conceived via In Vitro Fertilization vs Intracytoplasmic Sperm Injection. JAMA Netw Open. 2022 Dec 1;5(12):e2248141. doi: 10.1001/jamanetworkopen.2022.48141. PMID: 36547980. ↥
Li, Chen, Ferber, Hirst, Odouli (2020): Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort. JAMA Netw Open. 2020 Mar 2;3(3):e201417. doi: 10.1001/jamanetworkopen.2020.1417. PMID: 32207831; PMCID: PMC7093768. N = 1.454 Mutter-Kind Paare ↥
Li DK (2020): Notice of Retraction and Replacement. Li et al. Association Between Maternal Exposure to Magnetic Field Nonionizing Radiation During Pregnancy and Risk of Attention-Deficit/Hyperactivity Disorder in Offspring in a Longitudinal Birth Cohort. JAMA Netw Open. 2020;3(3):e201417. JAMA Netw Open. 2021 Feb 1;4(2):e2033605. doi: 10.1001/jamanetworkopen.2020.33605. PMID: 33599776. ↥
Hjorth, Lupattelli, Handal, Spigset, Ystrom, Nordeng (2021): Prenatal Exposure to Non-Steroidal Anti-Inflammatory Drugs and Risk of Attention-Deficit/Hyperactivity Disorder – a Follow-Up Study in the Norwegian Mother, Father and Child Cohort. Pharmacoepidemiol Drug Saf. 2021 Apr 18. doi: 10.1002/pds.5250. PMID: 33866622. n = 56 340 / 34 961 ↥
Brandlistuen, Eivind Ystrom, Hernandez-Diaz, Skurtveit, Selmer, Handal, Nordeng, Sasayama (2017): Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study; PLoS One. 2017; 12(7): e0181042. doi: 10.1371/journal.pone.0181042; PMCID: PMC5528839; n = 71.996 ↥
Chen VC, Wu SI, Lin CF, Lu ML, Chen YL, Stewart R (2022): Association of Prenatal Exposure to Benzodiazepines With Development of Autism Spectrum and Attention-Deficit/Hyperactivity Disorders. JAMA Netw Open. 2022 Nov 1;5(11):e2243282. doi: 10.1001/jamanetworkopen.2022.43282. PMID: 36413366; PMCID: PMC9682429. N = 1.516.846 ↥
Suarez EA, Bushnell GA (2022): Association Between Attention-Deficit/Hyperactivity Disorder and Benzodiazepines and Z-Hypnotics in Pregnancy-Questions Remain. JAMA Netw Open. 2022 Dec 1;5(12):e2246896. doi: 10.1001/jamanetworkopen.2022.46896. PMID: 36520443. METASTUDIE ↥
Chan AYL, Gao L, Howard LM, Simonoff E, Coghill D, Ip P, Lau WCY, Taxis K, Wong ICK, Man KKC (2023): Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study. Psychother Psychosom. 2023 Mar 10:1-11. doi: 10.1159/000529141. PMID: 36907183. ↥
Stokholm L, Juhl M, Talge NM, Gissler M, Obel C, Strandberg-Larsen K (2021): Obstetric oxytocin exposure and ADHD and ASD among Danish and Finnish children. Int J Epidemiol. 2021 May 17;50(2):446-456. doi: 10.1093/ije/dyaa076. PMID: 32535618. ↥
Instanes JT, Solberg BS, Kvalvik LG, Klungsøyr K, Posserud MR, Hartman CA, Haavik J (2024): Organic food consumption during pregnancy and symptoms of neurodevelopmental disorders at 8 years of age in the offspring: the Norwegian Mother, Father and Child Cohort Study (MoBa). BMC Med. 2024 Oct 21;22(1):482. doi: 10.1186/s12916-024-03685-5. PMID: 39428456; PMCID: PMC11492991. ↥
Camanni M, van Gelder MMHJ, Cantarutti A, Nordeng H, Lupattelli A (2025): Association of Prenatal Exposure to Triptans, Alone or Combined With Other Migraine Medications, and Neurodevelopmental Outcomes in Offspring. Neurology. 2025 Jun 24;104(12):e213678. doi: 10.1212/WNL.0000000000213678. PMID: 40397854. ↥
Cleary EN, Sujan AC, Rickert ME, Fischer F, Lagerberg T, Chang Z, Lichtenstein P, Quinn PD, Öberg AS, D’Onofrio BM (2025): Prescribed opioid analgesic use in pregnancy and risk of neurodevelopmental disorders in children: A retrospective study in Sweden. PLoS Med. 2025 Sep 16;22(9):e1004721. doi: 10.1371/journal.pmed.1004721. PMID: 40956781; PMCID: PMC12440195. ↥
Liu Y, Jiang H, Nie Z, Yu B, Qiu X, Zuo H, Han S (2024): Association between maternal exercise during pregnancy and attention-deficit/hyperactivity disorder among preschool children in Southwest China. Front Public Health. 2024 Nov 27;12:1493580. doi: 10.3389/fpubh.2024.1493580. PMID: 39664546; PMCID: PMC11631731. N = 4.184 ↥
Solberg BS, Kvalvik LG, Instanes JT, Hartman CA, Klungsøyr K, Li L, Larsson H, Magnus P, Njølstad PR, Johansson S, Andreassen OA, Bakken NR, Bekkhus M, Austerberry C, Smajlagic D, Havdahl A, Corfield EC, Haavik J, Gjestad R, Zayats T (2023): Maternal fiber intake during pregnancy and development of Attention-Deficit/Hyperactivity Disorder Symptoms Across Childhood: The Norwegian Mother, Father and Child Cohort Study (MoBa). Biol Psychiatry. 2023 Dec 22:S0006-3223(23)01794-8. doi: 10.1016/j.biopsych.2023.12.017. PMID: 38142720. ↥
Cendra-Duarte E, Canals J, Iglesias-Vázquez L, Jardí C, Martín-Luján F, Arija V (2024): Adherence to the Mediterranean diet during pregnancy and behavioural problems at 4 years of age. Matern Child Nutr. 2024 Oct;20(4):e13700. doi: 10.1111/mcn.13700. PMID: 38990125; PMCID: PMC11574668. N = 231 ↥